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ABSTRACT 
Cortney L. Cavanaugh: APPLICATIONS OF ORGANIC PHOTOREDOX CATALYSIS IN 
THE DEVELOPMENT OF ALKENE FUNCTIONALIZATION METHODS TOWARD THE 
SYNTHESIS OF α–BENZYLOXYAMINO- AND HALO-LACTONES 
(Under the direction of David A. Nicewicz) 
I. Introduction To Organic Photoredox Catalysis 
An overview of the photophysical and electrochemical components of organic photoredox 
catalysis and its applications in alkene functionalization reactions is addressed. 
II. Synthesis of α-Benzyloxyamino-γ-Butyrolactones Via a Polar Radical Crossover 
Cycloaddition Reaction  
 
The development of a direct catalytic synthesis of substituted α-benzyloxyamino-γ-
butyrolactones, beginning from simple oxime acids and alkenes, is discussed. The substituted O-
benzyloxime acid starting materials undergo cyclization with oxidizable alkenes, via Polar 
Radical Crossover Cycloaddition (PRCC) reactions. The catalytic reaction is carried out using an 
acridinium photooxidant and substoichiometric amounts of a redox-active cocatalyst. The utility 
of this methodology is demonstrated through the cyclization of 3 oxime acids and 19 oxidizable 
olefins to generate 21 highly substituted α-amino lactone products.   
III. Reversing The Regioselectivity Of Halofunctionalization Reactions Through 
Cooperative Photoredox And Copper Catalysis 
 
A novel method for reversing the regioselectivity of classic alkene halofunctionalization 
reactions is presented. This transformation relies on the implementation of a dual-catalytic 
system, incorporating the use of an acridinium photoredox catalyst in conjunction with a 
coppercocatalyst. The utility of the method is demonstrated through the application of chloro-
 iv 
and bromo-functionalization conditions in both an intra- and intermolecular fashion. Over 15 
synthetically and biologically relevant halo-lactones are accessed in a highly regioselective 
fashion. 
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CHAPTER ONE: INTRODUCTION TO ORGANIC PHOTOREDOX CATALYSIS 
1.1 Introduction  
Modern advances in photoredox catalysis stemmed from work out of the late 1970s and have 
continued to greatly impact recent synthetic methods.1–3 Over the past 40 years, the number of 
papers published annually in the field of organic photoredox catalysis has increased substantially 
approaching nearly 200 in 2015.4 These data are a direct reflection of the groundbreaking and 
exciting advancements being made in the field, garnering significant attention in both academia 
and industry. A major asset to using photon-absorbing catalysts (i.e. photoredox catalysts) is the 
ability to accesses unique substrate reactivity, which has been considered difficult, or even 
impossible, under classic organic reaction conditions. While significant advances have been 
made in the field of visible light photoredox catalysis using transition metal complexes,5 it is 
worth focusing directly on the rapidly advancing, distinctive field of organic photoredox 
catalysis, in which the Nicewicz laboratory and this thesis are grounded. 
1.2 The Photophysical and Electrochemical Components of Photoredox Catalysis 
At their foundation, organic photoredox catalysts are highly prized as participants in a 
process known as photoinduced electron transfer or PET. This term refers, overall, to an electron 
transfer event that occurs between an excited state and ground state molecule.6 In the case of 
visible light organic photoredox catalysis, the excited state refers to that of an organic 
chromophore. When the chromophore absorbs visible light (hυ), an electronically excited 
molecule is formed as an electron is promoted to a higher energy state from its original ground 
state (S0). The direct excitation from the ground singlet state to the first singlet excited state (S1) 
 2 
can be represented with a Jablonski diagram (Figure 1-1).7 Though many singlet excited states, 
of varying vibrational energy exist and may be accessed, non-radiative relaxation to the lowest 
energy S1 state occurs in a matter of picoseconds. The fate of S1 is dependent on both radiative 
and non-radiative photophysical pathways. A radiative pathway, for S1 to return to S0, involves 
the dissipation of energy in the form of a photon and is termed fluorescence. Two potential non-
radiative pathways may also dictate the fate of S1. Similar to fluorescence, S1 may also return to 
S0 through internal conversion (IC), however, in this case, the loss of energy is thermal. The final 
process is intersystem crossing (ISC) and involves the transition of S1 to T1, the first triplet 
excited state. This process is spin forbidden and is therefore slow. Upon entering T1, an 
additional radiative pathway, known as phosphorescence, may occur, allowing T1 to return to S0. 
This transition may also involve non-radiative pathways. 
 
	
Figure 1-1. Jablonski Diagram and a Simplistic View of Excitation/ISC 		
As a result of entering S1 or T1, organic chromophores become capable of participating in an 
electron transfer process. In principle, the excited state catalyst can act as an oxidant or 
reductant. This interaction may involve electron transfer in two directions; the excited state of 
the photoredox catalyst may donate an electron to the substrate, through an oxidative quenching 
process, or it may accept an electron through a reductive quenching cycle. To gain a thorough 
ΔG +hv
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S1
T1
v0
vn
-hv
-hv
non-radiative process
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Fluorescence
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understanding of the transformations to be discussed herein, an emphasis will be placed on 
exploring electron transfer through the reductive quenching cycle of photoredox catalysts. 
In this relationship, the photon-absorbing catalyst acts as an acceptor molecule (A), while the 
substrate functions as the donor molecule (D) (Figure 1-2). This simplified model demonstrates 
the interactions between the corresponding molecular orbitals of the catalyst and substrate in 
their ground and excited states. In the ground state, the acceptor molecule possesses a highest 
occupied molecular orbital (HOMO) and a lowest unoccupied molecular orbital (LUMO) that are 
each lower in energy than that of the corresponding HOMO and LUMO for the donor. As a 
result of these relative energy levels, electron transfer in either direction (A → D or D → A) is 
endergonic and therefore unfavorable. However, upon excitation by visible light, A is capable of 
accessing its excited state (A*), transferring an electron from its HOMO to its LUMO. The 
newly formed vacancy in the former HOMO of A* makes it an excellent excited state oxidant as 
it is more easily reduced than its ground state counterpart. As a result, single electron transfer 
(SET) from the HOMO of D to the lower energy SOMO (singularly occupied molecular orbital) 
of A* allows for the oxidation of D to an electron-deficient D+ species and the concurrent 
reduction of A* to the electron-rich A- species.  
 
				 	
Figure 1-2. Single Electron Transfer Model 
 
While this PET process is highly desirable for the single electron oxidation of organic 
substrates by a photoredox catalyst, its efficiency can be limited by an unproductive back 
A
D
A*
D
A
D
A
D
HOMO
LUMO +hv SET BET
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electron transfer (BET) pathway. BET is a general term associated with any event in which A- 
transfers an electron back to D+. This process may occur as a result of a close physical 
relationship between the radical ion pairs and is also a highly exergonic, competitive pathway.8 
To help promote forward electron transfer and limit BET, more polar solvents can be utilized as 
they stabilize polar intermediates and promote the separation of the radical ion pairs.9 The 
excited state from which PET occurs can either be the singlet or triplet state, though reaction 
efficiency is higher for those occurring from the latter.10 Though an acceptor in S1 possesses a 
higher oxidizing ability, PET from this state is less efficient than that from T1. This is a direct 
result of the long-lived nature of T1, which provides sufficient time for the species to diffuse, 
collide, and undergo electron transfer. The slower rate of BET associated with the triplet state 
allows for the radical ion pair to separate sufficiently before the unproductive event can occur. In 
order to achieve successful PET and limit BET, an appropriate acceptor/donor system must be 
identified.  
To aid in this determination, a general equation can be applied to identify the likelihood of a 
PET event occurring.6 Before considering the photoinduced transfer event, it is worth 
considering the equation that describes the Gibbs free energy of a single electron transfer event 
occurring in the ground state (Equation 1-1). This equation relates the redox potentials for A and 
D, undergoing reduction (!!"#) and oxidation (!!") events, respectively. It is worth clarifying 
the nomenclature and noting that that !!"# specifically refers to the single electron reduction of 
A to A- (A→A-, !!/!(A/A-)) and this value, measured in volts (V), is usually negative for most 
acceptors in the ground state. This value is associated with the fact noted previously, that single 
electron reduction of the acceptor molecule, in its ground state, is generally thermodynamically 
unfavorable. The oxidation potential of D, or !!", is technically defined as the reduction half 
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potential and is associated with the D+ to D reaction (D+ → D, !!/!(D+/D)). Unlike the 
reduction of A, the single electron reduction of D+ is generally an energetically favorable 
process and results in a positive voltage value.  
 
Equation 1-1. Gibbs Free Energy of Single Electron Transfer   
 ∆!!" =  −! !!"# −  !!" =  −!(!!/!(!/!⋅!)  −  !!/!(!⋅!/!)) 
 
  
 
 
Having considered single electron transfer in the ground state, the equation for PET can now 
be explored. The free energy of PET occurring between the excited state photoredox catalyst 
acceptor (where A = cat*) and a ground state substrate (D = sub) can be modeled by Equation 1-
2, where Coulombic interactions are disregarded. Here, !!"#∗  refers to the excited state reduction 
potential for the photoredox catalyst under consideration and can be calculated according to 
Equation 1-3. The excited state energy (!!,! ) refers to the transition between the lowest 
vibrational state of S1 or T1 to that of S0. This value can be estimated at the midpoint between the 
absorption and emission maxima from the overlaid spectra.  
 
Equation   1-2. Gibbs Free Energy of PET   
 ∆!!"# =  −!(!!"#∗ (!"#∗/!"# ⋅!) − !!"(!"#⋅!/!"#)) 
 
 
 
Equation 1-3. Excited State Reduction Potential of Photoredox Catalyst  
 
  !!"#∗ (!"#∗/!"# ⋅!)  =  !!"#(!"#/!"# ⋅!)  +  !!,! 
 
! = Faraday’s constant (23.061 kcal V-1 mol-1)	
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While a significant amount of information is contained within these equations, a valuable 
tool can be simplified from the mathematical relationship to determine the likelihood of a 
proposed PET between a photoredox catalyst and a substrate. A successful photoinduced 
electron transfer event is possible when !!"#∗  in more positive than !!"  of the substrate. 
Determining the feasibility of an electron transfer event can aid in the selection of a photoredox 
catalyst depending on substrate that is to be oxidized.6 
Cyclic voltammetry is commonly employed to measure the redox potential for a given 
substrate. From the cyclic voltammogram (CV), one can identify the oxidation potential for an 
organic compound by estimating the potential at half the maximum current, also known as the 
half-peak potential. A series of potentials, for a variety of organic functional groups, was 
reported by Roth et al.11 in 2016, to aid in the selection of an effective catalyst-substrate pairing. 
An abbreviated collection of these substrates, and the range for their corresponding potentials, 
are represented in Figure 1-3 with the values reported against a saturated calomel electrode 
(SCE). These potentials can be compared to the excited state reduction potential of some 
commonly used organic photoredox catalysts.6,12 Often, these catalysts are combined with 
sufficiently oxidizable substrates to carry out single electron oxidation of the organic donor 
molecule to generate reactive cation radical intermediates. 
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Figure 1-3. Series of Potentials for Various Organic Functional Groups and Catalysts 		
Early evidence for gaining access to these valuable cation radical intermediates through PET 
was first provided in groundbreaking work by the Arnold lab.13 While studying 
photocycloadditions, it was observed that when 1,1-diphenylethylene was reacted with methyl 4-
cyanobenzoate in acetonitrile an unexpected product had formed (Scheme 1-1). Ultimately, it 
was determined that the product corresponded to tetrahydronaphthalene product 1.2 and formed 
as a result of single electron oxidation of the olefin by 4-cyanobenzoate to generate the 
corresponding cation radical 1.1. Upon reacting with another equivalent of 1,1-diphenylethylene 
and ring closure, the observed product was formed. Arnold expanded this transformation to 
include an intermolecular variant in which alcohols, such as methanol and isopropanol were used 
as solvents to generate the corresponding ether products in an anti-Markovnikov fashion.  
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Scheme 1-1. Cyclization of 1,1-Diphenylethylene via Cation Radical Intermediate Formation   
	
 
From these results, it was concluded that, upon nucleophilic trapping of the cation radical, 
two potential carbon-centered radicals might form. However, the more populated form was that 
of the more stabilized radical, resulting in formation of the observed alkene functionalization 
product (Scheme 1-2). This pioneering work, towards the development of cation radical-
mediated anti-Markovnikov functionalization, was expanded upon by both Arnold14 and 
Gassman.15,16 While impressive, initial results in the fields were limited by nearly stoichiometric 
use of the photooxidant and undesirable reactivity and byproduct formation.  
 
Scheme 1-2. Anti-Markovnikov Functionalization of Alkenes via Cation Radical Intermediate  
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1.3 Organic Photoredox Catalysis and its Applications in Anti-Markovnikov Alkene 
Hydrofunctionalization 
 
The functionalization of alkenes through the addition of a proton and heteroatom across the 
double bond is one of the oldest and most applied transformations in organic chemistry. 
Typically, this reaction leads to the corresponding Markovnikov product. While this reactivity is 
often desirable, a significant amount of attention has been directed towards reversing the 
regioselectivity of olefin hydrofunctionalization reactions to favor the more elusive anti-
Markovnikov adduct.  
In response to this interest in developing anti-Markovnikov alkene functionalization 
methods, and based on precedent from within the field, the Nicewicz lab has turned its attention 
towards the development of an organic photoredox-mediated method, with a specific focus on 
identifying an effective catalytic variant. We have developed and applied methods for accessing 
anti-Markovnikov hydrofunctionalization products through PET between organic photoredox 
catalysts and olefin substrates. This method relies on the formation of a uniquely reactive cation 
radical intermediate and has proven to be a general approach towards alkene functionalization. In 
order to achieve the desired catalytic reactivity, we have applied a dual organic catalyst system in 
the transformation, utilizing an acridinium photoredox catalyst and a redox active, organic, 
hydrogen atom donor.  
Since our seminal publication in 2012, this methodology has been applied to the anti-
Markovnikov addition of alcohols,17 carboxylic acids,18 amines,19 trifluoromethyl groups,20 and 
mineral acids21 in the presence of a hydrogen atom source (Scheme 1-3). A variety of electron-
rich olefins were successfully functionalized, regioselectivly, using this novel method. This 
photoredox-meditated transformation was also expanded upon to include the synthesis of a 
variety of heterocycles through a related Polar Radical Crossover Cycloaddition (PRCC) reaction 
	 10 
approach.22–24 Though this approach has proven to be a highly successful method of 
functionalizing alkenes in a regioselective fashion, a substantial amount of attention has been 
placed on understanding the general transformation. Specifically, the identity of the organic 
photoredox catalyst (Figure 1-3) and hydrogen atom donor cocatalyst has required a thorough 
analysis to develop an optimal and effective dual catalytic process. 
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Scheme 1-3. Previous Anti-Markovnikov Hydrofunctionalization Methods Developed by 
Nicewicz et al. 	
	
 
1.3.1 Selecting an Effective Organic Photoredox Catalyst 
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expected to proceed through the single electron oxidation of olefins, the organic dye of choice 
would need to be capable of oxidizing a variety of alkenes, with a wide range of oxidation 
potentials, to ensure a thorough and diverse substrate scope. In order to ensure optimal reactivity, 
the photocatalyst would also need to exhibit key characteristics including the ability to undergo 
excitation upon irradiation with visible light, a sufficient fluorescence lifetime and quantum 
yield, and it must undergo limited, unproductive BET. Lastly, to access catalytic reactivity, the 
chromophore of choice would need to exhibit redox reversibility, ensuring that the catalyst 
would remain intact and could be turned over in the presence of a suitable oxidant. Upon an 
exploration of the literature, it was determined that 9-mesityl-10-methylacridinium (NMA), as 
disclosed by Fukuzumi, would best embody these characteristics and could be successfully 
applied as a photoredox catalyst in the hydrofunctionalization of alkenes.25 
 The photophysical characteristics of the acridinium catalyst lend itself well towards its 
incorporation into our hydrofunctionalization methodology (Figure 1-4).6 Firstly, the excited 
state reduction potential of NMA is +2.18 V vs SCE. With such a highly positive potential, 
NMA gives access to a variety of olefin substrates that are capable of being oxidized to their 
corresponding cation radical intermediate. Additionally, the excited state of the acridinium can 
be achieved through irradiation by visible light. While the absorbance maximum is reported to be 
425 nm for NMA, it is best to irradiate at the highest possible wavelength to prevent potentially 
competing photochemical pathways. Light emitting diodes (LEDs) have proven to be an asset in 
the development of photoredox mediated methods, as they are efficient, high-intensity light 
sources that are selective due to their narrow emission band. As a result, commercially available 
blue LEDs can be applied when NMA is used as a photoredox catalyst.  
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Figure 1-4. Photophysical Properties of 9-Mesityl-10-Methylacridinium Photoredox Catalyst 
     
 
Before it can be applied in synthesis, it is necessary to determine whether a photoredox 
catalyst can efficiently undergo PET with a given substrate. This determination is based on the 
fluorescence lifetime (τf). Longer lifetimes are indicative of photooxidants that are more likely to 
undergo PET with a substrate. Those exhibiting a lifetime of less than 1 ns will be unlikely to 
undergo efficient PET. The fluorescence lifetime of NMA is 6 ns, and while not impressively 
long, the value indicates that the acridinium is capable of undergoing PET. The likelihood of 
PET can also be gathered from the fluorescence quantum yield (ϕf) for a given catalyst. A value 
close to one indicates that PET from S1 could be more efficient as deactivation pathways are 
limited. That is, nearly all molecules in S1 undergo fluorescence rather than relaxing through a 
nonradiative pathway. With a ϕf of 0.035, nonradiative pathways are considered competitive but 
the value has proven to be sufficiently high to make NMA an effective photoredox catalyst.6 Not 
all of these nonradiative processes are deleterious however. For example, ISC would allow for 
PET to still occur efficiently from T1 despite the fact that it is lower in energy. Evidence has 
shown that NMA has a variety of singlet and triplet states that are capable of oxidizing organic 
substrates. Lastly, the acridinium cationic structure lends itself well to preventing back electron 
transfer as its overall positive charge, prior to electron transfer, makes it less likely to transfer the 
electron back to the oxidized substrate. A critical characteristic of NMA is its ability to be 
N
Me
Me
Me
Me
NMA
	 14 
efficiently turned over by a co-oxidant. The delicate balance between the photoredox catalyst and 
cocatalyst system has been explored closely through a series of mechanistic studies.  
1.4 Mechanistic Insight  
Ultimately, a suitable photoredox catalyst must successfully interact with all of the 
hydrofunctionalization reaction components as a cohesive, redox neutral system. As discussed 
previously, in order to achieve a net redox-neutral transformation, the photocatalyst’s reductive 
quenching cycle must be coupled with an additional oxidative quenching cycle. Through a series 
of reports, it was determined that NMA functions effectively in a system with a redox active 
hydrogen atom donor such as phenylmalononitrile (PMN).17,22 However, it was discovered that 
higher yields and shorter reaction times could be achieved using thiophenol (PhSH) and diphenyl 
disulfide ((PhS)2) as alternative hydrogen atom donors. An exploration of a general reaction 
mechanism is necessary to illustrate how the photoredox catalyst and cocatalyst function together 
to afford the generation of an anti-Markovnikov, alkene hydrofunctionalization product (Scheme 
1-4). Initially, olefin substrate 1.3 undergoes single electron transfer to an excited state 
acridinium NMA* to afford the characteristic cation radical intermediate (1.4). This intermediate 
can be detected through laser flash photolysis.26 Nucleophilic trapping of the cationic component 
affords the more stable (1.5) of the two potential carbon-centered radicals. The 
hydrofunctionalized product (1.7) is generated upon deprotonation and trapping of the radical 
intermediate (1.6) through efficient hydrogen atom transfer (HAT) by the thiophenol cocatalyst.  
 
 
 
 
 
	 15 
Scheme 1-4. General Mechanism for Anti-Markovnikov Alkene Hydrofunctionalization  	
			 	
 
A critical point in the transformation is where the two catalytic cycles intersect. As a result of 
HAT, a phenylthiyl radical (PhS) is generated which can function as a one-electron oxidant to 
turn over the acridine radical (NMA). The reduction potential of the thiyl radical (!!/!!"# = +0.16 
V vs. SCE) indicates that it is sufficiently oxidizing to undergo an exergonic electron transfer 
with NMA (!!/!!"# = -0.55 V vs. SCE).26 The thiophenol catalyst can be regenerated upon 
protonation of the resulting thiolate (PhS-) by an equivalent of substrate. Interestingly, the 
hydrogen atom donor cocatalyst serves multiple purposes in the production of product by 
functioning as an electron, hydrogen atom, and proton transfer agent throughout the reaction. 
An interesting observation was made when it was determined that diphenyl disulfide also 
functioned effectively as a HAT agent. The concept of using diphenyl disulfide was initially 
proposed after observing its formation as a byproduct during reactions that used thiophenol as a 
cocatalyst. The inverse observation was also noted when diphenyl disulfide was applied as a 
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HAT catalyst. It was hypothesized that the disulfide undergoes homolytic cleavage upon 
irradiation by visible light, ultimately generating thiophenol in situ. To support this proposed 
pathway, a crossover experiment was conducted in which diphenyl disulfide (1.8) was irradiated 
in the presence of 4-methyl diphenyl disulfide (1.9) and NMA (Scheme 1-5).26 The mixed-
disulfide product (1.10) was obtained along with the symmetric disulfides (1.8 and 1.9) as a 2:1:1 
mixture. These results were also observed when NMA was left out of the reaction conditions but 
no exchange was noted when the reaction was conducted in the dark, even when heated. In 
combination, these results strongly supported the visible light induced homolytic cleavage of 
diphenyl disulfide. 
 
 
 Scheme 1-5. Diaryl Disulfide Crossover Experiment 
			
While it has been noted that the rate-limiting step may change throughout the span of the 
reaction, evidence suggests that the deprotonation of intermediate 1.3 (Scheme 1-4) may have a 
rate determining influence.26 Reaction rates are higher when the thiol cocatalyst is employed as 
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thiolate necessary to carry out the deprotonation event. These observations, in addition to being 
easier to handle, make diphenyl disulfide an ideal cocatalyst in this novel organic photoredox-
mediated hydrofunctionalization of alkenes.  
1.5 Conclusion 
A rudimentary understanding of the photophysical and electrochemical factors that influence 
the activity of an organic photoredox catalyst is fundamental to the successful employment of 
such a species in a transformation. By understanding the oxidizing ability and photophysical 
properties of 9-mesityl-10-methylacridinium, we were able utilize this photoredox catalyst in the 
synthesis of a diverse set of hydrofunctionalized alkenes. The general, dual-catalytic process 
utilizes a redox active hydrogen atom donor cocatalyst in a concurrent cycle to access an overall, 
net redox neutral transformation. Photoredox catalysis has enabled access to unique reactivity, 
that is often difficult or impossible to achieve, including the anti-Markovnikov addition of 
nucleophiles to olefin substrates. An exploration of two novel transformations, based on this 
concept, is discussed herein. 
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CHAPTER TWO: SYNTHESIS OF α-BENZYLOXYAMINO-γ-BUTYROLACTONES 
VIA A POLAR RADICAL CROSSOVER CYCLOADDITION REACTION 
  
2.1 Introduction 
Cyclic esters, known as lactones, are structural motifs that have garnered significant 
attention for their presence in natural products and medicinal chemistry targets.1 In addition to 
being used as simple synthetic building blocks and monomers of polyesters, lactones possess 
significant economic value, especially in the fragrance industry.2 A subset of lactones that are 
especially valuable, due to their prevalence in synthesis, stability, and diverse bioactivity, are γ-
butyrolactones.  
The significance of γ-butyrolactones can be enhanced by the addition of heteroatom 
substituents at the α-position, with nitrogen functionality being particularly valuable. These α-
amino-γ-butyrolactones are a class of bioactive heterocycles that show especially great utility in 
synthesis and are highly prevalent in nature. Existing as the lactone form of the amino acid 
homoserine, α-amino lactones can be easily converted to the straight-chain, γ-hydroxyamino acid 
equivalent through hydrolysis or can be used in the preparation of several amino acids that are 
expensive and difficult to access, such as methionine3 and canaline.4  
α-Amino-γ-butyrolactones, also known as homoserine lactones, have been used as 
scaffolds in anti-allergy, immunosuppressant, and anti-asthma agents5 and in the synthesis of 
antibiotics, antifungal peptides, and serine protease inhibitors.6 This class of γ-butyrolactones 
have displayed anti-tumor and anti-cancer activity towards human colorectal and breast cancer
 21 
cell lines.7 The most significant biological activity exhibited by α-amino-γ-butyrolactones makes 
them desirable targets as antibiotics. In their N-acylated/sulfonylated form, these lactones act as 
signaling molecules for a population-density based, bacterial communication mechanism known 
as quorum sensing (Figure 2-1).7–9 This cell-to-cell communication, between individual 
microorganisms, controls several factors including the growth of biofilms, as well as enzyme and 
virulence factor production. Consequently, these small molecules can be targeted to intercept 
quorum sensing for the treatment of bacterial infections. The inherent biological activity of α-
amino-γ-butyrolactones makes them highly desirable as synthetic targets.  
 
      
Figure 2-1. Natural and Synthetic N-Acylated/Sulfonylated α-Amino-γ-Butyrolactones 
 
 
2.2 Synthesis of α-Amino-γ-Butyrolactones   
Given their apparent importance, several methods have been reported for the synthesis of 
α-amino-γ-butyrolactones. Amino lactones are most commonly accessed via the cyclization of 
amino acids including homoserine, methionine, and aspartic acid. The most direct route to 
generate α-amino lactones is through the cyclization of homoserine (Scheme 2-1).10 A protected 
α-amino-γ-butyrolactone can be achieved in two steps in an overall yield of 50%. While an 
achievable route, this method can be prohibitively expensive given the $316/g value of the amino 
acid starting material.11  
 
H
N
O
Me
O
O
H
N
O
O
O
O
Me
7
H
N
S
Me
O
O
O O
H HH
9
5
Natural - OdDHLSynthetic - QscR Agonists
	 	 22 
Scheme 2-1. Cyclization of Homoserine to Generate a Protected α-Amino-γ-Butyrolactone  	
		
Starting from methionine, upon acid protection and methylation, the resulting sulfonium 
intermediate is then cyclized under basic conditions to generate the Boc-protected α-amino-γ-
butyrolactone in 70% yield (Scheme 2-2).12  	
Scheme 2-2. Cyclization of Methionine to Generate a Protected α-Amino-γ-Butyrolactone  	
	
 
In 1978, Baldwin demonstrated the cyclization of protected, tritylated aspartic acid under 
reductive conditions (Scheme 2-3).13 The α-amino-γ-butyrolactone product was isolated as the 
HCl salt in excellent yield. A major shortcoming associated with the cyclization of amino acid is 
the limited substitution pattern and functionality achievable around the resulting lactone ring, 
due to the lack of substation on the carbon backbone of the starting material. 
 
Scheme 2-3. Cyclization of Aspartic Acid to Generate a Protected α-Amino-γ-Butyrolactone  	
        
HO OH
O
NH2 HO
O
HO
NH2
O
O
H
N O
O
Ph
1) NaHCO3, BnOCOCl, THF/H2O 50% 
over two steps2) PhMe, Δ
Me
BocHN
H
CO2H
S
1) TMSCl (1 equiv)
    MeCN, 25 ºC, 0.5 h
2) MeI (excess)
    25 ºC, 14 h
BocHN
H
O
O 70%
KOtBu
THF, reflux, 12 hIMe
Me
BocHN
H
CO2Si(CH3)3
S
H2N H
HO2C CO2H
1) BnOH, TsOH
TrHN H
BnO2C CO2Bn
1) DIBAL-H
2) CF3CO2H, HCl
Cl
H3N
H
O
O 95 %2) TrCl
	 	 23 
In 2014, Babu and coworkers demonstrated a stereoselective, acid-mediated, 
lactonization method beginning from α-amino γ,δ-unsaturated carboxylic acid esters (Scheme 2-
4).14 This method was applied to the synthesis of over 30, functionalized α-amino-γ-
butyrolactones with varying substitution on the amine. Despite its diverse product scope, this 
route is limited to non-commercially available, terminal alkene substrates, which are not always 
trivial to prepare.  
 
 
Scheme 2-4. Acid-Mediated Lactonization of α-Amino γ,δ-Unsaturated Carboxylic Acid Esters  	
			
An impressive enantioselective method for generating homoserine lactones has also been 
achieved through the use of dual organo- and biocatalysis (Scheme 2-5).15 Both enantiomer of an 
amino ketoesters can be converted to either possible diastereomers with high selectivity, in two 
steps, by altering the identity of the biocatalyst. The lactone product was obtained in high yield 
as well as enantio-, and diastereoselectivity. Despite the fact that only a single lactone product 
was obtained, this work demonstrates an excellent proof of concept for the selective generation 
of these valuable lactones.  
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Scheme 2-5. Accessing Homoserine Lactones via Dual Organo- and Biocatalytic System 		
	
 
 
 
While intramolecular cyclizations have often been favored for the synthesis of α-amino 
lactones, several multicomponent methods have also been developed, including an interesting 
aza-Prins cyclization (Scheme 2-6).16 Beginning with isobutylene and α-hydroxyhippuric acid,	it 
has been demonstrated that a γ-butyrolactone can be obtained under acidic conditions, albeit, in a 
7% yield.  
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Scheme 2-6. Synthesis of an α-Amino-γ-Butyrolactone via an Aza-Prins Cyclization  	
										 		
Additional methods have been reported for the production of α-amino lactones including 
the ring opening of aziridines (Scheme 2-7). The Loreto group successfully converted γ-ylidene-
lactones to their corresponding aziridines, which were then opened to reveal the α-amino-γ-
butyrolactones products.17  
 
 
Scheme 2-7. Aziridines Opening to Reveal α-Amino-γ-Butyrolactones Products 	
	 	
 
 
In the early 1990s, it was also demonstrated that the HCl salt of homoserine lactone could 
be accessed through the acidic hydrolysis of a substituted morpholinone derivative (Scheme 2-
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prefunctionalized starting materials, use of harsh conditions and exotic reagents, and the 
underwhelming diversity in substitution on the lactone product core.  
 
 	
Scheme 2-8. Acidic Hydrolysis of Morpholinone Derivative Toward the Synthesis of α-Amino-
γ-Butyrolactones 		
												 			
2.3  Synthesis of α-Benzyloxyamino-γ-Butyrolactones via Photoredox Catalysis 
2.3.1 Background and Precedent 
To overcome the limitations exhibited by current synthetic methods, we envisioned 
applying photoredox catalysis to the synthesis of α-amino-γ-butyrolactones, beginning from 
simple alkene starting materials, based on precedent from within our group. In 2013, Grandjean 
and Nicewicz reported the first example in our series of polar radical crossover cycloaddition 
(PRCC) reactions. The PRCC method involves the formation of multiple bonds through both a 
polar and radical reaction vector. Here, an intermolecular cycloaddition, between alkenes and 
alkenol coupling partners, was employed to generate highly substituted tetrahydrofurans 
(Scheme 2-9).19 
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Scheme 2-9. Tetrahydrofuran Synthesis Through PRCC Between Alkenes and Alkenols  	
		
Typically, alkene functionalization reactions occur through standard substrate reactivity 
in which an olefin interacts in a nucleophilic fashion with an electrophilic coupling partner. In 
order to expand the scope of reactivity for alkenes, our lab has sought to apply organophotoredox 
catalysis to achieve umpolung reactivity. As a result of this polarity reversal, alkene substrates 
can be rendered electrophilic and can then react with nucleophiles to obtain unique products in a 
regioselective fashion.   
To achieve this desired reactivity, 9-mesityl-10-methylacridinium (NMA) 
tetrafluoroborate, was employed as an excited state, single electron, photo-oxidant. When 
irradiated with blue LEDs, the ground state NMA enters its excited state (NMA*), allowing it to 
carry out single electron oxidation of an alkene substrate, such as β-methylstyrene  (2.1) (Scheme 
2-10). The resulting cation-radical species (2.2) then proceeds to react in both a polar and radical 
fashion. Initial trapping of the cation by allyl alcohol (2.3) occurs at the β-position to produce the 
stabilized benzylic radical (2.4). Upon deprotonation, the radical intermediate is poised to 
undergo a favorable 5-exo cyclization, with the tethered olefin, to generate a new reactive, 
radical species (2.5), which is then trapped with a hydrogen atom to give the final 
tetrahydrofuran product (2.6). In this system, terminal hydrogen atom transfer (HAT) was 
achieved using redox-active phenylmalononitrile (2.7) as a hydrogen atom donor. The resulting 
phenylmalononitrile radical (2.8) is capable of acting as a single electron oxidant, turning over 
the acridine radical (NMA). Phenylmalononitrile serves an additional purpose as its anionic 
O
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form (2.9) can neutralize acid that is generated during the course of the reaction to regenerate the 
H-atom donor.  
 
Scheme 2-10. Mechanism for Tetrahydrofuran Synthesis via PRCC 			
	
 
 
Ultimately, this photoredox system was applied to the synthesis of 18 highly substituted, 
tetrahydrofuran products beginning from a variety of alkenol and oxidizable alkene coupling 
partners (Figure 2-2). 
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Figure 2-2. Tetrahydrofuran Synthesis Substrate Scope  			
In the following year, Zeller, Riener, and Nicewicz applied a similar photoredox-
mediated PRCC to the synthesis of γ-butyrolactones (Scheme 2-11).20 These valuable products 
could be accessed from a variety of oxidizable olefins and α,β-unsaturated acids. In this 
example, thiophenol (PhSH) ultimately acted as the redox-active H-atom donor, which was also 
capable of turning over the acridinium photoredox catalyst. 
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Scheme 2-11. γ-Butyrolactones Accessed Through a Photoredox Mediated PRCC 		
								 	
 
Through the development of multiple photoredox-mediated transformations, our lab has 
been able to draw critical conclusions regarding the reactivity of the hydrogen atom donor co-
catalyst as utilized in the PRCC systems. In order to achieve successful HAT, it is necessary that 
the redox-active donor meet key requirements including the following:  
1) The hydrogen atom donor must possess a bond dissociation energy (BDE) that falls 
within the range of 70-80 kcal/mol for the X-H bond for the HAT event to occur 
2) The resulting radical that forms, upon HAT to the substrate, must be capable of 
undergoing single electron reduction to successfully turn over the photoredox catalyst 
and complete the catalytic cycle 
3) The pKa of the hydrogen atom transfer agent must be sufficiently high enough so that 
it is reformed upon reduction, allowing the donor to be utilized catalytically  
Multiple H-atom donors meeting these requirements have been utilized in our PRCC 
transformations (Figure 2-3). Thiophenol and its derivatives are often relied on as efficient H-
atom donors given their sufficient BDE and pKa values. However, diphenyl disulfide21 is 
commonly employed as an alternative thiophenol source due to its ease of use, lack of odor, and 
weak sulfur-sulfur bond (BDE ~50 kcal/mol22).23  
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Figure 2-3. Hydrogen Atom Donors and Their Corresponding BDE/pKa Values 		
 
Using catalytic quantities of diphenyl disulfide as a hydrogen atom donor, Zeller et al. 
successfully synthesized over 20 γ-butyrolactones varying both the olefin and α,β-unsaturated 
acid coupling partners (Scheme 2-12). In addition to trisubstituted alkenes (2.7), the oxidizable 
alkene scope included β-methylstyrene (2.8-2.10), as well as its derivatives substituted with both 
electron-withdrawing (2.11) and moderately electron-donating substituents (2.12-2.13). α-
Methylstyrene also proved to be a competent substrate providing the lactone product, containing 
an all carbon quaternary center, in an 81% yield (2.14). Impressively, it was shown that 
substituted alkynoic acids could be utilized as coupling partners to provide the corresponding 
unsaturated lactones in good yield (2.15). This abbreviated exploration of the substrate scope 
merely touches on the impressive diversity of the transformation, though several reaction 
conditions were necessary to achieve this variety.  
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Scheme 2-12. Abbreviated γ-Butyrolactones Substrate Scope 
  
			
In addition, the value of this system was further demonstrated with the synthesis of two 
bioactive, α-methylene paraconic acids (Scheme 2-13) known as methylenolactocin (2.16) and 
protolichesterinic acid (2.17). 
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Scheme 2-13. Synthesis of Methylenolactocin and Protolichesterinic Acid via PRCC 	
 			
Gesmundo, Grandjean, and Nicewicz accomplished a logical and valuable expansion of 
this PRCC method to the formation of γ-lactams and pyrrolidines.24 Using a system similar to 
those discussed previously, oxidizable olefins were found to couple successfully with 
unsaturated amides and protected amines to catalytically generate a variety of highly substituted, 
nitrogen heterocycles in a regioselective manner (Scheme 2-14). In a similar fashion to the 
previous PRCCs, this system was optimized using β-methylstyrene as the substrate of choice. 
Beginning with a protected cinnamamide coupling partner (2.18), the authors sought to 
overcome the major challenge of identifying reaction conditions that favored nucleophilic attack, 
at the cation radical intermediate, by the nitrogen, rather than the oxygen functionality, to favor 
lactam (2.19) over imidate (2.20) formation. Upon a closer analysis of amide protecting group 
identity, it was determined that a lack of protecting group or a labile group, such as a Boc group, 
led to substrate decomposition and a lack of product formation. However, sulfonyl-protected 
substrates were found to work efficiently, with more electron deficient groups leading to higher 
yields and a higher N:O addition ratio, favoring N-addition. 
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Scheme 2-14. Regioselective Synthesis of γ-Lactams Through a PRCC 										
							 	
  
The alkene scope explored in this system is reflective of those studied in previous PRCC 
work (Scheme 2-15). A variety of styrenyl (2.21-2.32) and non-styrenyl (2.33-2.35) oxidizable 
alkenes were demonstrated to work well in the formation of lactam products, displaying good to 
great regioselectivity and functional group tolerance.  
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Scheme 2-15. γ-Lactam Scope 	
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While protected cinnamamide derivatives worked well as an amide substrate (Scheme 2-
16, 2.35-2.40), it was determined that β-aryl functionality was not required for the cyclization to 
occur successfully (2.41-2.44).  
 
Scheme 2-16. Amide Scope for the Synthesis of Highly Substituted Lactams 	
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The disclosed scope for pyrrolidine product formation was limited compared to that of 
the γ-lactams (Scheme 2-17). Valuable however, was the discovery that the cyclization could be 
achieved using Boc-protected, unsaturated amines, which could then be easily deprotected upon 
treatment with TFA to afford the final, highly substituted, heterocycles.  
 
Scheme 2-17. Pyrrolidine Product Scope 		
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and efficient catalytic method, toward the synthesis of valuable and potentially bioactive, α-
amino-γ-butyrolactones. Work out of Derrick Clive’s lab in 1997 provided further evidence that 
R1
HN
Ph
Boc
N
HR
2
  (3 equiv)
H
NPhDMA (5 mol %)
(PhS)2 (20 mol %)
455 nm LEDs
CHCl3 [0.25 M], rt, 24 h
1)
2) TFA (8 equiv)
N
HMe
Ph
Bn
N
HMe
4-Cl-C6H4
Bn
N
HMe
4-Me-C6H4
Bn
N
H
Bn
2.45
51%, 3:1 dr
2.47 
65%, 3:1 dr
2.46 
38%, 3:1 dr
2.48
53%, 2.5:1 dr
R2
R1
CH2Cl2 [0.25 M]
Ph
H
H
N
Ph
Me
Me
Me
NPhDMA
Me Me
	 	 38 
it would be possible to use O-benzyloxime acids as substrates, along with oxidizable olefins, to 
generate these products.25,26 In this work, Clive presented the generation of a radical precursor 
(2.49) derived from glyoxylic acid O-benzyloxime with β-bromo alcohol, which is poised to 
undergo a radical cyclization to generate α-benzyloxyamino-γ-butyrolactone 2.50 (Scheme 2-
18). Upon esterification, the radical precursor was treated with Bu3SnH to generate the radical 
intermediate, which undergoes a 5-exo-trig cyclization to form the final lactone product in two 
steps and a 51% yield. Precedent for this ring closure and formation of the nitrogen-centered 
radical are strong evidence that a similar intermediate, achieved through a photoredox-mediated 
PRCC, could undergo successful conversion to a lactone product. This method, in combination 
with the PRCC reactions developed within the Nicewicz lab, inspired us to develop a system for 
the formation of highly substituted, α-benzyloxyamino-γ-butyrolactones, in a single synthetic 
step, via photoredox catalysis.27  
 
Scheme 2-18.  Clive’s Radical Cyclization of an O-Benzyloxime Derivative to Access an α-
Benzyloxyamino-γ-Butyrolactones 								 	
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2.3.2 Results and Discussion 
The investigation into the synthesis of α-benzyloxyamino-γ-butyrolactones began with 
conditions based on those optimized for the synthesis of γ-butyrolactones (Table 2-1). Initially, 
we tested β–methylstyrene and O-benzyloxime acid as the two potential reaction partners. The 
O-benzyloxime acid substrate was prepared through the efficient condensation of 
benzyloxyamine hydrochloride onto glyoxylic acid in a 96% yield (Scheme 2-19).  
 
Scheme 2-19. Preparation of O-Benzyloxime  Coupling Partner  		
	 		
A promising initial hit was realized using catalytic quantities of NMA and diphenyl 
disulfide, in DCM, which resulted in the formation of the desired lactone product in a moderate 
yield (57%) (Table 2-1, entry 1). A solvent screen revealed that solvents of varying polarity, 
including DCE, chloroform, and acetone, led to suppressed yields or complete inhibition of the 
reaction (Table 2-1, entries 2-4). Given the diversity of hydrogen atom donors that had been 
considered previously in similar systems, we believed it would be valuable to consider the 
identity of the cocatalyst in this transformation (Table 2-1, entries 5-7). Despite screening 
thiophenol derivatives of varying electronics, it was determined that diphenyl disulfide was the 
most efficient hydrogen atom donor cocatalyst. As was the case in the synthesis of γ-
butyrolactones and γ-lactams, it was found that the addition of catalytic quantities of 2,6-lutidine 
could help to enhance the reactivity, likely via deprotonation of the carboxylic acid nucleophile 
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in situ (Table 2-1, entries 8-11). An optimal loading of 15 mol% was observed, resulting in a 
yield of 69% (Table 2-1, entry 10). Higher (Table 2-1, entry 11) and lower (Table 2-1, entry 9) 
loadings of base led to diminished yields.  
 
Table 2-1. Optimization of PRCC Conditions for the Synthesis of α-Benzyloxyamino-γ-
Butyrolactones 
				 	
 
Having achieved an increase in product yield, a series of control experiments were 
carried out to confirm the catalytic activity in our proposed transformation. Omitting NMA 
resulted in no product formation thereby demonstrating the necessity of the photocatalyst in the 
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2 (PhS)2 2.5 0 CHCl3 35 
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4 (PhS)2 2.5 0 (CH2Cl)2 39 
5b 4-(MeO)PhSH 2.5 0 CH2Cl2 40 
6b 4-(NH2)PhSH 2.5 0 CH2Cl2 40 
7 4-(NO2PhS)2 2.5 0 CH2Cl2 29 
8 (PhS)2 2.5 0 CH2Cl2 38 
9 (PhS)2 2.5 5 CH2Cl2 53 
10 (PhS)2 2.5 15 CH2Cl2 69 
11 (PhS)2 2.5 20 CH2Cl2 51 
12c,d (PhS)2 0 15 CH2Cl2 0 
13 (PhS)2 5.0 0 CH2Cl2 42 
14 (PhS)2 7.5 0 CH2Cl2 39 
15d None 2.5 15 CH2Cl2 40 
16c,d (PhS)2 2.5 15 CH2Cl2 88 
Reactions were carried out on a 0.33 mmol scale in N2-sparged solvent [0.08 M] under 2 LED lamps (λmax = 450 nm) for 24 h. 
aYields were obtained relative to (Me3Si)2O 1H NMR internal standard of crude reaction mixtures. bReaction was run at [0.15 
M] c10 mol % disulfide. dalkene/acid = 1.5:1. 
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system (Table 2-1, entry 12). It should be noted however, that an increase in the loading of NMA 
resulted in lower yields of the lactone product (Table 2-1, entries 13-14). A curious observation 
was made upon exclusion of the hydrogen atom donor cocatalyst as the product was still 
observed, though in a limited yield of 40% (Table 2-1, entry 15). This product formation is 
accounted for in the succeeding discussion of the reaction mechanism. It was demonstrated that a 
change in the alkene/oxime ratio from 1:1.1 to 1.5:1, along with lowering the disulfide loading to 
just 10 mol%, improved the yield of the lactone product to 88% (Table 2-1, entry 16). 
Having developed optimal reaction conditions for the PRCC between oxidizable olefins 
and an oxime acid coupling partner, we then set out to study the scope of the transformation in 
relation to the O-benzyloxime acid (Scheme 2-20). O-Benzyloxime 2.51 was successfully reacted 
with β–methylstyrene to provide the α-benzyloxyamino-γ-butyrolactone (2.54) in a 71% yield. 
We were pleased to discover that the synthesis of oxime acids could be expanded to include 
substitution at the α-position. As a result, lactone products bearing α-quaternary carbons (2.55 
and 2.56) could be accessed from pyruvic acid (2.52) and phenylglyoxylic acid (2.53) derived 
oximes without diminishing the yield of the reaction. 
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Scheme 2-20. Exploration of O-Benzyloxime Acid Scope 	
			
Following the exploration of the oxime acid scope, a variety of alkene partners were then 
screened against benzyloxime acid 2.51 (Scheme 2-21). The initial investigation began with the 
consideration of various β–methylstyrene derivatives of varying substitution (2.57-2.68). Several 
halogenated derivatives were considered and produced the corresponding, desired lactones (2.57-
2.62) in good to excellent yields regardless of the substitution pattern. Anethole, along with its o- 
and m-regioisomers, models the tolerance of the system for varying electronic and steric effects, 
furnishing each of the corresponding lactones in fair to good yields (2.63-2.65). Alkyl-
substituted aryl rings verified that moderately electron-rich β–methylstyrene derivatives were 
also plausible coupling partners (2.66-2.68). Methyl-substituted products 2.66 and 2.67 were 
obtained in 64% and 62% yield, respectively. tert-Butyl-β–methylstyrene gave 2.68 in 60% 
yield. Changing from β–methyl to α-methylstyrene as the alkene component produced a β–
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quaternary substituted lactone (2.69) in 58% yield. We also considered trisubstituted alkenes as 
coupling partners (2.70-2.71), which provided the lactone products in varying yields. Lactone 
2.70 was obtained in an excellent yield of 88% from 1-phenylcyclohexene. Cyclization was more 
problematic when 2-methyl-2-butene was used as the coupling partner, furnishing the lactone 
product in a yield of 42% (2.71). We were pleased to observe that this method could be 
successfully applied to the formation of lactone products, possessing desirable all-carbon 
quaternary centers. Tricyclic lactone 2.72 was obtained in good yield (53%) from indene. Lastly, 
an alkene bearing a phthalimide-protected nitrogen and a β–methylstyrene derived tert-
butyldimethylsilyl (TBS) ether resulted in derivatives 2.73 and 2.74 in 41% and 71% yields, 
respectively. Overall, these results demonstrate that this photoredox-mediated PRCC system can 
be used to efficiently generate the desired, substituted α-amino lactone products in fair to 
excellent yields. 
	
	
  
	 	 44 
Scheme 2-21. Alkene Scope for the Synthesis of α-Benzyloxyamino-γ-Butyrolactone  					
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The dual-catalytic mechanism, proposed for this transformation, is reflective of the 
previous PRCC systems explored within our lab (Scheme 2-22). Beginning in its ground state, 
the acridinium (NMA) enters its excited state (NMA*) upon absorption of visible light. The 
excited state photoredox catalyst is now capable of undergoing single electron transfer with the 
alkene substrate (2.75), generating a cation radical intermediate (2.76), which simultaneously 
leads to the formation of the acridine radical (NMA). The cation radical is poised to undergo 
nucleophilic trapping by the oxime acid (2.77), resulting in the formation of carbon-centered 
radical 2.78. Following deprotonation of the intermediate, this radical undergoes an irreversible 
5-exo-trig cyclization. 	
 
Scheme 2-22. Proposed Mechanism for the Production of α-Benzyloxyamino-γ-Butyrolactones 
via a PRCC 
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Zeller et al. conducted an additional test reaction to determine the potential reversibility 
of this cyclization step (Scheme 2-23). Classical radical hydrodehalogenation conditions were 
applied to β–bromo substrate 2.81 resulting in the formation of product 2.82 only. The lack of 
uncyclized product (2.83) formation is suggestive of an irreversible trapping step, as this product 
would have formed if the radical cyclization were reversible. 
 
Scheme 2-23. Hydrodehalogenation of a β–Bromo Substrate to Test the Reversibility of the 
Radical Cyclization Step 	
																			 	
 
 
 The unique component of this PRCC system resides in the formation of nitrogen-
centered radical. While previous PRCC reactions have proceeded through the formation of a 
carbon-centered radical upon cyclization, this synthetic route requires irreversible radical 
trapping through the carbon-nitrogen double bond of the oxime, resulting in a stable nitrogen-
centered radical 2.79. 
A parallel, redox cycle exists for the hydrogen atom donor cocatalyst in conjugation with 
the photoredox catalyst cycle. This system was highly tolerant of diphenyl disulfide (PhS2) as a 
cocatalyst, relying on photolytic homolysis to generate a phenylthiyl radical (PhS) in situ.  With 
a reduction potential of +0.16 V vs SCE,23 this sulfur-centered radical functions efficiently as a 
single-electron oxidant to regenerate the acridinium ground state (NMA, !!"#!/! = -0.55 V vs 
SCE) and form the thiolate anion (PhS-), which is converted to thiophenol (PhSH) upon proton 
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transfer. This HAT step has been identified as exhibiting a significant rate-limiting influence on 
the system.  The thiophenol then acts as the terminal hydrogen atom donor, which converts 2.79 
to the desired α-benzyloxyamino-γ-butyrolactone product (2.80). Ultimately, the resulting 
thiophenol can then reenter the catalytic cycle. 
Based on the observation that a moderate amount of lactone product is generated in the 
absence of diphenyl disulfide (Table 2-1, entry 15), we proposed that an additional pathway likely 
operates without the involvement of a hydrogen atom donor cocatalyst (Scheme 2-24). To account 
for this observation in the mechanism, we propose that the nitrogen-centered radical 2.79 can be 
reduced by the acridine radical to simultaneously generate a nitrogen anion and regenerate the 
ground state acridinium (NMA). Protonation of the anion, likely via lutidinium or an equivalent 
of acid would lead to formation of the product. 
 
Scheme 2-24. Explanation of Product Formation When Hydrogen Atom Donor is Omitted  
             
                   
 
The final undertaking for this project was to determine the relative stereochemistry of the 
major and minor diastereomers. Though the transformation proved to not be especially selective 
for one stereoisomer over the other, we believed it was necessary to identify the major 
conformer. It is worth noting that no conclusions could be drawn directly from previously 
reported PRCC systems as the favored diastereomer alternates between a 3,4-cis/4,5-trans and 
3,4-trans/4,5-trans substituent relationship depending on the system. The all-trans diastereomer 
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was favored for the synthesis of γ-butyrolactones. Conversely, tetrahydrofuran, lactam, and 
pyrrolidine products were isolated as the 3,4-cis/4,5-trans conformer. Initially, we attempted to 
use similar epimerization conditions, as those used previously, to identify the major adduct.  
Based on previous evidence,20 it was assumed that the product was the 
thermodynamically favored 3,4-trans isomer. As demonstrated in the synthesis of γ-
butyrolactones, epimerization conditions can be used to determine the major/minor diastereomer 
(Scheme 2-25). Enrichment of the major diastereomer under epimerization conditions would 
suggest that the thermodynamically favored, all-trans conformation is the major diastereomer 
and the minor product exhibits a 3,4-cis/4,5-trans relationship. Epimerization, via deprotonation 
of the α-proton, leading to the enrichment of the minor diastereomer, would indicate that the cis-
trans conformation is the major product.  
 
Scheme 2-25. Determination of Major Diastereomer Conformation Under Epimerization 
Conditions 				
					 		
To our dismay, deprotonation at the α-carbon of the α-benzyloxyamino-γ-butyrolactone 
product resulted in a loss of the O-benzyl group (2.81) and subsequent enamine formation (2.82), 
as observed by GC-MS (Scheme 2-26).  
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Scheme 2-26. Enamine Formation Observed Under Epimerization Conditions 	
		
In an effort to circumvent the formation of the undesired elimination product, we directed 
our efforts towards the initial hydrogenation of the benzyloxyamino, followed by the application 
of the epimerization conditions to the free amine. Unfortunately, none of the reduced product 
was generated after screening several reduction methods (Table 2-2). We then attempted initial 
nitrogen acylation to facilitate benzyloxyamine reduction prior to applying the epimerization 
conditions.  
 
Table 2-2. Exploration Of Reduction Conditions to Access the Free Amine Product 	
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Zn(0) --- AcOH 120 24 0 returned starting material 
Pd/C Balloon MeOH 23 4 0 returned starting material 
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Acylation proved fruitless after many attempts using several methods and acylating 
agents (Table 2-3).  
 
Table 2-3. Exploration Of Acylation Conditions to Access the N-Acyl Amine  
	
Acylating Reagent Base Additive Solvent Temp (°C) Time (h) Yield (%) 
AcCl TEA --- THF 23 0.5 0 
AcCl TEA DMAP THF 23 24 0 
AcCl TEA DMAP THF 40 24 0 
BzCl K
2
CO
3
 --- H
2
O:EtOAc 23 7 0 
pCl-BzCl TEA DMAP THF 40 24 0 
TFAA TEA --- TFAA 23 4 0 
TFAA TEA --- TFAA 23 20 0 		
Ultimately, we determined that the most suitable method for identifying the preferred 
conformation of the benzyloxyamino lactones was through the use of selective 1D-NOESY 
NMR experiments (Figure 2-4) (see Experimental Section). Product 2.63 was used as a model to 
define the stereochemistry for the β–methylstyrene derived products. Due to challenges 
associated with separating diastereomers, this substrate was selected, as it possessed 1H NMR 
peaks that were distinguishable between the inseparable diastereomers. Upon individual 
irradiation of each proton, a stronger NOE was observed between the protons at the 3 and 5 
positions than between those at the 3/4 or 4/5 positions, indicating that the two were likely 
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located on the same face of the 5-membered ring in the major diastereomer. The minor 
diastereomer exhibited no NOE between the protons located at the 4 and 5 positions and a strong 
signal for protons in the 3 and 4. Based on these observations, we concluded that the major 
diastereomer was the all-trans product and the minor diastereomer exhibited a cis-trans 
relationship. So not to draw general conclusions from β–methylstyrene substrates, the 
stereochemistry of lactones 2.55 and 2.69-2.72 were assigned separately, using 1D-NOESY 
NMR experiments, from their respective spectra. In general, the product diastereoselectivity (dr) 
was consistently around 2.0:1 or less, with a few exceptions. 
 	
				 			
Figure 2-4. Major Diastereomer Identification Based on 1-D NOESY NMR Analysis 		
Lastly, we sought to demonstrate that our α-benzyloxyamino-γ-butyrolactones could be 
converted to the corresponding free amine. Since previous attempts to demonstrate the 
benzyloxyamine reduction failed, we turned our attention towards a report in the literature of the 
reduction of a similar substrate.28 Ultimately, the reduction was found to require more forcing 
conditions, using a super-stoichiometric loading of Pearlman’s catalyst, Pd(OH)2/C, and high H2 
pressure (40 psi) to achieve the reduction of substrate 2.55 in a 72% yield without a deleterious 
OBn
NH
O
Ar
Me O
H
H H
OBn
NH
O
Ar
Me O
H
H H
major diastereomer
"all-trans"
minor diastereomer
"cis-trans"
Proton Relationship Observed by 1D-NOESY NMR
2.63 Ar = 2-MeO-C6H4
34
5
34
5
	 	 52 
effect on the diastereoselectivity (Scheme 2-27). Obtaining the reduced, free amine product 
could allow for further functionalization of the lactones.  
 
Scheme 2-27.  O-Benzyl Amine Reduction to Generate Free α-Amino-γ-Butyrolactone  	
	
 
2.4 Conclusion  
Ultimately, we have developed a useful method for the synthesis of substituted, α-
benzyloxyamino-γ-butyrolactones from easily accessible oxime acid starting materials and 
simple, commercially available, alkenes. In addition to generating two α-disubstituted γ-
butyrolactones, 19 highly substituted lactone products were also prepared in fair to excellent 
yield. The scope of the transformation exhibited wide steric and electronic tolerance as well as 
functional group compatibility. We are confident that the use of this photoredox-mediated PRCC, 
for the generation of α-benzyloxyamino-γ-butyrolactones, will be useful in synthesis of small 
molecules and that these highly substituted lactones could be studied further for biological 
activity. 
In addition to these valuable features, this methodology provides a significant number of 
advantages over previously published methods for generating α-amino lactones. Unlike the work 
presented by Clive and others, this reaction is effective at forming three new σ bonds in a single 
step, beginning from easily made and/or commercially available starting materials. The 
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transformation also proceeds efficiently under mild reaction conditions, generating highly 
substituted, novel α-benzyloxyamino-γ-butyrolactone products, without the use of harsh and 
hazardous reagents. 
To further develop this project, we have made initial attempts toward employing alkynes, 
in place of alkenes, in the PRCC reaction manifold. It has been observed that alkynes, such as 
diphenylacetylene and 4-ethynylanisole, would be oxidizable using acridinium photoredox 
catalysts given their redox potentials of Ep/2 = +1.84 V and +1.65 V vs SCE, respectively.29 
Using alkynes as potential coupling partners in PRCC reactions would allow us to build 
complexity into heterocyclic compounds (Figure 2-5). The addition of unsaturation into the 
previously prepared lactone and lactam cores will allow for additional functionalization of the β–
γ-unsaturated ring. By incorporating unsaturation into the system, we are pursuing the generation 
of several highly substituted and valuable heterocycles including imidazoles, pyrroles, and 
thiophenes. 	
			 	
Figure 2-5. Potential Heterocycles Accessible Through PRCC With Alkyne Substrates  
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2.5 Experimental 
General Information: Materials and Methods 
Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa Aesar, or 
TCI, and used as received unless otherwise noted. Dichloromethane (DCM) was dried by passing 
through activated alumina columns under nitrogen prior to use. Irradiation of photochemical 
reactions was carried out using two 15W PAR38 blue LED floodlamp purchased from 
EagleLight (Carlsbad, CA) and one 21W PAR38 blue aquarium LED lamp (Model #6851) 
purchased from Ecoxotic (www.ecoxotic.com), with borosilicate glass vials purchased from 
Fisher Scientific. Thin layer chromatography (TLC) was performed on SiliaPlate 250 µm thick 
silica gel plates provided by Silicycle. Visualization was accomplished with short wave UV light 
(254 nm), aqueous basic potassium permanganate solution, or cerium ammonium molybdate 
solution followed by heating. Flash chromatography was performed using SiliaFlash P60 silica 
gel (40-63 µm) purchased from Silicycle. Yield refers to isolated yield of analytically pure 
material unless otherwise noted. Proton and carbon magnetic resonance spectra (1H NMR and 
13C NMR) were recorded on a Bruker model DRX 400 or a Bruker AVANCE III 600 CryoProbe 
(1H NMR at 400 MHz or 600 MHz and 13C NMR at 101 or 151 MHz) spectrometer with solvent 
resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, dd = doublet of doublets, ddt = doublet of doublet of triplets, ddd = doublet of doublet of 
doublets, dddd = doublet of doublet of doublet of doublets m = multiplet, brs = broad singlet), 
coupling constants (Hz), and integration. NMR yields were determined using 
hexamethyldisiloxane, (Me3Si)2O, as an internal standard. Infrared (IR) spectra were obtained 
using a Jasco 260 Plus Fourier transform infrared spectrometer. Dichloromethane (DCM) was 
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used as the solvent for FT-IR spectroscopy. High resolution mass spec (HRMS) was obtained on 
the Thermo LTqFT mass spectrometer with electro spray ionization in positive mode. 
 
Lamp Setup: 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Preparation of Photoredox Catalyst 
The acridinium photoredox catalyst (NMA) was prepared according to published literature 
procedures. Spectral data were in agreement with literature values.30 
 
Preparation of Alkene Substrates 
Purchased Alkenes: β-methylstyrene (1a), anethole (1b), indene (1c), α-methylstyrene (1d), 1-
phenyl-1-cyclohexene (1e), and 2-methyl-2-butene (1f) were purchased from a commercial 
source. 
Synthesized Styrenes: The following alkenes were prepared according to a published Wittig 
olefination procedure.24 
1.5 in 
0.5 in 
2.5 in 
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β-Methyl-3-bromostyrene (1g): Spectral data were in agreement with literature values.31  
 
 
 
β-Methyl-4-bromostyrene (1h): Spectral data were in agreement with literature values.32  
 
 
 
β-Methyl-2-chlorostyrene (1i): Spectral data were in agreement with literature values.33 
 
 
 
β-Methyl-3-chlorostyrene (1j): Spectral data were in agreement with literature values.31 
 
 
 
β-Methyl-4-chlorostyrene (1k): Spectral data were in agreement with literature values.31 
 
 
 
β-Methyl-4-fluorostyrene (1l): Spectral data were in agreement with literature values.34 
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β-Methyl-3-methylstyrene (1m): Spectral data were in agreement with literature values.35 
 
 
 
β-Methyl-4-methylstyrene (1n): Spectral data were in agreement with literature values.36 
 
 
 
β-Methyl-4-tert-butylstyrene (1o): Spectral data were in agreement with literature values.37  
 
 
 
 
β-Methyl-2-methoxystyrene (1p): Spectral data were in agreement with literature values.38 
 
 
 
β-Methyl-3-methoxystyrene (1q): Spectral data were in agreement with literature values.39 
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(E)-2-(3-(4-Methoxyphenyl)allyl)isoindoline-1,3-dione (1r): Prepared according to a published 
procedure. Spectral data were in agreement with literature values.34 
 
 
 
 
tert-Butyldimethyl(4-(prop-1-en-1-yl)phenyl)silane (1s): Spectral data were in agreement with 
literature values.40 
 
 
 
 
Preparation of O-Benzyl Oxime Acids 
(E)-2-((Benzyloxy)imino)acetic acid (2.51): Prepared according to a published procedure. 
Spectral data were in agreement with literature values.41 
 
 
 
 
(E)-2-((Benzyloxy)imino)propanoic acid (2.52): Prepared according to a published procedure. 
Spectral data were in agreement with literature values.41 
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2-((Benzyloxy)imino)-2-phenylacetic acid (2.53): Prepared according to an adapted 
procedure.41  
 
 
 
 
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 9.11 (s, 1H), 7.69 – 7.62 (m, 1H), 
7.57 – 7.51 (m, 1H), 7.50 – 7.32 (m, 8H), 5.35 (d, J = 3.1 Hz, 2H). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 167.55, 164.26, 150.21, 147.96, 
130.72, 137.03,  136.03, 130.37, 129.86, 129.68, 128.91, 128.80, 128.68, 128.60, 128.39, 128.21, 
128.18, 128.15, 126.66, 78.74, 77.50. 
IR (thin film, cm-1) 3450, 1722, 1496, 1454, 1366, 1213, 1082, 1059 
HRMS: m/z calculated for C15H13NO3[Na]+: 278.07876; found: 278.07889 
 
General Procedure A for Lactone Polar Radical Crossover Cyclization  
A flame dried 2-dram vial, equipped with a Teflon-coated septum cap, was charged with a stir 
bar, the Fukuzumi acridinium photoredox catalyst (Mes-Acr-Me, 2.5 mol%), diphenyl disulfide 
(10 mol%) and the appropriate O-benzyl oxime (0.33 mmol, 1.0 equiv). The vial and its contents 
were transferred to an inert atmosphere (glove box, N2). The alkene substrate (1.5 equiv) and 
2,6-lutidine (15 mol%) were added by microsyringe to the vial, followed by the addition of 
solvent (CH2Cl2, 0.08 M) by syringe. The vial was capped and removed from the glove box and 
placed in front of a light setup where it was irradiated (3x450 nm blue LED lamps) and stirred 
for 24 hours. The crude reaction was concentrated under reduced pressure and purified via 
O
N
O
HO
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column chromatography on silica gel. 
Notes:  
-Some substrates required deviations from standard conditions and are noted below. 
-Integration of peaks in 1H NMR spectra for inseparable diastereomers were determined based 
on the ratio between the methyl peaks of the major and minor diastereomers. The signals were 
assigned to the major and minor diastereomers where possible.  
 
3-((Benzyloxy)amino)-5-methyl-4-phenyldihydrofuran-2(3H)-one (2.54) 
 
 
 
 
 
 
The average isolated yield for 2.54 was 70 mg, 71% (2 trials), synthesized using General 
Procedure A with β-methylstyrene 1a, oxime 2.51, and an irradiation time of 24 hours. The title 
compound was obtained as a 2.0:1 mixture of inseparable diastereomers based on an average of 
two trials. The product was isolated by column chromatography on silica gel (10% Et2O/hexanes 
then 30% Et2O/hexanes) as a yellow oil.  
Analytical data for 2.54:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.39 (t, J = 7.4 Hz, 3H), 7.37 – 
7.27 (m, 7H), 7.24 – 7.20 (m, 5H), 6.11 (s, 1H-major), 5.67 (s, 1H-minor), 5.03 (dd, J = 7.4, 6.1 
Hz, 1H-minor), 4.69 (q, J = 11.6 Hz, 2H-major), 4.55 – 4.43 (m, 3H-2 minor, 1 major), 4.08 – 
Major Minor
+
O
NH
OMe O
O
NH
O
Me O
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4.02 (m, 2H-1 minor, 1 major), 3.45 – 3.39 (m, 2H-1 minor, 1 major), 1.46 (d, J = 6.3 Hz, 3H-
minor), 1.42 (d, J = 6.1 Hz, 3H-major). 
13C NMR for major/minor diastereomer (151 MHz, CDCl3) δ 174.02, 174.01, 173.46, 173.44, 
137.18,  136.85, 136.51, 134.59, 129.25, 128.98, 128.89, 128.71, 128.49, 128.45, 128.06, 128.04, 
127.97, 127.90, 80.73, 79.60, 77.24, 76.49, 67.89, 63.64, 52.92, 52.68, 20.12, 19.00. 
IR (thin film, cm-1)  3477, 3255, 3062, 3030, 2977, 2930, 1955, 1775, 1642, 1602, 1497, 1454, 
1387, 1365, 1333, 1283, 1190, 1061 
HRMS: m/z calculated for C18H19NO3 [Na]+: 320.12571; found: 320.12556 
 
3-((Benzyloxy)amino)-3,5-dimethyl-4-phenyldihydrofuran-2(3H)-one (2.55) 
 
 
 
 
 
 
 
The average isolated yield for 2.55 was 75 mg, 73% (2 trials), synthesized using General 
Procedure A with β-methylstyrene 1a, oxime 2.53, (2,6-lutidine was omitted) and an irradiation 
time of 24 hours. The title compound was obtained as a 5.0:1 mixture of inseparable 
diastereomers based on an average of two trials. The product was isolated by column 
chromatography on silica gel (10% Et2O/hexanes then 30% Et2O/hexanes) as a yellow oil.  
Analytical data for 3.55:  
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1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ7.44 – 7.38 (m, 2H), 7.38 – 7.35 
(m, 2H), 7.35 – 7.32 (m, 4H), 7.30 (q, J = 3.9, 3.3 Hz, 3H), 7.14 (d, J = 7.5 Hz, 1H), 5.70 (s, 1H-
minor), 5.28 (s, 1H-major), 5.16 – 5.06 (m, 1H-major), 4.93 – 4.80 (m, 3H-minor), 4.61 (d, J = 
3.7 Hz, 2H-major), 3.78 (d, J = 10.6 Hz, 1H-minor), 3.05 – 2.95 (m, 1H-major), 1.48 (d, J = 6.0 
Hz, 3H-minor), 1.37 (d, J = 6.2 Hz, 3H-major), 1.30 (d, J = 1.1 Hz, 3H-major), 0.84 (s, 3H-
minor). 
13C NMR for major/minor diastereomer (151 MHz, CDCl3) (some peaks of the minor/major 
diastereomers are overlapping) δ 177.25, 176.76, 137.35, 136.83, 134.16, 132.98, 129.42, 
129.01, 128.83, 128.62, 128.57, 128.51, 128.30, 128.12, 128.06, 127.81, 78.48, 76.85, 76.65, 
75.41, 67.86, 66.66, 60.61, 51.66, 20.35, 19.73, 19.48, 16.10. 
IR (thin film, cm-1) 3437, 3063, 3031, 2977, 2931, 2359, 1977, 1693, 1498, 1454, 1374, 1334, 
1283, 1247, 1203, 1178, 1160, 1116 
HRMS: m/z calculated for C19H21NO3 [Na]+: 334.14136; found: 334.14120 
 
 
3-((Benzyloxy)amino)-5-methyl-3,4-diphenyldihydrofuran-2(3H)-one (2.56) 
 
 
 
 
 
 
The average isolated yield for 2.56 was 41 mg, 64% (2 trials), synthesized using General 
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Procedure A with β-methylstyrene 1a, oxime 2.53 (0.17 mmol), 0.024M, (2,6-lutidine was 
omitted) and an irradiation time of 24 hours. The title compound was obtained as a 1.2:1 mixture 
of inseparable diastereomers based on an average of two trials. The product was isolated by 
column chromatography on silica gel (10% Et2O/hexanes then 30% Et2O/hexanes) as a yellow 
oil.  
Analytical data for 2.56:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ7.48 (d, J = 7.9 Hz, 2H), 7.40 (dd, 
J = 8.3, 6.8 Hz, 3H), 7.37 – 7.28 (m, 11H), 7.22 (ddd, J = 8.5, 5.3, 1.6 Hz, 3H), 7.20 – 7.15 (m, 
1H), 7.15 – 7.08 (m, 6H), 6.84 (dt, J = 8.8, 1.6 Hz, 2H), 6.60 – 6.48 (m, 2H), 6.15 (s, 1H-major), 
5.87 (s, 1H-minor), 5.32 – 5.17 (m, 1H-major), 5.05 – 4.92 (m, 2H-major), 4.76 – 4.61 (m, 3H-
minor), 3.96 (dd, J = 10.8, 2.2 Hz, 1H-major), 3.42 (dd, J = 10.3, 2.1 Hz, 1H-minor), 1.43 (d, J = 
6.1 Hz, 6H-3H minor, 3H major). 
13C NMR for major/minor diastereomer (151 MHz, CDCl3) (some peaks of the minor/major 
diastereomers are overlapping) δ 176.41, 175.76, 138.15, 137.30, 136.69, 134.08, 133.17, 
132.60, 129.58, 129.34, 128.93, 128.76, 128.74, 128.68, 128.66, 128.61, 128.53, 128.29, 128.22, 
128.19, 128.16, 128.12, 127.63, 127.47, 126.48, 78.52, 76.86, 76.54, 76.35, 73.11, 62.40, 54.74, 
19.89, 18.88.  
IR (thin film, cm-1) 3433, 3063, 3031, 2978, 2929, 2360, 1778, 1639, 1497, 1453, 1385, 1332, 
1277, 1194, 1060 
HRMS: m/z calculated for C24H23NO3 [Na]+: 396.15701; found: 396.15677 
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3-((Benzyloxy)amino)-4-(2-chlorophenyl)-5-methyldihydrofuran-2(3H)-one (2.57) 
 
 
 
 
 
 
 
 
The average isolated yield for 2.57 was 84 mg, 77% (2 trials), synthesized using General 
Procedure A with β-methyl-2-chlorostyrene 1i, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 1:1 mixture of separable diastereomers based on an 
average of two trials. The products were isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as yellow oils.  
Analytical data for 2.57:  
1H NMR for major diastereomer (600 MHz, CDCl3) δ 7.46 (dd, J = 7.8, 1.4 Hz, 1H), 7.33 – 7.27 
(m, 5H), 7.23 (t, J = 7.7 Hz, 3H), 6.13 (s, 1H), 4.77 – 4.63 (m, 2H), 4.55 (dq, J = 9.4, 6.1 Hz, 
1H), 4.22 (d, J = 10.8 Hz, 1H), 4.13 (dd, J = 10.9, 9.4 Hz, 1H), 1.45 (d, J = 6.1 Hz, 3H). 
13C NMR for major diastereomer (151 MHz, CDCl3) δ 173.41, 137.15, 134.79, 134.57, 130.63, 
129.20, 129.00, 128.60, 128.49, 128.08, 127.75, 79.80, 77.19, 67.25, 49.25, 19.53. 
IR (thin film, cm-1) 3054, 2360, 1778, 1421, 1265, 1189 
HRMS: m/z calculated for C18H18ClNO3 [Na]+ 354.08674; found: 354.08655 
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1H NMR for minor diastereomer (600 MHz, CDCl3) δ 7.49 – 7.45 (m, 1H), 7.33 – 7.31 (m, 2H), 
7.31 – 7.28 (m, 2H), 7.28 – 7.26 (m, 2H), 7.17 – 7.13 (m, 2H), 5.71 (s, 1H), 5.13 (dq, J = 8.9, 6.3 
Hz, 1H), 4.38 – 4.28 (m, 2H), 4.22 (d, J = 8.7 Hz, 1H), 3.82 (t, J = 8.8 Hz, 1H), 1.48 (d, J = 6.3 
Hz, 3H). 
13C NMR for minor diastereomer (151 MHz, CDCl3) δ 174.39, 136.74, 135.30, 132.67, 130.08, 
129.05, 128.89, 128.52, 128.39, 128.10, 127.17, 79.74, 76.33, 62.50, 49.51, 20.02. 
IR (thin film, cm-1) 3231, 3063, 3031, 2978, 2931, 1779, 1477, 1209, 1063 
HRMS: m/z calculated for C18H18ClNO3 [Na]+: 354.08674; found: 354.08661 
 
3-((Benzyloxy)amino)-4-(3-chlorophenyl)-5-methyldihydrofuran-2(3H)-one (2.58) 
 
 
 
 
 
 
The average isolated yield for 2.58 was 80 mg, 73% (2 trials), synthesized using General 
Procedure A with β-methyl-3-chlorostyrene 1j, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 1.8:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.58:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.32 (dt, J = 4.2, 1.8 Hz, 5H), 7.30 
	 	 66 
(dt, J = 5.0, 1.3 Hz, 3H), 7.26 – 7.21 (m, 3H), 7.16 (dd, J = 5.0, 2.6 Hz, 1H), 7.13 (d, J = 1.7 Hz, 
1H), 7.06 (s, 1H), 6.10 (s, 1H -major), 5.68 (s, 1H-minor), 4.96 (dq, J = 7.6, 6.3 Hz, 1H-minor), 
4.67 (s, 2H-major), 4.50 – 4.42 (m, 3H-2 minor, 1 major), 4.03 (d, J = 8.5 Hz, 1H -minor), 3.97 
(d, J = 11.3 Hz, 1H-major), 3.38 (t, J = 8.0 Hz, 1H-minor), 3.34 (dd, J = 11.2, 9.9 Hz, 1H-
major), 1.45 (d, J = 6.3 Hz, 3H-minor), 1.41 (d, J = 6.1 Hz, 3H-major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.73, 173.08, 138.76, 137.12, 
136.88, 136.52, 135.14, 134.89, 130.55, 130.23, 129.21, 128.89, 128.62, 128.60, 128.58, 128.35, 
128.29, 128.24, 128.23, 128.19, 127.23, 125.99, 80.69, 79.30, 77.25, 76.51, 67.80, 63.61, 52.69, 
52.26, 20.21, 19.13. 
IR (thin film, cm-1) 3063, 2981, 2931, 1772, 1455, 1266, 1191, 1065 
HRMS: m/z calculated for C18H18ClNO3 [Na]+: 354.08674; found: 354.08664 
 
3-((Benzyloxy)amino)-4-(4-chlorophenyl)-5-methyldihydrofuran-2(3H)-one (2.59) 
 
 
 
 
 
 
 
The average isolated yield for 2.59 was 67 mg, 62% (2 trials), synthesized using General 
Procedure A with β-methyl-4-chlorostyrene 1k, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 2.4:1 mixture of inseparable diastereomers. The product 
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was isolated by column chromatography on silica gel (10% EtOAc/hexanes then 30% 
EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.59:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.38 – 7.27 (m, 7H), 7.21 (ddd, J 
= 9.8, 7.3, 1.8 Hz, 3H), 7.13 – 7.08 (m, 2H), 6.12 (s, 1H-major), 5.67 (s, 1H-minor), 4.99 – 4.89 
(m, 1H-minor), 4.69 – 4.61 (m, 2H-major), 4.50 – 4.38 (m, 3H-2 minor, 1 major), 4.03 (d, J = 
8.5 Hz, 1H-minor), 3.97 (d, J = 11.3 Hz, 1H-major), 3.45 – 3.29 (m, 2H-1 minor, 1 major), 1.44 
(d, J = 6.3 Hz, 3H-minor), 1.40 (d, J = 6.1 Hz, 3H-major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.81, 173.15, 137.11, 136.63, 
135.08, 133.95, 133.87, 133.28, 130.30, 130.02, 129.42, 129.24, 129.11, 128.79, 128.55, 128.52, 
128.20, 128.17, 80.76, 79.34, 77.20, 76.47, 67.77, 63.49, 52.31, 52.12, 20.14, 18.98.  
IR (thin film, cm-1) 2980, 2931, 1777, 1592, 1494, 1455, 1386, 1266, 1191, 1091, 1014 
HRMS: m/z calculated for C18H18ClNO3 [Na]+: 354.08674; found: 354.08657 
 
3-((Benzyloxy)amino)-4-(3-bromophenyl)-5-methyldihydrofuran-2(3H)-one (2.60) 
 
 
 
 
 
 
 
The average isolated yield for 2.60 was 89 mg, 72% (2 trials), synthesized using General 
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Procedure A with β-methyl-3-bromostyrene 1g, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 1.8:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.60:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.53 – 7.46 (m, 2H), 7.38 – 7.33 
(m, 4H), 7.33 – 7.29 (m, 2H), 7.29 – 7.22 (m, 5H), 7.13 (dt, J = 7.8, 1.2 Hz, 1H), 6.15 (s, 1H-
major), 5.71 (s, 1H-minor), 5.02 – 4.95 (m, 1H-minor), 4.69 (s, 2H-major), 4.53 – 4.43 (m, 3H-2 
minor, 1 major), 4.05 (d, J = 8.5 Hz, 1H-minor), 4.00 (d, J = 11.3 Hz, 1H-major), 3.40 (t, J = 8.1 
Hz, 1H-minor), 3.34 (dd, J = 11.2, 9.9 Hz, 1H-major), 1.47 (dd, J = 6.3, 1.3 Hz, 3H-minor), 1.43 
(dd, J = 6.1, 1.5 Hz, 3H-major). 
113C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.72, 173.06, 139.02, 137.12, 
137.09, 136.59, 132.07, 131.22, 131.09, 131.03, 130.77, 130.46, 128.84, 128.56, 128.54, 128.24, 
128.18, 127.68, 126.48, 126.45, 123.25, 123.00, 80.64, 79.25, 77.18, 76.42, 67.74, 63.57, 52.59, 
52.15, 20.14, 19.07.  
IR (thin film, cm-1) 3251, 3062, 3030, 2977, 2929, 1777, 1714, 1595, 1567, 1476, 1192, 1064 
HRMS: m/z calculated for C18H18BrNO3 [Na]+: 398.03623; found: 398.03612 
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3-((Benzyloxy)amino)-4-(4-bromophenyl)-5-methyldihydrofuran-2(3H)-one (2.61) 
 
 
 
 
 
 
The average isolated yield for 2.61 was 91 mg, 73% (2 trials), synthesized using General 
Procedure A with β-methyl-4-bromostyrene 1h, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 1.8:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.61:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.50 (dd, J = 10.5, 8.2 Hz, 3H), 
7.35 – 7.28 (m, 5H), 7.24 – 7.18 (m, 3H), 7.15 (d, J = 8.4 Hz, 1H), 7.07 – 7.01 (m, 2H), 6.11 (s, 
1H-major), 5.66 (s, 1H-minor), 5.00 – 4.88 (m, 1H-minor), 4.69 – 4.61 (m, 2H-major), 4.45 (q, J 
= 5.6, 5.1 Hz, 3H-2 minor, 2 major), 4.03 (d, J = 8.5 Hz, 1H-minor), 3.97 (d, J = 11.3 Hz, 1H-
major), 3.41 – 3.29 (m, 2H-1 minor, 1 major), 1.44 (d, J = 6.3 Hz, 3H-minor), 1.40 (dd, J = 6.1, 
1.2 Hz, 3H-major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.76, 173.09, 137.10, 135.63, 
135.62, 133.84, 132.41, 132.10, 130.65, 130. 09, 129.58, 128.82, 128.58, 128.55, 128.23, 128.21, 
122.04, 122.01, 80.71, 79.29, 77.23, 76.51, 67.75, 63.47, 52.42, 52.26, 20.18, 19.02.  
IR (thin film, cm-1) 3470, 3257, 3063, 3031, 2978, 2930, 2871, 1779, 1715, 1587, 1491, 1455, 
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1386, 1192 
HRMS: m/z calculated for C18H18BrNO3 [Na]+: 398.03623; found: 398.03617 
 
 
3-((Benzyloxy)amino)-4-(4-fluorophenyl)-5-methyldihydrofuran-2(3H)-one (2.62) 
 
 
 
 
 
 
The average isolated yield for 2.62 was 69 mg, 66% (2 trials), synthesized using General 
Procedure A with β-methyl-4-fluorostyrene 1l, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 2.0:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.62:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.31 (td, J = 6.9, 6.2, 3.3 Hz, 4H), 
7.27 – 7.20 (m, 3H), 7.15 (dd, J = 8.5, 5.4 Hz, 2H), 7.07 (dt, J = 10.5, 8.6 Hz, 3H), 6.11 (s, 1H-
major), 5.66 (s, 1H-minor), 5.00 – 4.91 (m, 1H-minor), 4.71 – 4.63 (m, 2H-major), 4.51 – 4.41 
(m, 3H-2 minor, 1 major), 4.02 (d, J = 8.4 Hz, 1H-minor), 3.97 (dd, J = 11.5, 1.6 Hz, 1H-major), 
3.46 – 3.32 (m, 2H-1 minor, 1 major), 1.44 (d, J = 6.3 Hz, 3H-minor), 1.41 (d, J = 6.1 Hz, 3H-
major). 
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13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ  173.88, 173.27, 163.28, 163.21, 
161.65, 161.58, 137.17, 136.71, 132.28, 132.26, 130.61, 130.55, 130.46, 130.44, 129.49, 129.44, 
128.78, 128.55, 128.52, 128.16, 116.27, 116.13, 115.98, 115.83, 80.96, 79.52, 77.22, 76.51, 
67.88, 63.52, 52.27, 51.94, 20.11, 18.95.  
IR (thin film, cm-1) 3475, 2978, 2930, 1778, 1603, 1512, 1455, 1387, 1330, 1227, 1096 
HRMS: m/z calculated for C18H18FNO3 [Na]+: 338.11629; found: 338.11612 
 
 
3-((Benzyloxy)amino)-4-(2-methoxyphenyl)-5-methyldihydrofuran-2(3H)-one (2.63) 
 
 
 
 
 
 
The average isolated yield for 2.63 was 63 mg, 58% (2 trials), synthesized using General 
Procedure A with β-methyl-2-methoxystyrene 1p, oxime 2.51, and an irradiation time of 24 
hours. The title compound was obtained as a 1.2:1 mixture of inseparable diastereomers based on 
an average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.63:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.36 – 7.28 (m, 5H), 7.26 (td, J = 
6.9, 3.3 Hz, 4H), 7.19 (dd, J = 7.6, 1.6 Hz, 1H), 7.15 – 7.09 (m, 2H), 7.03 (dd, J = 7.4, 1.7 Hz, 
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1H), 7.00 (td, J = 7.5, 1.1 Hz, 1H), 6.97 – 6.89 (m, 3H), 6.11 (s, 1H-major), 5.67 (s, 1H-minor), 
5.09 – 4.99 (m, 1H-minor), 4.76 – 4.64 (m, 3H-2 minor, 1 major), 4.43 (d, J = 10.4 Hz, 1H-
major), 4.30 (s, 2H-minor), 4.15 (d, J = 8.8 Hz, 1H-minor), 3.82 (s, 3H-major), 3.79 (s, 3H-
minor), 3.65 (t, J = 8.5 Hz, 1H-minor), 3.51 (dd, J = 10.3, 9.2 Hz, 1H-major), 1.47 (d, J = 6.3 
Hz, 3H-minor), 1.37 (d, J = 6.2 Hz, 3H-major).  
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 174.97, 174.87, 157.86, 157.64, 
137.40, 137.14, 130.92, 129.30, 128.92, 128.76, 128.57, 128.47, 128.38, 128.35, 128.03, 127.89, 
124.63, 123.56, 121.14, 120.77, 111.28, 110.67, 79.79, 78.00, 77.20, 76.32, 65.58, 62.46, 55.44, 
55.32, 50.16, 47.48, 20.46, 19.91.  
IR (thin film, cm-1) 3436, 3063, 3013, 2976, 2932, 2839, 1777, 1601, 1587, 1495, 1463, 1455, 
1384, 1247 
HRMS: m/z calculated for C19H21NO4 [Na]+: 350.13628; found: 350.13606 
 
3-((Benzyloxy)amino)-4-(3-methoxyphenyl)-5-methyldihydrofuran-2(3H)-one (2.64) 
 
 
 
 
 
 
 
The average isolated yield for 2.64 was 70 mg, 65% (2 trials), synthesized using General 
Procedure A with β-methyl-3-methoxystyrene 1q, oxime 2.51, and an irradiation time of 24 
Major Minor
+
O
NH
OMe O
O
NH
O
Me O
MeO MeO
	 	 73 
hours. The title compound was obtained as a 2.0:1 mixture of inseparable diastereomers based on 
an average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.64:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.33 – 7.27 (m, 6H), 7.25 – 7.22 
(m, 3H), 6.89 – 6.83 (m, 3H), 6.81 (dt, J = 7.7, 1.2 Hz, 1H), 6.77 (t, J = 2.1 Hz, 1H), 6.09 (s, 1H-
major), 5.68 (s, 1H-minor), 5.00 (dq, J = 7.8, 6.3 Hz, 1H-minor), 4.70 (q, J = 11.6 Hz, 2H-
major), 4.55 – 4.46 (m, 3H-2 minor, 1 major), 4.07 – 3.99 (m, 2H-1 minor, 1 major), 3.81 (s, 3H-
major), 3.79 (s, 3H-minor), 3.45 – 3.32 (m, 2H-1 minor, 1 major), 1.44 (d, J = 6.3 Hz, 3H-
minor), 1.42 (d, J = 6.1 Hz, 3H-major).  
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.94, 173.45, 160.23, 160.07, 
138.17, 137.21, 136.89, 135.98, 130.36, 130.06, 128.71, 128.59, 128.48, 128.42, 128.11, 128.09, 
121.18, 120.07, 114.96, 114.18, 113.12, 112.93, 80.71, 79.53, 77.32, 76.67, 67.96, 63.73, 55.41, 
55.35, 53.15, 52.61, 20.12, 19.12.  
IR (thin film, cm-1) 3434,  2348, 1777, 1643, 1602, 1491, 1455, 1291, 1265, 119, 1063 
HRMS: m/z calculated for C19H21NO4 [Na]+: 350.13628; found: 350.13612 
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3-((Benzyloxy)amino)-4-(4-methoxyphenyl)-5-methyldihydrofuran-2(3H)-one (2.65) 
 
 
 
 
 
 
The average isolated yield for 2.65 was 50 mg, 46% (2 trials), synthesized using General 
Procedure A with anethole 1b, oxime 2.51, and an irradiation time of 24 hours. The title 
compound was obtained as a 2.1:1 mixture of inseparable diastereomers based on an average of 
two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.65:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.34 – 7.27 (m, 5H), 7.25 – 7.19 
(m, 4H), 7.14 – 7.10 (m, 2H), 6.93 – 6.88 (m, 3H), 6.09 (d, J = 1.9 Hz, 1H-major), 5.66 (d, J = 
3.1 Hz, 1H-minor), 4.96 (dq, J = 7.8, 6.3 Hz, 1H-minor), 4.73 – 4.64 (m, 2H-major), 4.52 (d, J = 
2.9 Hz, 2H-2 minor), 4.46 (dq, J = 10.0, 6.1 Hz, 1H-major), 4.02 – 3.94 (m, 2H-1 minor, 1 
major), 3.82 (d, J = 4.2 Hz, 6H-3 minor, 3 major), 3.40 – 3.31 (m, 2H-1 minor, 1 major), 1.43 (d, 
J = 6.3 Hz, 3H-minor), 1.40 (d, J = 6.1 Hz, 3H-major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 13C NMR (151 MHz, CDCl3) δ 
174.18, 173.61, 159.37, 159.27, 137.20, 136.83, 130.04, 128.95, 128.76, 128.56, 128.51, 128.49, 
128.21, 128.11, 126.14, 114.63, 114.38, 81.08, 79.76, 77.28, 76.60, 67.93, 63.68, 55.46, 55.43, 
52.45, 51.85, 20.06, 18.93.  
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IR (thin film, cm-1) 3465, 2975, 2932, 2837, 2348, 2282, 1778, 1613, 1515, 1455, 1386, 1250 
HRMS: m/z calculated for C19H21NO4 [Na]+: 350.13628; found: 350.13607 
 
3-((Benzyloxy)amino)-5-methyl-4-(m-tolyl)dihydrofuran-2(3H)-one (2.66) 
 
 
 
 
 
 
The average isolated yield for 2.66 was 66 mg, 64% (2 trials), synthesized using General 
Procedure A with β-methyl-3-methylstyrene 1m, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 2.4:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.66:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.32 – 7.27 (m, 4H), 7.25 – 7.23 
(m, 1H), 7.21 (td, J = 7.5, 1.7 Hz, 3H), 7.15 – 7.10 (m, 1H), 7.06 (d, J = 8.2 Hz, 1H), 6.99 (d, J = 
8.4 Hz, 2H), 6.07 (s, 1H-major), 5.64 (s, 1H-minor), 5.04 – 4.96 (m, 1H-minor), 4.72 – 4.63 (m, 
2H-major), 4.53 – 4.43 (m, 3H-2 minor, 1 major), 4.06 – 3.96 (m, 2H-1 major, 1 minor), 3.40 – 
3.30 (m, 2H-1 major, 1 minor), 2.35 (d, J = 3.4 Hz, 6H-3 major, 3 minor), 1.43 (d, J = 6.3 Hz, 
3H-minor), 1.40 (d, J = 6.1 Hz, 3H-major). 
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13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 174.07, 173.57, 139.00,  138.72, 
137.25, 136.96, 136.49, 134.41, 129.64, 129.17, 128.92, 128.88, 128.80, 128.77, 128.61, 128.51, 
128.49, 128.11, 128.07, 125.95, 124.99, 80.77, 79.72, 77.29, 76.57, 68.00, 63.72, 53.04, 52.61, 
21.60, 21.58, 20.15, 19.09.  
IR (thin film, cm-1) 3446, 3030, 2977, 2928, 1777, 1716, 1654, 1608, 1493, 1454, 1386, 1328, 
1190 
HRMS: m/z calculated for C19H21NO3 [Na]+: 334.14136; found: 334.14120 
 
 
3-((Benzyloxy)amino)-5-methyl-4-(p-tolyl)dihydrofuran-2(3H)-one (2.67) 
 
 
 
 
 
 
 
The average isolated yield for 2.67 was 64 mg, 62% (2 trials), synthesized using General 
Procedure A with β-methyl-4-methylstyrene 1n, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 2.1:1 mixture of inseparable diastereomers based on an 
average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.67:  
Major Minor
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1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.33 – 7.27 (m, 5H), 7.22 (ddt, J = 
5.1, 3.6, 1.6 Hz, 3H), 7.21 – 7.15 (m, 5H), 7.11 (d, J = 7.9 Hz, 2H), 6.08 (s, 1H-major), 5.66 (s, 
1H-minor), 5.04 – 4.97 (m, 1H-minor), 4.68 (q, J = 11.6 Hz, 2H-major), 4.54 – 4.44 (m, 3H-2 
minor, 1 major), 4.05 – 3.97 (m, 2H-1 minor, 1 major), 3.43 – 3.33 (m, 2H-1 minor, 1 major), 
2.37 (d, J = 2.4 Hz, 6H-3 minor, 3 major), 1.44 (d, J = 6.3 Hz, 3H-minor), 1.41 (d, J = 6.1 Hz, 
3H-major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 174.11, 173.56, 137.92,  137.81, 
137.25,  136.93, 133.43, 131.33, 129.97, 129.74, 128.80, 128.74, 128.56, 128.49, 128.47, 128.09, 
127.80, 80.86, 79.72, 77.30, 76.59, 67.99, 63.73, 52.79, 52.37, 21.22, 21.20, 20.10, 19.01.  
IR (thin film, cm-1) 3444, 1778, 1644, 1516, 1454, 1385, 1188, 1063 
HRMS: m/z calculated for C19H21NO3 [Na]+: 334.14136; found: 334.14118 
 
 
3-((Benzyloxy)amino)-4-(4-(tert-butyl)phenyl)-5-methyldihydrofuran-2(3H)-one (2.68) 
 
 
 
 
 
 
 
 
The average isolated yield for 2.68 was 70 mg, 60% (2 trials), synthesized using General 
Major Minor
+
O
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OMe O
O
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O
Me O
Me
MeMe Me
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Procedure A with β-methyl-4-tert-butylstyrene 1o, oxime 2.51, and an irradiation time of 24 
hours. The title compound was obtained as a 2.4:1 mixture of inseparable diastereomers based on 
an average of two trials. The product was isolated by column chromatography on silica gel (10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a yellow oil.  
Analytical data for 2.68:  
1H NMR for major/mnor diastereomers (600 MHz, CDCl3) δ 7.43 – 7.38 (m, 3H), 7.33 – 7.27 
(m, 4H), 7.24 – 7.19 (m, 4H), 7.18 – 7.14 (m, 2H), 6.11 (s, 1H-major), 5.66 (s, 1H-minor), 5.05 – 
4.99 (m, 1H-minor), 4.74 – 4.64 (m, 2H-major), 4.54 – 4.46 (m, 3H-2 minor, 1 major), 4.08 – 
3.99 (m, 2H-1 minor, 1 major), 3.40 (t, J = 10.5 Hz, 2H-1 minor, 1 major), 1.45 (d, J = 6.3 Hz, 
3H-minor), 1.42 (d, J = 6.1 Hz, 3H-major), 1.36 – 1.33 (m, 18H-9 minor, 9 major). 
13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 174.11, 173.58, 151.06, 151.00, 
137.16, 136.95, 133.36, 131.27,  128.75, 128.61, 128.54, 128.45, 128.08, 128.04, 127.56, 126.18, 
125.92, 80.81, 79.71, 77.32, 76.55, 67.94, 63.72, 52.67, 52.33, 34.66, 31.42, 20.10, 19.07.  
IR (thin film, cm-1) 3458, 3063, 3031, 2963, 2868, 2359, 1777, 2644, 1516, 1455, 1386, 1363, 
1330, 1268, 1189, 1064 
HRMS: m/z calculated for C19H21NO3 [Na]+: 376.18831; found: 376.18822 
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3-((Benzyloxy)amino)-4-methyl-4-phenyldihydrofuran-2(3H)-one (2.69) 
 
 
 
 
 
 
The average isolated yield for 2.69 was 57 mg, 58% (2 trials), synthesized using General 
Procedure A with α-methylstyrene 1d, oxime 2.51, Mes-Acr-Ph, 2.5 mol%, and an irradiation 
time of 24 hours. The title compound was obtained as a 2.9:1 mixture of separable diastereomers 
based on an average of two trials. The products were isolated by column chromatography on 
silica gel (15% EtOAc /hexanes then 20% EtOAc/hexanes) as yellow oils.  
Analytical data for 2.69:  
1H NMR for major diastereomer (600 MHz, CDCl3) δ 7.47 – 7.43 (m, 2H), 7.39 (dd, J = 8.4, 6.8 
Hz, 2H), 7.34 – 7.28 (m, 4H), 7.22 – 7.16 (m, 2H), 6.20 – 6.07 (m, 1H), 4.71 – 4.58 (m, 2H), 
4.35 (d, J = 3.0 Hz, 1H), 4.31 (d, J = 1.2 Hz, 2H), 1.50 (s, 3H). 
13C NMR for major diastereomer (151 MHz, CDCl3) δ 174.57, 142.57, 136.94, 129.04, 128.75, 
128.51, 128.18, 127.46, 125.93, 76.90, 76.72, 68.07, 47.43, 21.23.  
IR (thin film, cm-1) 3447, 3062, 3036, 2969, 2915, 2360, 1778, 1639, 1497, 1454, 1366, 1292, 
1188, 1141, 1062 
HRMS: m/z calculated for C18H19NO3 [Na]+: 320.12571; found: 320.12557 
1H NMR for minor diastereomer (600 MHz, CDCl3) δ 7.40 (ddd, J = 8.0, 6.6, 1.2 Hz, 2H), 7.34 
– 7.27 (m, 4H), 7.26 – 7.22 (m, 2H), 7.15 (dd, J = 7.7, 1.8 Hz, 2H), 5.70 (d, J = 4.4 Hz, 1H), 4.83 
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(d, J = 8.5 Hz, 1H), 4.39 – 4.25 (m, 3H), 3.77 (d, J = 4.2 Hz, 1H), 1.57 (s, 3H). 
13C NMR for minor diastereomer (151 MHz, CDCl3) δ 175.16, 140.14, 136.97, 128.97, 128.63, 
128.46, 128.09, 127.55, 126.79, 77.04, 76.48, 68.79, 46.90, 27.42.  
IR (thin film, cm-1) 3433, 3061, 3030, 2965, 2923, 2871, 2359, 1779, 1634, 1602, 1497, 1454, 
1387, 1364, 1291, 1213, 1176, 1118 
HRMS: m/z calculated for C18H19NO3 [Na]+: 320.12571; found: 320.12551 
 
 
3-((Benzyloxy)amino)-3a-phenylhexahydrobenzofuran-2(3H)-one (2.70) 
 
 
 
 
 
 
The average isolated yield for 2.70 was 98 mg, 88% (2 trials), synthesized using General 
Procedure A with 1-phenyl-1-cyclohexene 1e, oxime 2.51, and an irradiation time of 24 hours. 
The title compound was obtained as a 1.5:1 mixture of separable diastereomers based on an 
average of two trials. The products were isolated by column chromatography on silica gel (20% 
EtOAc /hexanes then 30% EtOAc/hexanes). The minor product was obtained as a coconut-
scented, yellow oil and the major product as a cream-colored solid.   
Analytical data for 2.70:  
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1H NMR for major diastereomer (600 MHz, CDCl3) δ 7.52 (dd, J = 8.3, 1.3 Hz, 2H), 7.43 (t, J = 
7.8 Hz, 2H), 7.37 – 7.30 (m, 1H), 7.23 (dd, J = 4.9, 1.9 Hz, 3H), 6.96 (dd, J = 6.7, 2.9 Hz, 2H), 
6.04 – 5.92 (m, 1H), 4.90 (t, J = 2.4 Hz, 1H), 4.50 – 4.36 (m, 2H), 4.26 (d, J = 2.3 Hz, 1H), 2.44 
(dt, J = 15.0, 3.2 Hz, 1H), 2.20 – 2.07 (m, 1H), 1.71 (dt, J = 13.2, 3.2 Hz, 1H), 1.59 – 1.45 (m, 
4H), 1.39 (dd, J = 11.2, 2.6 Hz, 1H). 
13C NMR for major diastereomer (151 MHz, CDCl3) δ 173.96, 139.33, 136.87, 128.96, 128.61, 
128.31, 127.98, 127.24, 126.89, 80.65, 76.66, 74.72, 48.61, 26.61, 24.91, 20.98, 19.56.  
IR (thin film, cm-1) 3436, 3258, 3054, 2934, 2867, 1779, 1601, 1496, 1449, 1364, 1297, 1264, 
1190, 1140, 1094, 1055, 1018 
HRMS: m/z calculated for C21H23NO3 [Na]+: 360.15701; found: 360.15690 
1H NMR for minor diastereomer (some major diastereomer peaks are present in the major 
diastereomers spectrum) (600 MHz, CDCl3) δ 7.43 (t, J = 7.7 Hz, 3H), 7.37 – 7.30 (m, 2H), 7.28 
(dd, J = 7.6, 2.0 Hz, 3H), 7.09 (dd, J = 7.4, 2.1 Hz, 2H), 5.60 (s, 1H), 5.35 (t, J = 3.4 Hz, 1H), 
4.24 (dd, J = 66.5, 11.4 Hz, 2H), 3.56 (s, 1H), 2.31 – 2.22 (m, 1H), 2.04 (d, J = 13.9 Hz, 1H), 
2.00 – 1.93 (m, 1H), 1.72 (td, J = 13.3, 3.2 Hz, 1H), 1.59 (ddt, J = 11.2, 7.6, 3.3 Hz, 2H), 1.53 – 
1.48 (m, 1H), 1.18 – 1.07 (m, 1H). 
13C NMR for minor diastereomer (151 MHz, CDCl3) δ 173.97, 139.35, 136.88, 128.98, 128.62, 
128.32, 127.99, 127.25, 126.91, 80.66, 76.68, 74.73, 48.62, 26.63, 24.92, 20.99, 19.57.   
IR (thin film, cm-1) 3446, 3060, 3030, 2938, 2861, 2360, 2341, 1771, 1669, 1601, 1496, 1366, 
1290, 1267, 1248, 1204 
HRMS: m/z calculated for C21H23NO3 [Na]+: 360.15701; found:360.15691 
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3-((Benzyloxy)amino)-4,4,5-trimethyldihydrofuran-2(3H)-one (2.71) 
 
 
 
 
 
 
 
The average isolated yield for 2.71 was 34 mg, 42% (2 trials), synthesized using General 
Procedure A with 2-methyl-2-butene 1f (3.0 equiv), oxime 2.51, Mes-Acr-Ph, 2.5 mol%, and an 
irradiation time of 24 hours in a 1-dram vial. The title compound was obtained as a 1.7:1 mixture 
of inseparable diastereomers based on an average of two trials. The product was isolated by 
column chromatography on silica gel (20% EtOAc /hexanes then 30% EtOAc/hexanes) as a 
yellow oil.  
Analytical data for 2.71:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.35 (t, J = 4.9 Hz, 6H), 7.34 – 
7.29 (m, 2H), 5.94 (s, 2H-1 minor, 1 major), 4.79 – 4.69 (m, 4H-2 minor, 2-major), 4.36 (q, J = 
6.7 Hz, 1H-minor), 4.15 (q, J = 6.5 Hz, 1H-major), 3.74 (s, 1H-major), 3.54 (s, 1H-minor), 
1.28(dd, J = 6.6, 3.5 Hz, 6H-3-minor, 3-major), 1.17 (s, 3H-major), 1.11 (s, 3H-minor), 1.09 (s, 
3H-minor), 0.89 (s, 3H-major). 
13C NMR for major/minor diastereomer (151 MHz, CDCl3) δ 174.80, 174.05, 137.23 ,137.01, 
128.76, 128.67, 128.60, 128.56, 128.21, 128.19, 84.39, 82.18, 76.71, 76.46, 70.07, 68.27, 43.80, 
41.51, 23.37, 22.02, 21.27, 15.45, 15.22, 13.07.  
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IR (thin film, cm-1) 3516, 3257, 3088, 5063, 3031, 2976, 2932, 2873, 1772, 1639, 1536, 1469, 
1469, 1455, 1389, 1572, 1284, 1212, 1186, 1064 
HRMS: m/z calculated for C14H19NO3 [Na]+: 272.12571; found: 272.12557 
 
 
3-((Benzyloxy)amino)-3,3a,8,8a-tetrahydro-2H-indeno[2,1-b]furan-2-one (2.72) 
 
 
 
 
 
 
 
The average isolated yield for 2.72 was 51 mg, 53% (2 trials), synthesized using General 
Procedure A with indene 1c, oxime 2.51, and an irradiation time of 24 hours. The title compound 
was obtained as a 1.0:1 mixture of separable diastereomers based on an average of two trials. 
The products were isolated by column chromatography on silica gel (10% EtOAc /hexanes then 
30% EtOAc/hexanes). The minor product was obtained as a brown solid and the major product 
as a purple oil.   
Analytical data for 2.72:  
1H NMR for major diastereomer (600 MHz, CDCl3) δ 7.54 – 7.26 (m, 7H), 7.25 (s, 2H), 6.23 (s, 
1H), 5.33 (s, 1H), 4.82 (d, J = 6.5 Hz, 2H), 3.91 (dd, J = 6.0, 1.8 Hz, 1H), 3.79 (d, J = 1.9 Hz, 
1H), 3.31 – 3.27 (m, 2H). 
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13C NMR for major diastereomer (151 MHz, CDCl3) δ 175.89, 140.59, 140.35, 137.07, 128.78, 
128.70, 128.60, 128.42, 127.91, 125.51, 125.09, 84.52, 77.22, 66.91, 51.12, 38.88. 
IR (thin film, cm-1) 3505, 3241, 3030, 2921, 1772, 1481, 1455, 1425, 1354, 1294, 1269, 1205, 
1176, 1114 
HRMS: m/z calculated for C18H17NO3 [Na]+: 318.11006; found: 318.10989 
1H NMR for minor diastereomer (600 MHz, CDCl3) δ 7.50 (d, J = 7.5 Hz, 1H), 7.42 – 7.35 (m, 
4H), 7.35 – 7.30 (m, 1H), 7.30 – 7.26 (m, 2H), 7.23 (td, J = 6.7, 5.9, 2.7 Hz, 1H), 5.97 (d, J = 5.2 
Hz, 1H), 5.23 (dt, J = 5.4, 3.4 Hz, 1H), 4.78 – 4.70 (m, 2H), 4.40 (d, J = 8.8 Hz, 1H), 4.20 (ddd, 
J = 8.8, 5.5, 1.0 Hz, 1H), 3.29 (d, J = 3.4 Hz, 2H). 
13C NMR for minor diastereomer (151 MHz, CDCl3) δ 173.40, 141.26, 137.22, 136.87, 128.78, 
128.67, 128.65, 128.29, 127.55, 127.33, 125.50, 81.82, 76.38, 62.89, 48.91, 39.18. 
IR (thin film, cm-1) 3428, 3055, 3030, 2922, 1770, 1699, 1496, 1478, 1455, 1425, 1362, 1296, 
1266, 1173 
HRMS: m/z calculated for C18H17NO3 [Na]+: 318.11006; found: 318.10991 
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2-((4-((Benzyloxy)amino)-3-(4-methoxyphenyl)-5-oxotetrahydrofuran-2-
yl)methyl)isoindoline-1,3-dione (2.73)  
 
 
 
 
 
 
 
 
The average isolated yield for 2.73 was 64 mg, 41% (2 trials), synthesized using General 
Procedure A with (E)-2-(3-(4-methoxyphenyl)allyl)isoindoline-1,3-dione 1r, oxime 2.51, and an 
irradiation time of 24 hours. The title compound was obtained as a 3.2:1 mixture of inseparable 
diastereomers based on an average of two trials. The product was isolated by column 
chromatography on silica gel (30% EtOAc /hexanes then 50% EtOAc/hexanes) as a cream solid.  
Analytical data for 2.73:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.74 (dd, J = 5.4, 3.1 Hz, 3H), 
7.67 (dd, J = 5.5, 3.0 Hz, 3H), 7.34 – 7.24 (m, 6H), 7.19 (ddd, J = 14.2, 7.4, 1.9 Hz, 1H), 7.12 – 
7.07 (m, 2H), 6.73 (t, J = 8.5 Hz, 3H), 6.00 (s, 1H-major), 5.60 (s, 1H-minor), 5.25 (dt, J = 8.8, 
6.7 Hz, 1H-minor), 4.90 (dt, J = 10.1, 6.2 Hz, 1H-major), 4.74 – 4.64 (m, 2H-major), 4.51 (q, J = 
11.7 Hz, 2H-minor), 4.07 (dd, J = 14.1, 6.6 Hz, 2H-1 minor, 1 major), 3.99 – 3.94 (m, 2H-1 
minor, 1 major), 3.84 (d, J = 11.1 Hz, 2H-1 minor, 1 major), 3.68 (d, J = 1.6 Hz, 6H-3 minor, 3 
major), 3.61 (t, J = 10.6 Hz, 1H-major), 3.55 (t, J = 8.6 Hz, 1H-minor). 
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13C NMR for major/minor diastereomers (151 MHz, CDCl3) δ 173.24, 172.57, 167.96, 167.94, 
159.27, 159.24 137.17, 134.12, 134.11, 131.77, 130.08, 128.80, 128.78, 128.53, 128.11, 127.93, 
124.89, 123.41, 79.77, 78.06, 77.31, 76.64, 68.39, 63.38, 55.35, 55.31, 49.13, 47.72, 40.64, 
40.10. 
IR (thin film, cm-1) 3470, 3560, 3061, 2937, 2838, 1774, 1716, 1694, 1515, 1467, 1455, 1422, 
1395, 1369, 1307, 1254, 1181, 1087 
HRMS: m/z calculated for C27H24N2O6 [H]+: 473.17071; found: 473.17079 
 
 
3-((Benzyloxy)amino)-4-(4-(tert-butyldimethylsilyl)phenyl)-5-methyldihydrofuran-2(3H)-
one (2.74) 
 
 
 
 
 
 
 
The average isolated yield for 2.74 was 100 mg, 71% (2 trials), synthesized using General 
Procedure A with tert-butyldimethyl(4-(prop-1-en-1-yl)phenyl)silane 1s, oxime 2.51, and an 
irradiation time of 24 hours. The title compound was obtained as a 1.9:1 mixture of inseparable 
diastereomers based on an average of two trials. The product was isolated by column 
chromatography on silica gel (15% EtOAc /hexanes then 20% EtOAc/hexanes) as a yellow oil.  
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Analytical data for 2.74:  
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.34 – 7.27 (m, 5H), 7.27 – 7.21 
(m, 4H), 7.14 (d, J = 8.5 Hz, 1H), 7.09 – 7.04 (m, 2H), 6.84 (t, J = 8.4 Hz, 3H), 6.08 (s, 1H-
major), 5.65 (d, J = 3.1 Hz, 1H-minor), 4.95 (dq, J = 7.7, 6.3 Hz, 1H-minor), 4.68 (q, J = 11.6 
Hz, 2H-major), 4.50 (d, J = 2.9 Hz, 2H-minor), 4.44 (dq, J = 10.0, 6.1 Hz, 1H-major), 3.98 (dd, J 
= 9.9, 6.1 Hz, 2H-1 minor, 1 major), 3.38 – 3.30 (m, 2H-1 minor, 1 major), 1.43 (d, J = 6.3 Hz, 
3H-minor), 1.40 (d, J = 6.1 Hz, 3H-major), 1.00 (s, 18H= 9 minor, 9 major), 0.21 (s, 12H-6 
minor, 6 major). 
13C NMR for major/minor diastereomer (151 MHz, CDCl3) δ  174.11, 173.60, 155.56, 155.49, 
137.30, 136.99, 129.99, 128.91, 128.88, 128.75, 128.55, 128.49, 128.08,  126.95, 120.73, 120.55, 
81.00, 79.77, 77.30, 76.63, 67.93, 63.63, 52.46, 52.01, 25.79, 25.77, 20.10, 18.97, 18.33, 18.30, -
4.25, -4.27.  
IR (thin film, cm-1) 3251, 3062, 3032, 2955, 2930, 2895, 2895, 2857, 2302, 1779, 1692, 1609, 
1511, 1472, 1455, 1421, 1387, 1362, 1329, 1266, 1199, 1174 
HRMS: m/z calculated for C24H33NO4Si [H]+: 428.22516; found: 428.2254 
 
 
Benzyloxyamine Reduction 
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Reduction of product 2.52 was achieved using a procedure adapted from a previously reported 
method.28 A flame dried high-pressure vessel was charged with a stir bar, lactone 2.52 (79 mg, 
0.25 mmol), and Pearlman’s catalyst Pd(OH)2/C (54 mg, 0.38 mmol). The mixture was stirred in 
MeOH (8.5 mL) under hydrogen (40 psi) for 24 hours followed by filtration over celite and a 
MeOH wash. After the solvent was evaporated, the product was dissolved in 5 mL DCM and 
acidified to pH 5 with 1N HCl. The aqueous layer was washed once with 10 mL Et2O and then 
basified to pH 8 with saturated NaHCO3. The product was extracted three times (3x) with 10 mL 
DCM. The combined organic layers we dried over MgSO4 before the solvent was evaporated to 
afford the free amine product as a clear oil (37 mg, 72%). The product was obtained as a 5:1 
mixture of inseparable diastereomers. 
Analytical data: 
1H NMR for major/minor diastereomers (600 MHz, CDCl3) δ 7.42 – 7.33 (m, 6H-3 minor, 3 
major), 7.31 – 7.27 (m, 2H-major), 7.26 – 7.22 (m, 2H-minor), 5.04 (dq, J = 10.1, 6.2 Hz, 1H-
major), 4.84 (dq, J = 12.0, 6.1 Hz, 1H-minor), 3.07 (d, J = 10.7 Hz, 1H-minor), 2.92 (d, J = 10.1 
Hz, 1H-major), 1.45 (d, J = 6.1 Hz, 3H-minor), 1.39 (d, J = 6.2 Hz, 3H-major), 1.37 (s, 3H-
major), 1.01 (s, 3H-minor). 
13C NMR for major diastereomer (151 MHz, CDCl3) δ 179.64, 177.36, 132.76, 132.18, 128.31, 
127.97, 127.88, 127.52, 127.37, 127.08, 76.37, 74.59, 59.79, 59.49, 59.00, 57.67, 24.83, 19.86, 
18.25, 17.82.  
IR (thin film, cm-1) 3853, 3696, 3061, 3032, 2975, 2870, 2389, 1958, 1769, 1690, 1601, 1584, 
1500, 1454, 1376, 1287, 1168,, 1061 
HRMS: m/z calculated for CHNO [H]+ : 206.11756 ; found: 206.11761 
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Stereochemical Assignment- Selective 1D-NOESY 
The stereochemistry for β-methylstyrene-derived products was determined based on 3-
((benzyloxy)amino)-4-(2-methoxyphenyl)-5-methyldihydrofuran-2(3H)-one (2.63) using 
selective 1D-NOESY experiments. Four proton environments were selectively irradiated for the 
major and minor diastereomers. The relative peak amplifications, resulting from a NOE, were 
used to assign the relative stereochemistry of the product. The same procedure was used to 
identify the stereochemistry of 3-((benzyloxy)amino)-4-methyl-4-phenyldihydrofuran-2(3H)-one 
(2.69), 3-((benzyloxy)amino)-3a-phenylhexahydrobenzofuran-2(3H)-one (2.70), 3-
((benzyloxy)amino)-4,4,5-trimethyldihydrofuran-2(3H)-one (2.71), and 3-((benzyloxy)amino)-
3,3a,8,8a-tetrahydro-2H-indeno[2,1-b]furan-2-one (2.72) and 3-((benzyloxy)amino)-3,5-
dimethyl-4-phenyldihydrofuran-2(3H)-one (2.55) (extrapolated to 2.56). See below for spectra.  
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CHAPTER THREE: REVERSING THE REGIOSELECTIVITY OF 
HALOFUNCTIONALIZATION REACTIONS THROUGH COOPERATIVE 
PHOTOREDOX AND COPPER CATALYSIS 
 
3.1 Introduction 
A 1,2-relationship between oxygen and halogen functionality has proven to be an invaluable 
feature in the synthesis of small, bioactive molecules and as a component in advanced synthetic 
routes. Whether existing in the halohydrin or halolactone form, this relationship is widely found 
in biologically active natural and unnatural products (Figure 3-1).  
 
							 	
 
Figure 3-1. Biologically Active Natural and Unnatural Products Exhibiting a 1,2- 
Oxygen/Halogen Relationship
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For example, halolactones 3.1-3.3 have been shown to express potent activity as non-
nucleoside reverse transcriptase inhibitors (NNRTIs).1 In order for HIV-1 to integrate its genetic 
information into its host’s DNA, the reverse transcriptase (RT) enzyme must act to convert the 
virus’ single-stranded viral RNA into the necessary double-stranded DNA form. Interrupting RT 
activity has proven to be an effective method for the treatment of HIV and consequently, NNRTI 
type drugs have been used in HIV combination therapy. As a result, the identification and 
synthesis of these inhibitors has been a key goal in the development of anti-HIV medication. In 
2015, Zhou et al. reported this class of novel halolactone inhibitors and observed anti-HIV 
activity associated with them. 
A common scaffold for the development of highly biologically active materials is the rose 
ketone, or ionone. It was been observed that analogues of this ketone are prevalent in nature, 
exhibiting a variety of biological properties in both plants and animals. Halolactones occur in 
molecules having cytotoxic, antifungal, antiviral, antibacterial, and anticancer activity. For 
example, chloro- and bromolactone derivatives 3.4 have been prepared by Anioł et al. in 2013 
(Figure 3-1).2 While potential bioactivity was recognized in the halolactone form, the value of 
these compounds was further demonstrated through the conversion to their hydroxylactone form 
(3.5). The latter class of lactones was studied for activity against bacteria, fungi, and yeast and 
was found to display activity against the growth of a variety of these microorganisms.  
The natural product bromphycolide A (3.6) has both halolactone and halohydrin functionality 
that contribute to its interesting bioactivity. Since its initial isolation in 2015 from Fijian red 
algae (Callophycus Serratus), this macrolactone has been of interest due to its unique, molecular 
complexity as well as its antitumor and antimalarial activity. Additionally, bromphycolide 
derivatives have been shown to inhibit the growth of problematic bacterial strains such as MRSA 
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and VREF. Krauss and coworkers have presented a concise and impressive route to the 
asymmetric synthesis of the bromphycolide A and D skeleton, both displaying the highly 
valuable 1,2-relationship between oxygen and halogen functionality.3  
Similarly, halohydrins are commonly incorporated into complex synthetic targets. Numerous 
syntheses have been directed toward the preparation of natural product exhibiting a 1,2-
relationship between oxygen and chlorine/bromine atoms (Figure 3-2).4 One of the most 
common arrangements in which this relationship exists is in the form of β-chloro/bromo cyclic 
ethers. This functionality has been observed in the core structure of a significant number of 
natural products (3.7-3.13), which have all been the target of impressive synthetic efforts.  
 
 
				 	
 
Figure 3-2.	Biologically Active β-Halo-Cyclic Ethers 			
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Accessing the desirable 1,2-oxygen-halogen relationship has long been a goal for organic 
chemists given their extensive presence in natural product structures and a diverse display of 
bioactivity. Given such interest, it is not surprising that halofunctionalization methods have been 
studied, developed, and applied extensively throughout the chemical literature.  
3.2 Halofunctionalization of Alkenes 
The halofunctionalization of alkenes is one of the oldest and most commonly employed 
reactions in the field of organic chemistry. In addition, it is also one of the introductory 
transformations has had a well-defined place within entry level textbooks since the 1930s.5 The 
transformation is often introduced as a method of generating vicinal dihalides (Scheme 3-1).6 Pi 
electrons of an olefin, acting as a nucleophile, are capable of attacking halogen molecules, 
including Br2 and Cl2, expelling a halide anion to form a positively charged, three-membered 
ring. The resulting halonium ion, possessing a halide atom with a complete octet, is particularly 
electrophilic given the positive charge and significant ring strain. Back-side, nucleophilic attack 
on the reactive species, by a halide anion, leads to efficient ring opening and stable, vicinal 
dihalide formation. By altering the nucleophilic, ring-opening reagent, it is possible to redirect 
the reactivity toward the formation of halohydrins rather than the dihalide adduct. The addition 
of a nucleophilic solvent, rather than using an inert solvent or neat reactions conditions, favors 
this alternative reaction pathway. Water efficiently opens halonium ions to generate chloro- or 
bromohydrins upon deprotonation. 
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Scheme 3-1. Halofunctionalization of Alkenes  	
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been determined, in many cases, that the nucleophilic partner actually enhances the reactivity of 
the alkene through a form of electron donation known as nucleophile-assisted alkene activation 
(NAAN). Rather than relying on a general mechanism for halohydrin formation, Borhan suggests 
multiple mechanistic pathways, including a concerted process as well as stepwise routes that 
involve the formation of a distinct carbocation intermediate. In cases involving NAAN, 
electrophilic addition to the alkene is assisted by simultaneous nucleophilic attack, resulting in 
pre-polarization of the substrate (Scheme 3-2). The nucleophile’s approach activates the olefin, 
through electron donation, allowing for more efficient attack on the electrophile rather than 
electronic repulsion, ultimately leading to increased reaction rates. However, evidence suggests 
that a classic mechanistic pathway dominates in systems with electron rich olefin substrates and 
sufficient halonium ion donor nucleofugality. 
 
Scheme 3-2. Nucleophile-Assisted Alkene Activation in Olefin Halofunctionalization Reactions 	
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3-3).9 The method, utilizing stoichiometric quantities of a chiral titanium complex, was applied 
to the cyclization of a diallyl hydroxyacetic acid and an unsaturated diol affording the desired 
iodolactone products in a 67% and 65% ee, respectively. 
 
 
Scheme 3-3. Enantioselective Iodolactonization Achieved Using a Chiral Titanium Complex 	
						 			
 Inspired by this early work by Taguchi, the Borhan group, in 2010, sought to develop a 
organocatalytic, enantioselective method to generate chlorolactones from olefin substrates 
(Scheme 3-4).10 By applying the chiral, hydroquinidine-derived catalyst (DHQD)2PHAL, in the 
presence of DCDPH (1,3-dichloro-5,5-diphenylhydantoin), acting as a terminal chlorine source, 
the chlorolactonization of substituted 4-pentenoic acids was achieved. While other chlorinating 
agents were explored, including DCDMH (1,3-dichloro-5,5-dimethylhydantoin) and N-
chlorosuccinimide. DCDPH was determined to be sufficiently reactive to allow for lower 
temperatures without being overly reactive, to the point where the nonselective, uncatalyzed, 
background reaction prevails.  
 
 
CO2H
OH
O
O
OH
I
67% yield
65% ee
Ti(iPrO)4 (1 equiv)
ligand (1 equiv)
pyridine (1 equiv)
I2 (1.5 equiv)
DCM, 15 h
23  -78  0 ºC
O
OMe
Ph
Ph
OH
Ph
Ph Ph
OH
ligand
	 120 
Scheme 3-4. Enantioselective Chlorolactonization  	
		 	 		
A catalyst–hydantoin complex was observed by 1H NMR and was proposed as a key 
component in the asymmetric delivery of the halogen atom. Preliminary explorations of the 
system suggest that the interaction may exist in two possible forms, either as a hydrogen bond or 
ion pair mediated complex (Figure 3-3). Several chlorolactone products were produced in good 
yield with synthetically useful enantioselectivities. 
 
 
																								 	
Figure 3-3. Proposed Catalyst–Hydantoin Complexes  
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In 2011, Yeung and coworkers developed an enantioselective synthesis of bromo-δ-lactones 
using a chiral amino-thiocarbamate catalyst and N-bromosuccinimide (NBS) as the bromine 
source (Scheme 3-5).11 By applying this method to 1,2-disubstituted olefinic acids, it was 
possible to access δ-lactones moieties, rather than the typical γ-lactones that are obtained through 
the cyclization of 1,1-disubstituted unsaturated acids, as demonstrated in previous work.12  
 
Scheme 3-5.  Amino-Thiocarbamate Catalyzed Synthesis of Bromo-δ-Lactones  
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Figure 3-4. δ- and γ-Bromolactone Scope 			
	
Figure 3-5. Stereochemical Model for Bromolactonization  
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 The Johnston group also disclosed a method for the production of δ-lactones, this time 
using NIS as the halogen source.13 This novel system relies on the relationship between a chiral 
Brønsted acid catalyst and an achiral counterion (Scheme 3-6). It has been proposed that the high 
enantioselectivity observed upon applying this system to the lactonization of substituted 
hexenoic acid derivatives is the result of acid activation of the iodine source and Brønsted base 
activation of the carboxylic acid substrate. Through a counterion screen, it was determined that 
more highly dissociative achiral counterions were critical in achieving high enantioselectivity as 
its identity may have a major effect on the catalyst’s interaction with the substrate by influencing 
the size and shape of the binding pocket.  
 
 
Scheme 3-6. Enantioselective Iodolatonization Achieved via Chiral Brønsted Acid Catalysis  	
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After developing a class of novel C3-symmetric chiral cinchonine-squaramide (CSCS) 
organocatalysts,15–18 Zhou hoped to apply their activity to the synthesis of valuable halolactones 
(Scheme 3-7). While the achiral lactone product could be achieved in good yield (95%) with the 
CSCS catalyst and DCDMH as a chlorine source, 4-nitrobenzenesulfonamide (NsNH2) was 
necessary as a super-stoichiometric additive to access the product enantioselectively.  
 
 
Scheme 3-7. Enatioselective Synthesis of Chlorolactones Using a Novel CSCS Organocatalyst 
		
When exploring the scope of the transformation, it was observed that the substitution pattern 
of the substrate played a significant role in determining the regioselectivity of chloronium 
opening (Table 3-1). As expected, terminal alkenes gave the 5-exo products (Table 3-1, entries 1-
3). When internal alkenes were utilized as substrates, the product distribution varied favoring the 
6-endo cyclization pathway when electron withdrawing groups were present (Table 3-1, entries 
4-6).  
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Table 3-1. Scope and Regioselectivity of CSCS Catalyzed Chlorolactonization   
	 	
Entry R1 R2 Yield (%) 3.14 : 3.15 ee (%) 
1 Me H 93 >99:1 83 
2 H H 95 99:1 67 
3 Ph H 92 99:1 57 
4 4-BrC6H4 Me 92 1:3 99 
5 4-FC6H4 Me 93 1:2 92 
6 4-ClC6H4 Me 93 1:3 90 		
Additional studies were carried out to further demonstrate the value of this transformation. 
The CSCS class of squaramide catalysts was especially prized as it was observed that the species 
could be recovered and reused for six catalytic cycles without a significant erosion of yield or 
enantioselectivity (Table 3-2).  	
Table 3-2. Catalyst Recyclability  
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Cycle Recovery (%) Yield (%) ee (%) 
0 91 93 99 
1 92 93 98 
2 90 92 99 
3 93 92 99 
4 90 90 98 
5 90 91 94 
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Two products obtained via this transformation were tested and found to be highly potent 
HIV-1 inhibitors (Figure 3-6).  
 
	
Figure 3-6. Demonstrated Potency Against HIV-1 in TZM-bl cells 			
Lastly, δ-lactone product 3.16 was further functionalized through an alkyne coupling to 
generate four enantiopure isochroman-1-ones possessing potential anti-bacterial and fungal 
activity (Scheme 3-8).  
 
Scheme 3-8. Generation of Bioactive Products Through the Functionalization of Chlorolactone 
Products 	
	
 
 Given the apparent importance of halolactones as biologically-active, small 
molecules, their ability to be easily modified, and their versatility as organic building blocks, 
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halolactonizations have been considered to be highly valuable transformations. As a result, a 
significant amount of attention has been placed on developing methods of generating the 
halolactone scaffold. However, one major limitation of these current methods in the literature 
is the predetermined regioselectivity of the halonium opening/cyclization process, as 
governed by the substrate and the previously discussed, extended, Markovnikov rule. While 
this predictability can be an asset, we recognized the inherit significance in being able to 
reverse this classical selectivity when generating halolactones from unsaturated acid 
substrates.  
3.4 Halofunctionalization Achieved Through Photoredox Catalysis  
3.4.1 Background and Precedent 
In seminal work by the Nicewicz lab from 2012, a novel, photoredox-mediated, anti-
Markovnikov, hydroetherification method was applied to the cyclization of alkenol substrates.19 
Typically, the regioselectivity of electrophilic addition to alkenes is dictated by Markovnikov’s 
rule. This longstanding rule, for olefin functionalization under acidic conditions, dates back to 
1869 when Russian chemist Vladimir Markovnikov reported a defined regioselectivity for the 
addition of HBr to alkenes (Scheme 3-9). Upon protonation, the more stabilized cation 
intermediate forms, leading to nucleophilic attack by the bromide at this more substituted site 
resulting in the Markovnikov product. While this selectivity has be an undeniable advantage in 
synthesis, a significant amount of effort has been focused on the development of anti-
Markovnikov, alkene functionalization methods to access products exhibiting the reverse 
selectivity. Though Hartwig20,21 and Grubbs22 have developed several methods for the anti-
Markovnikov addition of amines and water to olefins, the methods rely on expensive transition 
metal catalysts and have only been successfully applied to the functionalization of terminal 
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styrene substrates. Methods developed by Gassman23,24 and Arnold,25 while impressive for their 
time, are limited in substrate scope, result in undesired side reactivity, and require large 
quantities of a single-electron photooxidant.  
 
Scheme 3-9. Alkene Functionalization Demonstrating Markovnikov Selectivity  	
	
 
Seeking to overcome limitations in the literature and the precedent by Gassman and 
Arnold, our group developed a hydroetherification method utilizing the NMA photoredox 
catalyst to reverse the selectivity and favor anti-Markovnikov product formation. Hamilton and 
Nicewicz began by first determining favorable reaction conditions (Table 3-3). Alkenol 3.17 was 
used a model substrate to study reaction conditions, beginning with 5 mol% loading of NMA, in 
DCE, under irradiation by blue LEDs (450 nm) (Table 3-3, entry 1). To increase the yield from 
the initial hit of 36%, alternative photooxidants were then explored, including 9,10-
dicyanoanthracene (Table 3-3, entry 2) and 1-cyanonaphthalene (Table 3-3, entry 3). Both led to 
diminished yields of the desired cyclic ether and increased byproduct formation. In order to 
render the transformation catalytic, the addition of a hydrogen atom donor cocatalyst was 
considered to complete the catalytic cycle. While screening potential cocatalysts, the BDE of 
each species was considered closely to ensure that HAT was an exothermic process. Those that 
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were screened possessed R-H BDE of <90 kcal/mol and included N-hydroxyphthalimide (BDE = 
87 kcal/mol), 9-phenylfluorene (BDE = 74 kcal/mol), and 2-phenylmalononitrile (BDE = 77 
kcal/mol) (Table 3-3, entries 4-5). While all three H-atom donors led to an increase in product 
formation, 2-phenylmalononitrile (PMN) proved to be the most efficient cocatalyst, 
regioselectively producing the ether, in 73% yield (Table 3-3, entry 6). Control reactions 
excluding photoredox catalyst (Table 3-3, entry 7) and light (Table 3-3, entry 8) demonstrated 
that both components were necessary to obtain the desirable reactivity. It was also determined 
that the commonly employed transition metal photooxidant Ru(bpy)3 was incapable of oxidizing 
the alkene substrate and was ineffective at generating the expected product (Table 3-3, entry 9). 
 
Table 3-3. Optimization of Photoredox Mediated Anti-Markovnikov Hydroetherification  	
								
With the necessary reaction components identified, a mechanism was proposed for the 
transformation (Scheme 3-10). The catalytic cycle begins with the photoexcitation of NMA via 
blue LEDs to its excited state (NMA*). Irradiation and the resulting excited state catalyst allows 
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3.17
Entry Conditions Yield (%) 
1 NMA (5 mol%) 36 
2 
9,10- dicyanoanthracene(20 mol%) 
light source: fluorescent bulbs >290 nm 
5 
3 
1-cyanonaphthalene (50 mol%) 
light source: fluorescent bulbs >290 nm 
15 
4 N-hydroxyphthalimide (50 mol%) 41 
5 9-phenylfluorene (50 mol%) 51 
6 PhCH(CN)2 (50 mol%) 73 
7 No photooxidant <5 
8 No light <5 
9 Ru(bpy)3Cl2 (5 mol%) <5 
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for single–electron oxidation of the unsaturated alcohol substrate (3.18) to occur, forming the 
reactive cation–radical species (3.19).  This intermediate is then poised to undergo an 
intramolecular cyclization, exhibiting anti-Markovnikov regioselectivity, to generate 3.20. To 
furnish the final product, deprotonation and HAT steps must occur. Phenylmalononitrile (3.23), 
utilized in substoichiometric quantities, is capable of donating its hydrogen atom to the resulting 
trisubstituted radical species (3.21). This step affords the final product (3.22) and the 
corresponding phenylmalononitrile radical (3.24). To complete the cycle, the redox-active 
phenylmalononitrile radical then undergoes a single electron transfer with the acridine radical 
(NMA) to turn over the photoredox catalyst and generated phenylmalononitrile anion (3.25).  
Protonation, via an equivalent of the substrate, regenerates the phenylmalononitrile that reenters 
the cycle to continue to function as a hydrogen atom donor.   
 
 
Scheme 3-10. Proposed Mechanism For the Anti-Markovnikov Hydroetherification  	
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The alkenol scope of this photoredox-mediated hydroetherification method was explored to 
generate an electronically diverse substrate scope (Scheme 3-11). It was determined that more 
easily oxidized, electron-rich styrenes, results in the efficient generation of the 
hydroetherification product in 80% yield (3.26). The system was also tolerant of the more 
electron deficient 4-ClC6H4–substituted styrene, affording the corresponding product in 60% 
yield (3.27). While the desired 5-exo cyclization benefitted from gem-dialkyl substitution, it was 
not required as demonstrated by the highly selective formation of 3.28 from a substrate lacking 
the geminal dimethyl of diphenyl substitution pattern. Non-styreneyl, trisubstituted olefin 
substrates were also accessible through this methodology as alkenols 3.29 and 3.30 provided the 
ether product in good yield, with the latter exhibiting good diastereoselectivity as well. The mild 
nature of the transformation was highlighted with the successful cyclization of substrate 3.31, 
possessing a silyl-protected alcohol, which remains intact upon application of the reaction 
conditions.  	 	
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Scheme 3-11. Substrate Scope for Photoredox Mediated Hydroetherification  		
				 			
Because the regioselectivity of the transformation is dependent on the formation of the 
more stabilized carbon-centered radical upon cyclization, utilizing substrates with additional 
carbons between the alcohol and olefin functionality can alter the resulting ring size. This 
variation was modeled using substrates 3.32 through 3.34. Beginning with three carbons between 
the reactive functionality leads to 5-exo product formation (3.32). One and two additional 
carbons in the backbone allow for the 6- and 7-membered cyclic ethers to be generated, 
respectively, in good yield (3.33-3.34).  
The efficiency of this regioselective transformation was further demonstrated through a set 
of comparative reactions (Scheme 3-12). Substrates 3.35 and 3.36 were allowed to react under 
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both Brønsted acid and photoredox-mediated conditions. Under acidic conditions, alkenol 3.35 
forms the 6-endo Markovnikov product (3.37) while the photoredox methodology resulted in the 
formation of 5-membered cyclic ether 3.38. Substrate 3.36, while poised to undergo the 
kinetically favorable 5-exo cyclization, forms the 6-endo product in an impressive 77% yield 
when reacted under photoredox-mediated conditions (3.40). Alternatively, acidic conditions lead 
to the efficient formation of the Markovnikov product (3.39). This direct comparison between 
cyclization methods and product distribution excellently highlights the impressive selectivity of 
this novel transformation. 
 
Scheme 3-12. Markovnikov vs. Anti-Markovnikov Regioselectivity of Hydroetherification 
Conditions 	
			 		 	
The identity of the oxygen-centered nucleophile was the final component of this 
transformation to be explored (Scheme 3-13). Beginning with anethole as a coupling partner, an 
intermolecular variant of the transformation was developed. The product was formed in an anti-
Markovnikov fashion upon nucleophilic attack by methanol and the successive HAT step. Lastly, 
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an unsaturated acid was considered as a substrate to give completely regioselective access the 
anti-Markovnikov-type lactone adduct in a 72% yield.  
 
Scheme 3-13. Intermolecular and Lactonization Variants of Hydrofunctionalization of Alkenes 	
								 			
Overall, Hamilton and Nicewicz disclosed a method for the hydroetherification of alkenols 
substrates in a completely selective anti-Markovnikov fashion. A wide variety of substrates, with 
varying electronics, were cyclized to generate cyclic ether products in good to excellent yield. 
While this worked severed as an excellent model for the preparation oxygen heterocycles, 
including lactones, we wondered whether alternative radical traps, namely halogens, could be 
used to access desirable halolactone products.  
3.4.2 Results and Discussion 
The pervasive existence of halogens in organic molecules is impressive. As of 2016, it was 
reported that over 5,000 natural products containing at least one halogen atom have been 
discovered.4 As a result methods for incorporating halogen functionality into molecules have 
been aggressively pursued. Having developed a wide variety of hydrofunctionalization methods 
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in our lab,26–30 we decided to turn our attention towards the development of a photoredox-
mediated, halofunctionalization system, which utilizes a halogen source as a radical trap rather 
than the previously explored hydrogen atom donor.  
In a similar fashion to the previously reported hydrofunctionalization reactions, we hoped 
to develop a system, which is capable of outcompeting the Markovnikov-type regioselectivity 
exhibited by traditional halofunctionalization reactions (Scheme 3-14).31 When we first set out to 
accomplish this goal, we recognized three potential pitfalls associated with generating 
halogenated products using photoredox catalysis: 
1) In general, radical halogen sources are capable of reacting efficiently with olefins 
to directly form halonium ions. Consequently, the system requires that the 
catalytic pathway be much faster than this background reaction in order to 
outcompete it.  
2) Halogen sources, with heteroatom-halogen bonds, are prone to homolysis. The 
potential to generate highly reactive, halogen-centered radicals could be 
problematic and lead to a variety of unwanted byproduct formation. 
3) The halogenated products, obtained through this transformation, may be prone to 
further reactivity under the developed reaction conditions. This challenge is 
especially risky for cases in which the product possesses a benzylic halogen as 
they have been reported to undergo hydrolysis rapidly.   
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Scheme 3-14. Reversing Classical Regioselectivity of Alkene Halofunctionalization Reactions 	
             	
 
 
With these potential drawbacks in mind, we first began to develop a chlorolactonization 
system. Hamilton and Nicewicz’s lactonization result served as inspiration for the initial 
application of this method. Optimization of these conditions, accomplished by Jeremy Griffin, 
started with the evaluation of several traditional chlorine radical sources, in combination with the 
NMA photoredox catalyst, to determine whether the simple addition of a halogen radical source 
would be sufficient to obtain the halofunctionalized product (Table 3-4). Tosyl chloride (TsCl) 
was first applied to the cyclization of aliphatic-substituted alkene-acid substrates and did, in fact, 
lead to the formation of the desired product though these conditions could not be successfully 
extended to the styrenyl-acid, model substrate (3.41) (Table 3-4, entry 1). Switching to other 
typical radical halogen sources, such as N-chlorosuccinimide (NCS) and N-chlorophthalimide 
(NCP), proved fruitless in generating the desired γ-lactone (3.42) but rather gave only small 
quantities of the undesired δ-lactone (3.43) regioisomer (Table 3-4, entries 2-3). Given the lack 
of desired product formation, this initial investigation illustrated inefficiencies in the halogen 
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transfer step of the current reaction conditions. At this point, it was determined that an additive 
would likely be required to aid in halogen radical transfer.  
 
 
Table 3-4. Optimization of Chlorolactonization Conditions 	
                             					
		
 
An exploration of the literature suggested that a copper (I) cocatalyst may be necessary in 
the system, to facilitate chlorine radical transfer, based on its reported efficiency in atom transfer 
radical polymerization (ATRP) (Scheme 3-15).32 To achieve controlled polymerization 
conditions, it is necessary to regulate every component of several elementary reactions including 
the concentration and reactivity of each species involved. Consequently, halogen radical 
concentrations must be controlled and their transfer must only occur upon initiation of an 
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Entry Cl Source CuCl2/Ligand A (%)a dr (A) B (%)a 
1 TsCl --- --- --- --- 
2 NCS --- --- --- 50 
3 NCP --- --- --- 30 
4b --- CuCl2/bpy 62 1.5:1 --- 
5c Lut+Cl- CuCl2/bpy 19 2.6:1 --- 
6 NCP CuCl2/bpy 90 2.3:1 --- 
7 NCP CuCl/bpy 92 2.4:1 -- 
8 NCP CuCl2/phen 85 3.2:1 --- 
9d NCP CuCl2/phen 25 2.2:1 12 
10e NCP --- --- --- --- 
11d NCP --- --- --- --- 
Reactions were carried out in N2-sparged MeCN [0.1m] under two LED lamps (lmax=450 nm) for 18 h.	[a] Yield as 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture relative to the internal standard (Me3Si)2O. [b] 
The reaction was carried out with 1 equivalent of CuCl2/bpy under air. [c] The reaction was carried out with CuCl2/bpy (20 
mol%) in the presence of O2. [d] The reaction was carried out without NMA. [e] Reaction ran in dark 
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activation process. In this system, bromine-capped polymer (Pn-Br) and Cu(I)(bpy)2 are the 
dominant structural forms and the equilibrium heavily favors a low radical concentration (k-1 
~107 M-1s-1). Due to its affinity for halogens, this copper (I) species is capable of abstracting the 
halogen atom, generating a radical polymer species (Pn), which is able to react further with an 
equivalent of monomer (Pm), leading to the uniform elongation of the polymer chain (Pn-Pm). A 
second halogen transfer event, by the copper (II) species, leads to the regeneration of the copper 
(I) complex. This efficiency at abstracting and transferring halogen radicals led us to believe that 
a copper (I)/2,2’-bipyridine catalyst system could be effectively applied to our existing reaction 
conditions to support the problematic radical transfer step. Additionally, we were encouraged by 
evidence in the literature which suggests that copper(II) chloride is capable of undergoing 
irreversible chlorine-radical transfer with aryl cation radicals.33 
 
 
Scheme 3-15. Copper Mediated Atom Transfer Radical Polymerization  	
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simple addition of 2,2’-bipyridine, as a copper ligand, the product could be obtained in a 62% 
yield (Table 3-4, entry 4). While pleased with this result, we were concerned about the use of 
stoichiometric copper and hoped to reduce its loading to catalytic quantities through the addition 
of a secondary chlorine source. Lutidinium chloride (Lut+Cl-) was first considered as chlorine 
source though this returned the product in only a limited quantity (19%) and resulted in 
significant byproduct formation (Table 3-4, entry 5). A significant increase in reaction efficiency 
was achieved with the addition of NCP in combination with just 10 mol% CuCl2. The desired 
lactone was obtained, regioselectivity, in a 90% yield, with a dr of 2.3:1 (Table 3-4, entry 6). As 
a mechanistic probe, the CuCl/bpy complex was also tested under these conditions and provided 
the product in a comparable yield (Table 3-4, entry 7). This result suggests that the chlorinating 
agent, NCP, may be responsible for generating CuCl2 in situ. Switching the bpy ligand out for 
1,10-phenanthroline (phen) caused a minor drop in yield to 85% but displayed the added benefit 
of reducing the reaction time from 18 to just 2 hours and led to a boost in diastereoselectivity 
(3.2:1) (Table 3-4, entry 8).   
As a control experiment, the reaction was run without the addition of NMA (Table 3-4, 
entry 9). After 18 hours of irradiation, under these reaction conditions, both regioisomers did 
form in a combined yield of 37%. However, it is important to note that when the reaction was 
stopped after 2 hours (reflective of the final conditions used in scope development), only 
unreacted starting material was observed. Running the reaction in the presence of NMA without 
irradiation results in returned starting material (Table 3-4, entry 10). When both the acridinium 
and copper catalysts were omitted, no reaction occurred (Table 3-4, entry 11).  
The observed formation of undesired δ-lactone 3.43 with NMA and no copper (Table 3-4, 
entry 9) in combination with the lack of this product formation when NMA and copper were both 
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omitted (Table 3-4, entry 11) warrants a further explanation. We hypothesized that this 
background reactivity, in the presence of irradiated NMA, is the result of the in situ generation of 
a strong acid that is capable of activating the chlorine source, and leads to the observed 
formation of 3.43. We proposed that the strong acid (3.44) forms as a result of nucleophilic 
attack by the acid on the cation radical intermediate (Scheme 3-16). A second equivalent of the 
substrate is then able to undergo the background reaction to form an additional equivalent of 
strong acid (3.45), which can go on to propagate the reaction.  
 
 
Scheme 3-16. Proposed Mechanism for In Situ Strong Acid Formation  	
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was obtained. When a significantly stronger acid was employed, i.e. triflic acid (CF3SO3H, pKa 
= -14), 66% of the undesired lactone was obtained  (Scheme 3-17). From these results we 
concluded that the strong acid that forms in the presence of NMA and under irradiative 
conditions could be responsible for producing a more electrophilic chlorinating agent, existing in 
the form of either protonated NCS or Cl2.   
 
Scheme 3-17. Background Reactivity Initiated by Strong Acid Formation  
 
						 		
   Concurrently, conditions were developed for the complementary bromolactonization 
system (Table 3-5). The development of chlorolactonization conditions provided a solid starting 
point for the development of bromination methodology though the conditions were not found to 
be directly transferable. Initially TsBr was found to be highly ineffective, leading to a 1:1 
product regioisomer distribution (3.46:3.47) (Table 3-5, entry 1). While NCS and NCP were 
found to be competent halogen sources in the dual catalytic system, their bromine counterparts, 
NBS and NBP, were less efficient (Table 3-5, entries 2-4). Excellent mass balance was achieved, 
but while the desired 5-exo-type products were observed, the major product, in both cases, was 
the δ-lactone isomer.  
 
OHO
Me
MePh
OO
Me
Me
Ph
X
O
O
Ph
X
Me
Me
0.1M MeCN
TFA, pKa = -0.25
NCS (1 equiv)
0% 0%
OHO
Me
MePh
OO
Me
Me
Ph
X
O
O
Ph
X
Me
Me
0.1M MeCN
CF3SO3H, pKa = -14
NCS (1 equiv)
0% 66%
	 142 
Table 3-5. Optimization of Bromolactonization Conditions 	
								 	
 
 
 
 
 
 
 
 
 
A literature search provided insight as to a potential alternative to the typical nitrogen-
based bromine sources, as those proved to be too electrophilic to achieve strict regiocontrol. In 
their exploration of a triethylborane-induced bromine atom-transfer radical addition, Oshima et 
al. compiled a list of effective bromine radical sources. Diethyl bromomalonate (DEBM) was 
determined to be one of the most efficient bromine traps for carbon-centered radicals (Scheme 3-
18).34  
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Entry Br Source CuBr2/Ligand 3.46a dr (3.46) 3.47a 
1 TsBr CuBr2/bpy 1 n.d. 1 
2 NBS CuBr2/bpy 1 >20:1 2.5 
3 NBS CuBr2/phen 1 1.0:1 1.8 
4 NBP CuBr2/bpy 39% 3.0:1 61% 
5 DEBM CuBr/bpy 79% 2.0:1 6% 
6 DEBM CuBr2/phen 94% 2.0:1 6% 
7 DEBM CuBr2/bpy 97% 2.4:1 3% 
8b DEBM --- --- --- --- 
9 DEBM CuBr2/bpy --- --- --- 
10 DEBM --- --- --- --- 
11c --- CuBr2/bpy 35% 1.0:1 15% 
      
Reactions were carried out in N2-sparged MeCN [0.1m] under two LED lamps (lmax=450 nm) 
for 18 h.	[a] Yield as determined by 1H NMR spectroscopic analysis of the crude reaction 
mixture relative to the internal standard (Me3Si)2O.[b] The reaction was carried out without 
NMA. [c] Ran with 1 equiv CuBr2/bpy 
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Scheme 3-18. Diethyl Bromomalonate as a Bromine Radical Source in Atom-Transfer Radical 
Addition Reactions 	
			 	
 
 
To our satisfaction, DEBM displayed the same proficiency as a halogen radical transfer 
agent in our lactonization conditions. Initially, a CuBr/bpy system provided the product in 79% 
yield (Table 3-5, entry 5) but the mass balance was improved by switching to a CuBr2/phen 
catalyst system (Table 3-5, entry 6). Ultimately, the desired lactone regioisomer was obtained in 
97% yield and a 2.4:1 dr when the phen ligand was exchanged for bpy (Table 3-5, entry 7).  
 Having optimized the bromolactonization reaction conditions, additional control 
experiments were conducted to further explore the transformation. When DEBM was the lone 
reagent included in the reaction vial with the unsaturated acid substrate (3.41), only returned 
starting material was observed (Table 3-5, entry 8). The same result was obtained upon 
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irradiation of the system also containing catalytic quantities of CuBr2/bpy (Table 3-5, entry 9). 
Interestingly, no background or desired reactivity was observed when the system consisted of 
NMA and DEBM under irradiation by 450 nm LEDs (Table 3-5, entry 10). Based on the results 
of these control experiments, it seemed plausible that the copper had an additional role in the 
reaction, possibly activating the malonate towards more efficient halogen atom transfer (Scheme 
3-19). When 1 equivalent of CuBr2/bpy was used without the addition of DEBM both 3.46 and 
3.47 were obtained in a 2.3:1 ratio (Table 3-5, entry 11). 
 
Scheme 3-19. Proposed Copper Activation of Diethyl Bromomalonate  		
	
 
With both optimized chloro- and bromolactonization conditions in hand, we set out to 
explore the substrate scope of this novel methodology (Scheme 3-20). Styrene-derived acid 
substrates were first explored beginning with 1,2-disubstituted alkene 3.48. Both chlorination 
and bromination cyclization conditions were applied to the substrate successfully to give the 
products in comparable yields and diastereoselectivity (73%, 2.5:1 dr for 3.49, 74%, 2.3:1 dr for 
3.50). Despite the potential for acceleration due to the Thorpe-Ingold effect, the addition of 
geminal dimethyl substitution to the carbon backbone did not have a significant influence on the 
yield of the chlorolactone (3.52), which was obtained in a 75% yield. Notably, a similar yield 
(66%) could be obtained when the reaction was conducted on a 1.3 gram scale. The 
bromolactonization of this substrate was very successful, affording the desired product in a 94% 
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yield (3.53). A trisubstituted olefin functioned effectively as a substrate under 
chlorolactonization conditions, albeit with a lack of diastereoselectivity (3.55). The 
bromolactonization conditions were successfully applied to this substrate as well, however the 
five-membered lactone was also the favored product regioisomer under classical 
halofunctionalization conditions. Products with varying substitution on the arene could also be 
obtained under both sets of conditions. Substrates bearing electron-withdrawing chorine (3.56) 
functionality were tolerant of chloro- and bromolactonization conditions (3.57 and 3.58). Moving 
to more electron-rich substrates, 3.59 and 3.61, provided the desired adducts in 64% and 72%, 
respectively. Bromination was successfully accomplished on moderately electron-rich substrates 
(3.61) but failed on the more electron-rich OMe-substituted styrene (3.59). The latter substrate 
was likely problematic due to the instability of the electron-rich, benzyl bromide product. Two 
additional γ-lactones were accessed from trisubstituted aliphatic olefin substrates. Highly 
substituted chlorolactone 3.65 was obtained in a 63% yield while the TBS-protected alcohol gave 
the corresponding lactone product in a slightly diminished, 46% yield (3.67). 		 	
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Scheme 3-20. γ-Halolactone Scope 
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[a] CuCl2/phen (10 mol%), NCP (1 equiv); [b] CuBr2/bpy (10 mol%), DEBM (1 equiv); [c] with AcOH (5.0 equiv) 
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After thoroughly exploring internal olefin substrates, we turned our attention toward 
several 1,1-disubstituted-styrene substrates (Scheme 3-21). These terminally, unsaturated acids 
have been demonstrated as model substrates in classical halolactonization conditions and react in 
a Markovnikov fashion. Chloro-δ-lactones 3.68–3.72 were accessed in good yields from alkenes 
functionalized with electron-rich, -neutral, and -deficient arenes. The reactivity of the system 
shifted slightly upon the addition of geminal dimethyl groups to the α- and β-positions of the 
acid substrate. In the case of 3.74, a catalytic quantity of 2,6-lutidine base was required as an 
additive to aid in the cyclization under the bromination conditions. The regioselectivity of the 
chlorolactonization of substrate 3.74 and 3.77 proved mildly problematic. Lactone 3.75 was 
obtained in a 72% yield and 19:1 rr while 3.78 was accessed in a 66% yield but only with a 
selectivity of 4.4:1. This observed decrease in regioselectivity is likely a direct result of the 
Thorpe–Ingold effect accelerating the uncatalyzed background reaction. The final lactone 
product (3.80) was achieved by applying the chlorolactonization conditions to a benzoic acid 
substrate. The product was obtained in a good yield (64%) albeit with low regioselectivity 
(2.5:1). 	 	
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Scheme 3-21. δ-Halolactone Scope 
								 	
 
 
While the generated products were directly compared to those previously reported in 
literature, for the purpose of identifying major diasterio- and regioisomers, additional steps were 
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[c ] with 2,6-lutidine (10 mol%); [d] with AcOH (5.0 equiv);	
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taken to confirm that a trans relationship was indeed favored between the alcohol and halogen 
functionality. Model γ-lactone 3.52 was used to confirm this configuration using Borhan’s 
conditions for reducing chlorolactones to the corresponding epoxy-alcohol (Scheme 3-22).35 The 
major lactone diastereomer was subjected to the reaction conditions resulting in the formation of 
the epoxide (3.81). The products were isolated via column chromatography and were analyzed 
by 1H NMR. A coupling constant of 2.1 Hz was observed between the protons of the epoxide. 
The small magnitude of this value is indicative of a trans relationship between the protons, 
arising from the epoxidation of a trans starting lactone. To emphasize this observation, the minor 
diastereomer was also subjected to these reduction conditions. In this case, the cis epoxide was 
obtained (3.82) and the coupling constant between the epoxide protons was determined to be 4.3 
Hz. This larger coupling constant reinforced that a cis relationship existed between the protons of 
the minor diastereomer. From these observations, it was concluded that this transformation 
favors the production of a trans halogen-nucleophile relationship.  
 
Scheme 3-22. Identification of Major/Minor Diastereomer Using Epoxidation Conditions 
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An additional effort was made to expand the substrate scope of the transformation by 
varying the identity of the nucleophile (Scheme 3-23). Further inspired by the work of Hamilton 
and Nicewicz,19 we sought to demonstrate that our system could be applied to the synthesis of 
halogenated, cyclic ethers beginning from unsaturated alcohols. We were successfully able to 
generate 5- (3.84) and 6-membered (3.87) cyclic ethers under the chlorination conditions in good 
yields (61% and 57%, respectively). The 1,2-disubstituted alkene functioned successfully under 
our bromination conditions to form the 5-membered cyclic ether in a 71% yield (3.85). Inspired 
by other alkene hydrofunctionalization work from our lab, we successfully applied these 
halofunctionalization conditions with amine and acetate nucleophiles in intra- and intermolecular 
fashions. An unsaturated Boc-amine (3.88) could be cyclized to generate a chlorinated 
pyrrolidine adduct (3.89). Using β-methylstyrene (3.90) as an oxidizable olefin substrate, two 
intermolecular transformations were achieved. Though low yielding, these chloro-acetoxylation 
(3.91) and bromo-amination (3.92) reactions act as a proof of concept that this methodology can 
be extended to a variety of untethered nucleophiles.  	 	
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Scheme 3-23. Alkene Halofunctionalization Scope  	
									 	
 
   
Overall, a widely developed substrate scope was achieved for this novel, 
halofunctionalization reaction. Though selective and high yielding when successful, the 
bromofunctionalization conditions proved to be less broadly applicable than the chlorination 
conditions. Substrates failed for various reasons including a lack of reactivity, returning only 
starting material, or a lack of regioselectivity resulting from highly competitive background 
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reactivity. To our dismay, in several cases, the uncatalyzed background reaction also resulted in 
the anti-Markovnikov-type product formation. 
 Based on insight obtained through control experiments and the mechanistic precedent 
from our lab’s hydrolactonization work, we proposed a potential mechanism to accompany this 
novel halolactonization transformation (Scheme 3-24). Single electron oxidation of the olefin 
functionality (3.93), by the excited state NMA, affords the reactive cation radical (3.94). 
Reversible nucleophilic trapping of the polar component of 3.94 results in the more stabilized 
carbon-centered radical (3.95) upon deprotonation. The second component of this dual catalytic 
system begins with the copper-mediated transfer of the halogen atom. CuCl2 is proposed to be 
the active chlorine transfer agent, trapping the carbon centered radical producing the final, 
desired product (3.96) and CuCl species. This atom radical trapping step may proceed through an 
outer-sphere direct atom-transfer or and inner-sphere Cu(III) pathway. The Cu(II) species, 
reflective in its catalytic use, can be regenerated from the resulting Cu(I) complex, which is 
reoxidized by the stoichiometric chlorine source, NCP.  It is likely that NMA could be 
successfully turned over by the nitrogen-centered radical (PhthN or SucN) or a copper(III) 
species to regenerate the ground state photoredox catalyst and reset the cycle. This proposed 
turnover step is supported by literature evidence that has demonstrated the ability of succinimide 
radical to undergo a very rapid and efficient single-electron oxidation event with [Ru(bpy)3]2+ (k 
= 109 M-1s-1).36 In combination with the fact that SucN has a sufficiently high reduction 
potential (+1.96 V vs. SCE)36 to successfully oxidize NMA, we have concluded that it is highly 
likely that the imidyl radicals would be capable of closing the catalytic cycle by regenerating the 
photoredox catalyst. This redox neutral process would include the formation of the reduced 
succinimide and phthalimide radicals (PhthN- or SucN-). In further support of the proposed 
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mechanism, both succinimide (SucNH) and phthalimide (PhthNH) were observed, by 1H NMR, 
as byproducts of these reaction conditions.  
 
Scheme 3-24. Proposed Chlorolactonization Mechanism 																
		 	
 
 The bromolactonization method is proposed to undergo as comparable mechanism to that 
proposed for the chlorination conditions (Scheme 3-25). Under CuBr2 catalyzed conditions, the 
carbon-centered radical is trapped in a similar fashion, either through an inner- or outer-sphere 
process. CuBr would then be reoxidized by DEBM to generate more of the Cu(II) active halogen 
transfer agent. The resulting malonate radical (DEM) or copper(III)-malonate (Cu(III)-DEM) 
complex, is poised to undergo single electron transfer with the acridine radical, resetting the 
catalytic cycle and generating an equivalent of malonate anion (DEM-). Protonation of this 
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species, by an equivalent of substrate, results in the generation of malonate (DEM), which was 
observed in the crude 1H NMR and GC-MS. Given control experiment results, it is possible that 
bromine radical transfer may also occur from the activated DEBM-copper complex proposed in 
Scheme 3-19. 
 
Scheme 3-25.	Proposed Bromolactonization Mechanism 	
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Cu(II) complex spectrum showed absorbances at and 388 and 714 nm. With these values in 
hand, a solution of NCP was added to the Cu(I) complex and a spectrum was obtained. The 
resulting spectrum match that of the lone Cu(II) complex, suggesting the immediate oxidation of 
Cu(I) in the presence of NCP.  
This process was repeated for with CuBr, CuBr2, and CuBr/DEBM (see experimental section 
for spectra). The characteristic peak for the Cu(I) complex at 424 nm immediately disappeared 
upon addition of DEBM and a peak, corresponding to the independently synthesized Cu(II) 
complex, formed. While these results do not eliminate the potential for other mechanistic 
pathways, they do support our proposal for the in situ generation of a copper (II) complex, 
turning over the copper catalytic cycle. Though the current proposed mechanism is supported by 
the literature, control experiments, and observations, we believe that additional mechanistic 
studies would only help to enhance our understanding of this novel dual catalytic system.  
3.5 Conclusion 
Ultimately, we have developed a novel method for the efficient generation of halolactones. 
This dual catalytic system, consisting of an acridinium photoredox catalyst and copper 
cocatalyst, was successfully applied to the synthesis of 19 halofunctionalized products, in good 
to excellent yields. The unique reactivity of the transformation made it possible to outcompete 
the regioselectivity of traditional halofunctionalization methods in favor of the anti-
Markovnikov-type product formation in a completely selective fashion, excluding a few noted 
exceptions. Both chloro- and bromofunctionalization conditions were developed and applied to a 
variety of substrates. In addition to synthesizing both γ- and δ-lactone adducts from unsaturated 
acid substrates, we were able to extend this transformation to various nitrogen- and oxygen-
centered nucleophiles in both an intra- and intermolecular fashion. While this innovative method 
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is highly valuable itself, the utility of the products enhance its appeal. The halofunctionalized 
products could potentially undergo functional group modifications, be used a synthetic building 
blocks, or function as biologically active small molecules. Additional efforts have been started 
towards developing an enantioselective variant of this methodology through the use of chiral 
copper ligands.  
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3.6 Experimental 
General Methods 
Proton, carbon, Heteronuclear Single Quantum Coherence, and Correlated Spectroscopy  (1H 
NMR, 13C NMR, HSQC, COSY, respectively) were recorded on a Bruker model DRX 400 or 
AVANCE III 600 CryoProbe spectrometer (1H NMR at 400 MHz or 600 MHz, 13C NMR at 100 
MHz or 150 MHz respectively). Chemical shifts for proton NMR are reported in parts per 
million downfield from tetramethylsilane and are referenced to residual CHCl3 in solution 
(CHCl3 set to 7.26 ppm). Chemical shifts for 13C NMR are reported in parts per million 
downfield from tetramethylsilane and are referenced to the carbon resonances of the solvent 
(CDCl3 set to 77.00 ppm). NMR data are represented as follows: chemical shift, multiplicity (s = 
singlet, br s = broad singlet, d = doublet, dd = doublet of doublet, t = triplet, ddd = doublet of 
doublet of doublet, q = quartet, m = multiplet, etc.), coupling constants (Hz), and integration. 
High Resolution Mass Spectra (HRMS) were obtained using Thermo LTqFT mass spectrometer 
with electrospray ionization in positive mode. Low Resolution Mass Spectra (LRMS) were 
obtained using GC-MS (Agilent 6850 series GC equipped with Agilent 5973 network Electron 
Impact-MSD). Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform 
infrared spectrometer. Thin layer chromatography (TLC) was performed on SiliaPlate 250 µm 
thick silica gel plates purchased from Silicycle. Visualization was accomplished using 
fluorescence quenching, KMnO4 stain, or ceric ammonium molybdate (CAM) stain followed by 
heating. Purification of the reaction products was carried out by chromatography using 
Siliaflash-P60 (40-63 µm) silica gel purchased from Silicycle. All reactions were carried out 
under an inert atmosphere of nitrogen in flame-dried glassware with magnetic stirring unless 
otherwise noted. Reactions were carried out in standard borosilicate glass vials purchased from 
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Fisher Scientific. Yield refers to isolated yield of analytically pure material unless otherwise 
noted. NMR yields were determined using hexamethyldisiloxane, (Me3Si)2O, as an internal 
standard.  
 
Materials 
 Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa Aesar, Fisher 
Scientific, or TCI, and used as received unless otherwise noted. Diethyl ether (Et2O), 
dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and dimethylformamide 
(DMF) were dried by passing through activated alumina columns under nitrogen prior to use. 
1,2-dichloroethane (DCE) was purchased from Fischer and sparged with N2 before being stored 
over activated 4Å molecular sieves in a glovebox. Acetonitrile (MeCN) was dried by passing 
through activated alumina column under nitrogen. MeCN was commonly stored in a glovebox 
after sparging with N2. Glacial acetic acid (AcOH) stored in the glovebox with 5% v/v acetic 
anhydride. Other common solvents such as chloroform (CHCl3) were purified by standard 
published methods when necessary. Trans-β-methylstyrene was distilled over potassium 
hydroxide, sparged with N2, and stored in a glovebox freezer. 
  
Photoreactor Setup and Lamp Information 
 
Reactions were irradiated using a photoreactor which consists of two Par38 Royal Blue 
Aquarium LED lamps (Model #6851) purchased from ecoxotic. A standard magnetic stir plate 
was used as the support. Reaction efficacy can be impacted by the type of LED used. A fan was 
added above to cool the reaction and keep the temperature below 30˚C. 
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Preparation of Substrates 
1,2 disubstituted styrene substrates were prepared according to the following Wittig olefination 
procedure: 
 
1.8 equiv (relative to the necessary aldehyde precursor) of 3-
carboxypropyl)triphenylphosphonium bromide37 or chloride was dispensed into a flame-dried 
round bottom flask equipped with a magnetic stir bar.  The flask was flushed with N2 and THF 
R
O
H
OH
O
Ph3P
2.4 eq NaHMDS
1.8 eq
0.3M THF, 18 hrs
OH
O
R
X
Photoreactor setup used for halofunctionalization reactions. Reaction vials were 
placed about 5 cm from the face of both lamps. Above a simple fan was used to 
cool the reaction. 
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was added to 0.3 M concentration. The solution was cooled to 0˚C before 2.4 equiv sodium 
hexamethyldisilazane (1.0 M in THF) was carefully added to the stirring solid. The contents 
were warmed to room temperature and stirred for 0.5 to 1 hour after which the solution was 
cooled to  -78˚C and 1 equiv of the necessary aldehyde was added dropwise to the stirring ylide. 
The reaction stirred overnight while warming to room temperature. The reaction was quenched 
with H2O, and diluted with equal amounts DI H2O and diethyl ether, and the aqueous phase was 
acidified to pH of 1 before extracting 3 times with ethyl acetate. The organics were combined 
and dried over Na2SO4 and concentrated under reduced pressure. Purification was accomplished 
via column chromatography (gradient: 2:1 Et2O:hexanes with 1% acetic acid by volume→1:1 
Et2O:hexanes with 1% acetic acid by volume).  
 
(E)-5-Phenylpent-4-enoic acid: 
 
Obtained as the pure E-isomer in 65% isolated yield. Analytical data matched were in agreement 
with literature values.11 
 
(E)-5-(4-Chlorophenyl)pent-4-enoic acid: 
 
Obtained as a 6:1 mixture of E:Z isomers in an 89% isolated yield. Analytical data matched were 
in agreement with literature values.11 
 
HO
O
HO
O
Cl
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(E)-5-(4-Methoxyphenyl)pent-4-enoic acid: 
 
Obtained as a 8:1 mixture of E:Z isomers in an 84% isolated yield. Analytical data matched were 
in agreement with literature values.11 
 
(E)-5-(o-Tolyl)pent-4-enoic acid: 
 
Obtained as a 1.9:1 mixture of E:Z isomers in an 93% isolated yield. Analytical data matched 
were in agreement with literature values.11 
 
7-((tert-Butyldimethylsilyl)oxy)-2,2,5-trimethylhept-4-enoic acid 
 
 
To a flame-dried 250 mL round bottom flask containing 3.9 g of 4-((tert-
butyldimethylsilyl)oxy)butan-2-one38 was flushed with N2 before adding 100 mL dry THF. The 
solution was cooled to 0 ˚C before adding 21 mL of vinyl magnesiumbromide solution (1 M in 
THF) dropwise. This was allowed to stir for an additional hour while warming to room 
temperature, before 2.4 mL of isobutyryl chloride was added. The reaction was then stirred for 2 
hours before the reaction was quenched with H2O and then a saturated solution of ammonium 
chloride. The mixture was transferred to a separatory funnel where Et2O was added. The phases 
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were separated, and the aqueous layer was back extracted twice with Et2O. The combined 
organics were dried over MgSO4 and the solution was concentrated. 5-((tert-
butyldimethylsilyl)oxy)-3-methylpent-1-en-3-yl isobutyrate was obtained cleanly after column 
chromatography to give 3.3 g (57% yield) of a clear oil. 
 
1H NMR: (400 MHz, Chloroform-d) δ 5.97 (dd, J = 17.5, 11.0 Hz, 1H), 5.19 – 5.06 (m, 2H), 
3.68 (t, J = 7.3 Hz, 2H), 2.48 (hept, J = 7.0 Hz, 1H), 2.07 (tdd, J = 20.5, 13.9, 7.3 Hz, 2H), 1.55 
(s, 3H), 1.14 (d, J = 7.0 Hz, 6H), 0.88 (s, 9H), 0.04 (s, 6H). 
 
To a flame-dried 250 mL round bottom flask was added 80 mL of dry toluene and 20 mL of 
freshly distilled triethylamine. Next, 3.3 g 5-((tert-butyldimethylsilyl)oxy)-3-methylpent-1-en-3-
yl isobutyrate was added in a solution of toluene and the solution was cooled to -78˚C. Then a 33 
mL of a solution of NaHMDS in THF (1M) was slowly added while stirring. This was stirred for 
1 hour at -78 ˚C before 1.5 mL of TMSCl was added, and the solution was allowed to warm to 
room temperature while stirring overnight. The reaction was quenched by adding H2O and 3M 
HCl solution. The reaction mixture was transferred to a separatory funnel and the aqueous layer 
was brought to a pH of 1 then extracted with Et2O three times. The combined organics were 
washed with H2O and brine, before drying with MgSO4, filtered and concentrated to give a 
yellowish oil. The title compound was purified on column chromatography (15% 
EtOAc:hexanes, 150 mL dry silica gel) to obtain 1.7 g (52% yield) of 7-((tert-
butyldimethylsilyl)oxy)-2,2,5-trimethylhept-4-enoic acid (1.4:1 E:Z, yellowish oil).  
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1H NMR: Mixture of E:Z isomers (400 MHz, Chloroform-d) δ 5.17 (t, J = 6.7 Hz, 1H E/Z), 3.70 
– 3.55 (m, 2H E/Z), 2.27 (t, J = 6.9 Hz, 2H, E/Z), 2.22 (t, J = 7.1 Hz, 1H, E/Z), 2.17 (d, J = 1.5 
Hz, 1H, E/Z), 1.73 (s, 3H Z), 1.63 (s, 3H E), 1.19 (s, 6H E/Z), 0.89 (s, 3H Z), 0.88 (s, 3H E), 0.05 
(d, J = 1.6 Hz, 6H Z), 0.04 (d, J = 1.6 Hz, 6H E). 
13C NMR:	(151 MHz, CDCl3) δ 183.58, 183.45, 135.37, 134.99, 121.81, 121.43, 62.39, 61.72, 
53.41, 43.31, 42.58, 42.32, 38.23, 38.20, 35.60, 25.96, 25.94, 24.65, 24.49, 24.26, 18.36, 18.31, 
16.61, -5.30. 
IR (thin film cm-1): 3447, 2956, 2930, 2858, 1701, 1473, 1256, 1095 
HRMS: m/z calculated for C16H32O3Si[H]+: 301.2193; found: 301.2193 
 
 
2-(Prop-1-en-2-yl)benzoic acid: 
 
 
 
 
15 mL of 36% HBr and 35 mL of H2O were added to a 250 mL round bottom flask, followed by 
3 mL 1-(2-aminophenyl)ethan-1-one. The solution was cooled to 0˚C before adding 1.7 g of 
NaNO2 dissolved in H2O dropwise. This was allowed to stir about 20 minutes after all of the 
NaNO2 had been added. 3.6 g of CuBr was added, with N2 bubbles forming immediately. This 
was stirred overnight before quenching the reaction with a saturated solution of NaHCO3. A 
precipitate formed which was filtered under vacuum. The mixture was then transferred to a 
separatory funnel and extracted 3 times with Et2O. The organics were combined and dried over 
MgSO4, and concentrated giving a brownish oil. This was passed through a plug of silica to give 
NH2
Me
O
1.0 eq NaNO2
1.0 eq CuBr
2:1 H2O:HBr
Br
Me
O
60% yield
2.0 eq MePPh3Br
2.5 eq KOtBu
Br
Me
60% yield
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Mg(0), I2
then CO2 ∆
Me
74% yield
OH
O
THF
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3.0 g of 1-(2-bromophenyl)ethan-1-one as a yellow oil (60% yield). No further purification was 
necessary. Characterization matched previous reports.39 
 
To a flame-dried 250 mL round bottom flask was added 10.8 g of methyltriphenylphosphonium 
bromide and 4.2 g of KOtBu. The flask was then evacuated and refilled with N2 before adding 
150 mL of dry THF and stirring for 20 minutes. 3 g of 1-(2-bromophenyl)ethan-1-one was added 
and the solution was stirred overnight. The reaction was quenched with a saturated solution of 
ammonium chloride and the mixture was transferred to a separatory funnel. Et2O was added and 
the two phases were separated. The aqueous layer was back extracted twice with Et2O. The 
combined organics were dried with MgSO4, filtered, and concentrated. The product was purified 
by dry loading the resulting material on celite and eluted from a short silica plug with hexanes. 
1.8 g of 1-bromo-2-(prop-1-en-2-yl)benzene was obtained as a clear oil (60% yield). 
Characterization matched previous reports.40 
 
To a flame-dried 100 mL round bottom flask was added 500 mg Mg˚ (2.0 equiv), and a small 
amount of I2. The flask was purged with N2 before adding 25 mL dry THF, resulting in an orange 
solution. 1.8 g of 1-bromo-2-(prop-1-en-2-yl)benzene was added. After about ten minutes the 
orange color subsided; the solution was allowed to stir an addition 30 minutes before the solution 
was sparged with a balloon of CO2 for about 5 minutes. The flask was kept under a balloon of 
CO2 while stirring overnight. The reaction was then quenched with H2O and transferred to a 
separatory funnel where more H2O and Et2O were added. The organic layer was removed before 
bringing the aqueous layer to a pH of 1 forming a white precipitate. The aqueous layer was 
extracted three times with Et2O and the combined organics were dried with MgSO4, filtered, and 
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concentrated to give 1.1 g of 2-(prop-1-en-2-yl)benzoic acid (74% yield). No further purification 
was required. Characterization matched previous reports.41 
 
tert-Butyl (E)-(2,2-dimethyl-5-phenylpent-4-en-1-yl)carbamate: 
 
 
 
To a flame-dried 100 mL round bottom flask was added 1 gram of (E)-2,2-dimethyl-5-
phenylpent-4-en-1-amine42 and 2.3 grams of di-tert-butyl dicarbonate. The flask was flushed 
with N2 before adding 25 mL of dry DCM and 2.2 mL of freshly distilled triethylamine. The 
reaction was allowed to stir overnight before removing DCM and most triethylamine under 
vacuum. The crude material was then purified on silica gel (20% EtOAc:hexanes) to give the 
product as a white solid 1.4 grams, 87% yield.  
 
1H NMR:(400 MHz, ) δ 7.38 – 7.33 (m, 2H), 7.30 (dd, J = 8.5, 6.7 Hz, 2H), 7.23 – 7.17 (m, 1H), 
6.39 (d, J = 15.7 Hz, 1H), 6.24 (dt, J = 15.4, 7.5 Hz, 1H), 4.59 (s, 1H), 3.01 (d, J = 6.5 Hz, 2H), 
2.12 (dd, J = 7.5, 1.2 Hz, 2H), 1.45 (s, 9H), 0.92 (s, 6H). 
13C NMR: (151 MHz, CDCl3) δ 156.19, 137.56, 132.54, 128.48, 127.01, 126.73, 126.04, 79.07, 
50.49, 43.48, 35.46, 28.41, 24.84. 
IR (thinfilm cm-1): 3379, 2965, 2929, 1702, 1510, 1365, 1245, 1171, 967, 736 
HRMS: m/z calculated for C18H27NO2[Na]+: 312.1934; found: 312.1932 
 
 
BocHN
Me
Me
H2N
Me
Me
2.0 eq Boc2O
3.0 eq TEA
0.2M DCM
87% yield
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(E)-2,2-Dimethyl-5-phenylpent-4-enoic acid:  
 
Prepared according to a previously reported literature procedure19 
 
(E)-2,2,4-Trimethyl-5-phenylpent-4-enoic acid: 
 
Prepared according to a previously reported literature procedure19 
 
5-Methyl-2,2-diphenylhex-4-enoic acid: 
 
 
Prepared according to a previously reported literature procedure19 
 
4-Phenylpent-4-enoic acid: 
 
 
Prepared according to a previously reported literature procedure21 
OH
O
Me Me
Me
HO
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HO
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4-(p-Tolyl)pent-4-enoic acid: 
 
Prepared according to a previously reported literature procedure43 
 
4-(4-Chlorophenyl)pent-4-enoic acid: 
 
Prepared according to a previously reported literature procedure43 
 
3,3-Bimethyl-4-phenylpent-4-enoic acid: 
 
 
Prepared according to a previously reported literature procedure19 
 
2,2-Dimethyl-4-phenylpent-4-enoic acid: 
 
Prepared according to a previously reported literature procedure44 
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(E)-2,2-Dimethyl-5-phenylpent-4-en-1-ol  
 
 
Prepared according to a previously reported literature procedure19  
 
4-Phenylpent-4-en-1-ol: 
 
Prepared according to a previously reported literature procedure45 
 
Halofunctionalization Procedures  
General Procedure for Chlorofunctionalization: 
 
 
The carboxylic acid substrate, N-chlorophthalimide (NCP, 1.0 equiv) or N-chlorosuccinimide 
(NCS, 1.0 equiv), CuCl2 (0.1 equiv), 1,10-phenanthroline, (0.1 equiv) and acridinium 
photoredox catalyst (0.05 equiv) were weighed and dispensed into a flame-dried vial (2-dram) 
equipped with a stir bar and Teflon-coated septum cap. The vial was moved to a nitrogen filled 
glovebox where solvent was dispensed by syringe (MeCN or DCE to 0.1 M). Where noted acetic 
acid was added to the vial as well. The vial was then sealed and removed from the glovebox and 
HO
Me
Me
OH
5 mol % NMA
10 mol% CuCl2
10 mol% 1,10-Phenanthroline
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O OH
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R3
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O
O
R3
Cl O
Cl
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O
R2 R1
R3
R2
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the reaction vial was sealed with electrical tape. The reactions were irradiated (2x455 nm blue 
LED lamps) and stirred until completion. Reaction progress was monitored by GC/MS. Upon 
completion, the crude reactions were passed through a silica plug to remove CuCl2 before NMR 
analysis.  
 
General Procedure for Bromofunctionalization: 
 
	
The carboxylic acid substrate (1.0 equiv), diethyl bromomalonate (1.0 equiv), CuBr2 (0.1 equiv), 
2,2’-bipyridine, (0.1 equiv) and acridinium photoredox catalyst (0.05 equiv) were weighed and 
dispensed into a flame-dried vial (2-dram) equipped with a stir bar and Teflon-coated septum 
cap. The vial was moved to a nitrogen filled glovebox where solvent was dispensed by syringe 
(MeCN to 0.1 M). When noted, 2,6-lutidine (0.1 equiv) was added to the vial as well. The vial 
was then sealed and removed from the glovebox and the reaction vial was sealed with electrical 
tape. The reactions were irradiated (2x455 nm blue LED lamps) and stirred until completion. 
Reaction progress was monitored by GC/MS. Upon completion, the crude reactions were 
concentrated then passed through a silica plug to remove CuBr2 before NMR analysis.  
 
 
Note: NCP and NCS were purchased from Sigma and stored in a desiccator away from light. 
This was found to be particularly important for avoiding background reactivity, most likely 
5 mol % NMA
10 mol% CuBr2
10 mol% 2, 2’-Bipyridine
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R3
R2
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through formation of Cl2. Copper (II) sources as well as ligands were stored in the desiccator as 
well to avoid absorption of H2O. 
 
Note: Products 1m, 1n, and 1v were found to decompose upon standing. Characterization data 
for these compounds was collected after preparing fresh samples. It was also noted that 
compounds 1o, 1p, 1q, 1r, and 1s were slightly less prone to decomposition, but still experienced 
some degree of decomposition upon standing. 
 
Note: Under the normal conditions products 1k and 1l were isolated with significant quantities of 
a new alkene product which was suspected to arise from chloride elimination. Using acetic acid 
as a buffer was found to alleviate this issue, and increased the yield of the desired chlorolactone. 
 
5-(Chloro(phenyl)methyl)dihydrofuran-2(3H)-one (3.49) 
 
The average yield for the title compound was 75% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalization using 88 mg of the starting carboxylic acid 
(0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9 mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. The average diasteromeric ratio was 3.1:1. The products were 
isolated by column chromatography on silica gel (20 mL dry silica, 2 cm column, 15% 
EtOAc/hexanes) as a low melting white solid.  
Analytical data for 1a:  
O
O
Cl
O
O
Cl
Major Minor
+
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1H NMR Major/minor diastereomers: 1H NMR (600 MHz, Chloroform-d) δ 7.47 – 7.33 (m, 
10H-5 major, 5 minor), 5.05 (d, J = 5.7 Hz, 1H-major), 4.98 (d, J = 5.1 Hz, 1H-minor), 4.92 – 
4.88 (m, 1H-minor), 4.88 – 4.84 (m, 1H-major), 2.53 (m  3H-2 major, 1 minor), 2.47 – 2.39 (m, 
1H-minor), 2.39 – 2.32 (m, 1H-major), 2.29 (dddd, J = 13.4, 12.5, 5.6, 3.9 Hz, 1H-major), 2.25 – 
2.19 (m, 1H-minor), 2.15 – 2.07 (m, 1H-minor). 
13C NMR Major/minor diastereomers: (151 MHz, CDCl3) δ 176.19 (minor), 176.16 (major), 
136.28 (major), 136.04 (minor), 129.13 (minor), 129.04 (major), 128.82 (major), 128.80 (minor), 
127.94 (minor), 127.70 (major), 81.93 (major), 81.90 (minor), 64.03 (major), 63.60 (minor), 
28.27 (major), 28.05 (minor), 24.53 (minor), 24.18 (major). 
IR (thin film, cm-1): 1778, 1455, 1175, 1028, 919, 701 
HRMS m/z calculated for C11H11ClO2 [H]+: 211.0520 and 213.0491; found: 211.0520 and 
213.0491 
 
5-(Bromo(phenyl)methyl)dihydrofuran-2(3H)-one (3.50) 
 
The average yield for the title compound was 74% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 88 mg of the starting carboxylic acid 
(0.1M in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-
bipyridine, and an irradiation time of 16 hours. The average diasteromeric ratio was 2.3:1. The 
products were isolated by silica gel (40 mL dry silica, 2.5 cm column, 10% EtOAc/hexanes then 
30% EtOAc/hexanes) as a white solid.  
O
O
Br
O
O
Br
Major Minor
+
	 172 
 
Analytical data for 3.50:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.45 (dd, J = 8.0, 1.4 Hz, 2H-
minor), 7.44 – 7.40 (m, 2H-major), 7.39 – 7.30 (m, 6H-3 major, 3 minor), 5.01 (d, J = 6.9 Hz, 
1H-major), 4.99 (d, J = 5.5 Hz, 1H-minor), 4.95 – 4.88 (m, 2H-1 major, 1 minor), 2.57 – 2.43 
(m, 4H-3 major, 1 minor), 2.41 (dd, J = 10.0, 5.3 Hz, 1H-minor), 2.31 – 2.19 (m, 2H-1 major, 1 
minor), 2.05 (dddd, J = 13.4, 10.1, 8.3, 6.8 Hz, 1H-minor). 
13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 176.12 (major), 176.06 
(minor) 137.08 (major), 136.87 (minor), 129.18 (minor), 129.12 (major), 128.93 (minor), 128.90 
(major), 128.46 (minor), 128.30 (major), 82.03 (minor), 81.70 (major), 55.48 (major), 55.24 
(minor), 28.63 (major), 28.40 (minor), 26.42 (major), 25.73 (minor). 
IR (thin film, cm-1): 1778, 1636, 1170, 1022, 911, 699 
HRMS m/z calculated for C11H11BrO2 [H]+: 255.0015 and 256.9995; found: 255.0014 and 
256.9994 
 
 
5-(Chloro(phenyl)methyl)-3,3-dimethyldihydrofuran-2(3H)-one (3.52) 
 
The average yield for the title compound was 75% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 102 mg of the starting carboxylic 
acid (0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, 
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and an irradiation time of 2 hours. The average diasteromeric ratio was 3.1:1. The products were 
isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc/hexanes) as a white solid.  
 
The reaction was performed on 2.0 gram scale (8.38 mmol). 1.7 g of the starting carboxylic acid, 
1.5 g of NCP (1.0 equiv), 167 mg of NMA (0.05 equiv), 112.5 mg CuCl2 (0.1 equiv), and 151 
mg 1,10-phenanthroline (0.1 equiv) to a 100 mL round bottom flask (flame-dried) equipped with 
a Teflon stir bar. The flask was fitted with a septum and evacuated and then refilled with N2 
three times. 80 mL of dry MeCN (0.1M) was sparged with N2 for 15 minutes and then 
transferred to the flask containing solid reagents via cannula. The flask was irradiated with two 
455 nm blue LED lamps from either side, while cooling with a fan (see S3). After 3 hours TLC 
revealed the reaction had reached full conversion. Solvent was then removed in vacuo. The crude 
material was loaded onto celite and purified on column chromatography (4.5 cm column, 200 
mL dry silica, gradient solvent system 3%→5%→7.5%→10% EtOAc in hexanes). Gradient 
column conditions were used in order to separate a small amount of undesired regioisomer as 
well the diastereomers. The combined yield of both diastereomers was 66%, 1.3 g, with 3.3:1 dr 
Diastereomers were only partially separated under these conditions. All fractions containing the 
minor disastereomer contained some of the major diastereomer.  
 
 
Analytical data for 3.52:  
1H NMR Major/minor diastereomers: (400 MHz, Chloroform-d) δ 7.39 (m, 10H-5major, 5 
minor), 4.98 (d, J = 6.6 Hz, 1H-major), 4.87 (d, J = 6.4 Hz, 1H-minor), 4.84 – 4.78 (m, 1H-
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minor), 4.75 (dt, J = 9.4, 6.4 Hz, 1H-major), 2.29 – 2.08 (m, 2H-major), 1.87 (qd, J = 13.0, 7.9 
Hz, 2H-minor), 1.29 (s, 3H-major), 1.26 (s, 3H-major), 1.24 (s, 3H-minor), 1.19 (s, 3H-minor).  
13C NMR Major/minor diastereomers: (151 MHz, CDCl3) δ 180.83 (major), 180.69 (minor), 
136.75 (major), 136.41(minor), 129.16 (minor), 129.03 (major), 128.84 (minor), 128.75 (major), 
127.91 (minor), 127.73 (major), 79.02 (minor), 78.49 (major), 63.87 (minor/major), 40.47 
(minor), 40.39 (minor), 40.31 (major), 40.14 (major), 24.90 (major), 24.77 (minor), 24.71 
(major), 24.66 (minor). 
IR (thin film cm-1) 2969, 2360, 1774, 1455, 1205, 1119, 1035, 915, 699, 667 
HRMS m/z calculated for C13H15ClO2 [H]+: 239.0833 and 241.0804; found: 239.0833 and 
241.0803 
 
NMR Spectra (1H, 13C, HSQC, COSY): S51-S52 
5-(Bromo(phenyl)methyl)-3,3-dimethyldihydrofuran-2(3H)-one (3.53) 
 
 
 
The average yield for the title compound was 94% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 102 mg of the starting carboxylic acid 
(0.1M in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-
bipyridine, and an irradiation time of 16 hours. The average diasteromeric ratio was 2.1:1. The 
products were isolated by silica gel (3 mL dry silica, 2 cm column, DCM) as a white solid.  
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Analytical data for 3.53:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.47 – 7.40 (m, 4H-2 major, 2 
minor), 7.40 – 7.30 (m, 6H-3 major, 3 minor), 4.94 (d, J = 7.7 Hz, 1H-major), 4.90 (d, J = 6.8 
Hz, 1H-minor), 4.84 (dtd, J = 9.5, 7.9, 6.1 Hz, 2H-1 major, 1 minor), 2.41 (dd, J = 13.0, 6.1 Hz, 
1H-major), 2.09 (dd, J = 13.0, 9.6 Hz, 1H-major), 1.95 (dd, J = 13.0, 6.2 Hz, 1H-minor), 1.81 
(dd, J = 13.1, 9.7 Hz, 1H-minor), 1.29 (d, J = 4.9 Hz, 6H-major), 1.25 (s, 3H-minor), 1.22 (s, 
3H-minor). 
13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 180.83 (major), 180.49 
(minor), 137.40 (major), 137.07 (minor), 129.12 (minor), 129.03 (major), 128.90 (minor), 128.78 
(major), 128.24 (minor), 128.19 (major), 78.92 (minor), 78.15 (major), 55.52 (major), 55.02 
(minor), 42.25 (major), 41.48 (minor), 40.66 (minor), 40.64 (major), 24.80 (major), 24.74 
(minor), 24.68 (major/minor). 
IR (thin film cm-1): 2969, 2360, 1774, 1455, 1205, 1119, 1035, 915, 699, 667 
HRMS m/z calculated for C13H15BrO2 [H]+: 283.0328 and 285.0308; found: 283.0327 and 
285.0306 								
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5-(Chloro(phenyl)methyl)-3,3,5-trimethyldihydrofuran-2(3H)-one (3.55):	
 
 
The average yield for the title compound was 76% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 109 mg of the starting carboxylic 
acid (0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, 
and an irradiation time of 2 hours. The average diastereomeric ratio was 1.3:1. The products 
were isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.55:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.51 – 7.30 (m, 10H, 5 major, 
5 minor), 4.94 (s, 1H-minor), 4.84 (s, 1H-major), 2.60 (d, J = 13.4 Hz, 1H-minor), 2.51 (d, J = 
13.5 Hz, 1H-major), 1.93 (t, J = 13.8 Hz, 2H-1 major, 1 minor), 1.47 (s, 3H-minor), 1.46 (s, 3H-
major), 1.33 (s, 3H-minor), 1.32 (s, 3H-major), 1.15 (s, 3H-minor), 1.07 (s, 3H-major). 
13C NMR Major/minor diastereomers:(151 MHz, CDCl3) δ 181.53, 181.30, 136.44, 136.22, 
129.01, 128.96, 128.85, 128.70, 128.45, 128.27, 83.74, 83.34, 68.95, 68.91, 44.69, 44.16, 40.73, 
40.41, 28.60, 28.29, 27.46, 26.29, 26.08, 25.64. 
 IR (thin film cm-1): 2974, 1773, 1455, 1236, 1093, 962, 755, 701 
HRMS m/z calculated for C14H17ClO2 [H]+: 253.0990 and 255.0960; found: 253.0988 and 
255.0959 
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5-(Chloro(4-chlorophenyl)methyl)dihydrofuran-2(3H)-one (3.57): 
 
 
The average yield for the title compound was 72% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 105 mg of the starting carboxylic 
acid (0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, 
and an irradiation time of 2 hours. The average diasteromeric ratio was 2.7:1. The products were 
isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc/hexanes) as a low melting white solid.  
 
Analytical data for 3.57:  
1H NMR Major/minor diastereomers:(600 MHz, Chloroform-d) δ 7.39 (m, 8H-4 major, 4 
minor), 5.00-4.98 (m, 2H-1 major, 1 minor), 4.89 (ddd, J = 7.7, 6.2, 4.6 Hz, 1H-minor), 4.83 (td, 
J = 7.1, 6.2 Hz, 1H-major), 2.59 – 2.55 (m, 2H-major), 2.54 – 2.45 (m, 1H-minor), 2.45 – 2.40 
(m, 1H-major), 2.40 – 2.35 (m, 1H-minor), 2.33 – 2.23 (m, 2H-1 major, 1 minor), 2.14 (dddd, J 
= 13.6, 10.2, 7.7, 6.2 Hz, 1H-minor). 
13C NMR Major/minor diastereomers:(151 MHz, CDCl3) δ 175.99 (minor), 175.87 (major), 
135.09 (minor), 135.00 (major), 134.96 (major), 134.73 (minor), 129.35 (minor), 129.09 (major), 
129.02 (major), 128.97 (minor), 81.70 (major), 81.49 (minor), 63.14 (major), 62.91 (minor), 
28.22 (major), 27.97 (minor), 24.52 (major), 24.45 (minor). 
IR (thin film cm-1): 2925, 1779, 1493, 1174, 1091, 1015, 916 
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HRMS m/z calculated for C11H10Cl2O2 [H]+: 245.0131 and 247.0101; found: 245.0131 and 
247.0101 
 
5-(Bromo(4-chlorophenyl)methyl)dihydrofuran-2(3H)-one (3.58) 
 
 
The average yield for the title compound was 84% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 105 mg of the starting carboxylic acid 
(0.1M in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-
bipyridine, and an irradiation time of 16 hours. The average diasteromeric ratio was 1.5:1. The 
products were isolated by silica gel (40 mL dry silica, 2.5 cm column, 10% EtOAc/hexanes then 
30% EtOAc/hexanes) as a clear oil.  
 
 
Analytical data for 3.58:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.43 – 7.38 (m, 2H-1 major, 1 
minor), 7.38 – 7.30 (m, 6 H-3 major, 3 minor), (d, J = , 1H-minor), 4.93 (d, J = 7.4 Hz, 1H-
major), 4.91 – 4.82 (m, 2H-1 major, 1 minor), 2.58 – 2.45 (m, 5H-3 major, 2 minor), 2.31 – 2.24 
(m, 1H-minor), 2.24 – 2.16 (m, 1H-major), 2.05 (ddq, J = 8.5, 5.0, 1.8 Hz, 1H-minor). 
13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 175.94 (minor), 175.92 
(major), 135.80 (major), 135.66 (minor), 135.05(minor), 134.96 (major), 129.87 (major), 129.65 
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(minor), 129.09 (major/minor), 81.61 (minor), 81.50 (major),  54.48 (minor), 54.20 (major), 
28.62 (major), 28.31 (minor), 26.63 (major), 25.76 (minor). 
IR (thin film cm-1): 1777, 1492, 1168, 1014, 915, 836 
HRMS m/z calculated for C11H10ClBrO2 [H]+:288.9625 and 290.9605; found: 288.9625 and 
290.9605 
 
5-(Chloro(4-methoxyphenyl)methyl)dihydrofuran-2(3H)-one (3.60): 
 
The average yield for the title compound was 64% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 103 mg of the starting carboxylic 
acid (0.1M in DCE), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. The average diasteromeric ratio was 2.2:1. To separate from 
phthalimide, after the 2 hour reaction time the reaction was transferred to a separatory funnel and 
washed with a 10% NaOH solution and H2O. The aqueous layer was back-extracted twice with 
DCM. The combined organics were dried and concentrated giving a dark brown oil. The 
products were isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 
20% EtOAc/hexanes) as a low melting white solid.  
 
Analytical data for 3.60:  
1H NMR Major/minor diastereomers:	(600 MHz, Chloroform-d) δ 7.38 – 7.35 (m, 2H-minor), 
7.35 – 7.32 (m, 2H-major), 6.93 – 6.87 (m, 4H-2 major, 2 minor), 5.00 (d, J = 5.8 Hz, 1H-
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major), 4.94 (d, J = 5.2 Hz, 1H-minor), 4.87 (ddd, J = 7.6, 6.2, 5.2 Hz, 1H-minor), 4.84 (ddd, J = 
7.3, 6.6, 5.8 Hz, 1H-major), 3.81 (s, 6H-3 major, 3 minor), 2.54 – 2.48 (m, 2H-major), 2.45 – 
2.42 (m, 1H-minor), 2.42 – 2.34 (m, 1H-major), 2.32 – 2.25 (m, 2H-1 major, 1 minor), 2.24 – 
2.16 (m, 1H-minor), 2.09 (dddd, J = 13.6, 10.2, 7.6, 6.2 Hz, 1H-minor). 
13C NMR Major/minor diastereomers:(151 MHz, CDCl3) δ 176.27 (minor), 176.20 (major), 
160.04 (minor), 159.98 (major), 129.21 (minor), 129.01 (major), 128.36 (major), 128.08 (minor), 
114.13 (major), 114.10 (minor), 82.09 (minor), 82.04 (major), 63.86 (major), 63.43 (minor), 
55.33 (major), 55.32 (minor), 28.28 (major), 28.08 (minor), 24.53 (minor), 24.42 (major). 
IR (thin film cm-1): 2936, 2839, 1778, 1611, 1514, 1252, 1177, 1029, 836 
HRMS  m/z calculated for C12H13ClO3 [H]+: 241.0626 and 243.0596; found: 241.0625 and 
243.0596 
 
 
5-(Chloro(o-tolyl)methyl)dihydrofuran-2(3H)-one (3.62): 
 
The average yield for the title compound was 72% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 95 mg of the starting carboxylic acid 
(0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and an 
irradiation time of 2 hours. The average diastereomeric ratio was 2.9:1. The products were 
isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc/hexanes) as a colorless oil.  
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Analytical data for 3.62:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.61 – 7.54 (m, 1H-minor), 
7.51 (dd, J = 7.3, 1.9 Hz, 1H-major), 7.31 – 7.22 (m, 4H-2 major, 2 minor), 7.20 – 7.17 (m, 2H- 
1 major, 1 minor), 5.32 (d, J = 6.2 Hz, 1H-major), 5.21 (d, J = 5.7 Hz, 1H-minor), 4.98 (ddd, J = 
7.5, 6.9, 5.7 Hz, 1H-minor), 4.87 (td, J = 7.0, 6.2 Hz, 1H-major), 2.65 (ddd, J = 17.9, 9.8, 5.4 Hz, 
1H-major), 2.57 (ddd, J = 18.1, 9.7, 8.9 Hz, 1H-major), 2.53 – 2.44 (m, 2H-minor), 2.44 – 2.35 
(m, 8H-5 major, 3 minor), 2.30 – 2.21 (m, 1H-1 minor), 2.06 (dddd, J = 13.4, 9.8, 8.4, 6.7 Hz, 
1H-1minor). 
13C NMR Major/minor diastereomers:(151 MHz, CDCl3) δ 175.94 (major), 175.80 (minor), 
135.51(major), 135.44 (minor), 134.62 (minor), 134.60 (major), 130.64 (minor), 130.55 (major), 
128.75 (minor), 128.59 (major), 127.78 (minor), 127.05 (major), 126.56 (minor), 126.43 (major), 
81.76 (minor), 80.80 (major), 60.17 (major), 59.79 (minor), 28.19 (major), 28.02 (minor), 25.06 
(minor), 24.32 (major), 19.32 (minor), 19.12 (major). 
IR (thin film cm-1): 2919.7, 1784, 1460, 1169, 917, 734 
HRMS  m/z calculated for C12H13ClO2 [H]+: 225.0677 and 227.0647; found: 225.0676 and 
227.0647 
 
5-(Bromo(o-tolyl)methyl)dihydrofuran-2(3H)-one (3.63) 
 
The average yield for the title compound was 83% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 95 mg of the starting carboxylic acid 
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(0.1M in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-
bipyridine, and an irradiation time of 16 hours. The average diasteromeric ratio was 1.6:1. The 
products were isolated by silica gel (40 mL dry silica, 2.5 cm column, 10% EtOAc/hexanes then 
30% EtOAc/hexanes) as a white solid.  
 
Analytical data for 3.63:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.59 – 7.53 (m, 1H-minor), 
7.50 (dd, J = 7.4, 1.7 Hz, 1H-major), 7.26 – 7.19 (m, 4H-2 major, 2 minor), 7.19 – 7.14 (m, 2H-1 
major, 1 minor), 5.26 (d, J = 7.7 Hz, 1H-major), 5.22 (d, J = 6.3 Hz, 1H-minor), 5.01 (dq, J = 
16.4, 7.3 Hz, 2H-1 major, 1 minor), 2.68 – 2.51 (m, 5H- 3 major, 2 minor), 2.39 (d, J = 3.2 Hz, 
6H-3 major, 3 minor), 2.36 – 2.23 (m, 2H-1 major, 1 minor), 1.94 (dtd, J = 13.3, 9.4, 7.4 Hz, 1H-
minor). 
13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 176.04 (major), 175.79 
(minor), 135.92 (major), 135.62 (minor), 135.58 (minor), 135.50 (major), 130.88 (minor), 130.80 
(major), 128.95 (minor), 128.83 (major), 128.22 (minor), 127.63 (major), 126.88 (minor), 126.67 
(major), 82.00 (minor), 80.76 (major), 51.91 (major), 51.42 (minor), 28.68 (major), 28.51 
(minor), 26.98 (major), 26.35 (minor), 19.44 (minor), 19.31 (major). 
IR (thin film cm-1): 1777, 1174, 1022, 916, 728, 657 
HRMS  m/z calculated for C12H13BrO2 [H]+:269.0172 and 271.0151; found: 269.0171 and 
271.0150 
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5-(2-Chloropropan-2-yl)-3,3-diphenyldihydrofuran-2(3H)-one (3.65): 
 
The average yield for the title compound was 63% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 140 mg of the starting carboxylic 
acid (0.1M in DCE), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, 
150µL of 95:5 Acetic acid:Acetic anhydride, and an irradiation time of 3 hours. The products 
were isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 5% 
EtOAc/hexanes) as a white crystalline solid.  
 
 
Analytical data for 3.65:  
1H NMR (400 MHz, Chloroform-d) δ 7.59 – 7.12 (m, 10H), 4.30 (dd, J = 10.6, 5.2 Hz, 1H), 3.09 
(dd, J = 13.2, 5.2 Hz, 1H), 2.96 (dd, J = 13.2, 10.6 Hz, 1H), 1.68 (s, 3H), 1.62 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 176.41, 141.92, 139.17, 129.04, 128.44, 127.95, 127.71, 127.34, 
127.32, 81.88, 68.18, 58.35, 39.38, 29.18, 27.88. 
IR (thin film cm-1): 3060, 2979, 1770, 1496, 1447, 1170, 698 
HRMS  m/z calculated for C19H19ClO2 [H]+: 315.1146 and 317.1117; found: 315.1145 and 
317.1116  
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5-(4-((tert-Butyldimethylsilyl)oxy)-2-chlorobutan-2-yl)-3,3-dimethyldihydrofuran-2(3H)-
one (3.67): 
 
The average yield for the title compound was 47% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 150 mg of the starting carboxylic 
acid as a mixture of alkene isomers (0.1M in DCE), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 
9mg of 1,10-phenanthroline, 150µL of 95:5 Acetic acid:Acetic anhydride, and an irradiation time 
of 3 hours. The average diastereoisomeric ratio was 1.1:1. The products were isolated by column 
chromatography on silica gel (25 mL dry silica, 2 cm column, 5% EtOAc/hexanes), 
diastereomers could be separated on silica gel and thus were characterized separately. Both 
appeared as clear viscous oils. 
 
Analytical data for 3.67-major:  
1H NMR (600 MHz, Chloroform-d) δ 4.59 (t, J = 8.1 Hz, 1H), 3.84 (dd, J = 6.8, 5.7 Hz, 2H), 
2.15 (d, J = 8.1 Hz, 2H), 2.01 (td, J = 6.3, 5.8, 4.7 Hz, 2H), 1.65 (s, 3H), 1.31 (s, 3H), 1.28 (s, 
3H), 0.89 (s, 9H), 0.06 (d, J = 0.8 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 181.25, 80.94, 71.94, 59.22, 43.22, 40.33, 38.65, 25.88, 25.43, 
25.42, 24.69, 18.19, -5.44, -5.47. 
IR (thin film cm-1):2956, 2930, 2857, 1780, 1463, 1255, 1122, 835, 778 
HRMS m/z calculated for C26H35ClO3Si[H]+: 335.1804 and 337.1774; found: 335.1802 and 
337.1772 
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Analytical data for 3.67-minor:  
1H NMR (600 MHz, Chloroform-d) δ 4.54 (dd, J = 9.5, 6.7 Hz, 1H), 3.90 – 3.84 (m, 2H), 2.23 – 
2.04 (m, 4H), 1.54 (s, 3H), 1.31 (s, 3H), 1.29 (s, 3H), 0.89 (s, 9H), 0.06 (d, J = 1.4 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 181.08, 81.15, 72.16, 59.52, 42.78, 40.33, 38.53, 25.87, 25.56, 
25.33, 24.65, 18.18, -5.42, -5.45. 
IR (thin film cm-1): 2956, 2930, 2857, 1780, 1463, 1255, 1101, 835, 778 
HRMS m/z calculated for C26H35ClO3Si[H]+: 335.1804 and 337.1774; found: 335.1802 and 
337.1773 
 
5-Chloro-5-phenyltetrahydro-2H-pyran-2-one (3.69):		
 
 
 
The average yield for the title compound was 54% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 88.4 mg of the starting carboxylic 
acid (0.1M in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. After the reaction, the contents were transferred to a separatory 
funnel and diluted with DCM. The organic layer was washed with H2O to remove succinimide. 
The aqueous layer was extracted twice more with DCM. All organics were combined and dried 
over Na2SO4. The organics were passed through a small plug of silica to remove any remaining 
Cu or acridinium impurities. After removing the solvent in vacuo the title compound was found 
to be clean by NMR.  
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Analytical data for 3.69:  
1H NMR: (600 MHz, Chloroform-d) δ 7.58 – 7.54 (m, 2H), 7.46 – 7.42 (m, 2H), 7.41 – 7.37 (m, 
1H), 4.68 (dd, J = 12.4, 2.6 Hz, 1H), 4.62 (dd, J = 12.3, 0.6 Hz, 1H), 3.08 – 2.98 (m, 1H), 2.76 – 
2.67 (m, 2H), 2.66 – 2.59 (m, 1H). 
13C NMR: (151 MHz, CDCl3) δ 168.32, 139.10, 129.19, 129.00, 125.79, 76.92, 66.05, 34.04, 
27.58. 
IR (thin film cm-1): 2932, 1744, 1447, 1399, 1263, 1186, 1089, 753 
HRMS  m/z calculated for C11H11ClO2 [H]+:211.0520 and 213.0491; found: 211.0520 and 
213.0491 
 
 
5-Chloro-5-(p-tolyl)tetrahydro-2H-pyran-2-one (3.71):  
 
 
 
The average yield for the title compound was 50% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 95 mg of the starting carboxylic acid 
(0.1M in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and an 
irradiation time of 2 hours. After the reaction, the contents were transferred to a separatory 
funnel and diluted with DCM. The organic layer was washed with H2O to remove succinimide. 
The aqueous layer was extracted twice more with DCM. All organics were combined and dried 
over Na2SO4. The organics were passed through a small plug of silica to remove any remaining 
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Cu or acridinium impurities. After removing the solvent in vacuo the title compound was found 
to be clean by NMR.  
 
Analytical data for 3.71:  
1H NMR:	(600 MHz, Chloroform-d) δ 7.44 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.1 Hz, 2H), 4.67 
(dd, J = 12.3, 2.5 Hz, 1H), 4.60 (d, J = 12.4 Hz, 1H), 3.06 – 2.97 (m, 1H), 2.71 (dt, J = 7.1, 3.7 
Hz, 1H), 2.68 (q, J = 7.4, 6.6 Hz, 1H), 2.65 – 2.59 (m, 1H), 2.37 (s, 3H). 
13C NMR: (151 MHz, CDCl3) δ 168.32, 139.28, 136.21, 129.66, 125.69, 76.82, 66.05, 34.11, 
27.64, 21.05. 
IR (thin film cm-1):1775, 1740, 1644, 1180, 818, 736 
HRMS m/z calculated for C12H13ClO2 [H]+:225.0677 and 227.0647; found: 225.0677 and 
227.0648 
 
 
5-Chloro-5-(4-chlorophenyl)tetrahydro-2H-pyran-2-one (3.73):		
 
 
The average yield for the title compound was 57% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 105 mg of the starting carboxylic 
acid (0.1M in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. After the reaction, the contents were transferred to a separatory 
funnel and diluted with DCM. The organic layer was washed with H2O to remove succinimide. 
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The aqueous layer was extracted twice more with DCM. All organics were combined and dried 
over Na2SO4. The organics were passed through a small plug of silica to remove any remaining 
Cu or acridinium impurities. After removing the solvent in vacuo the title compound was found 
to be clean by NMR.  
 
Analytical data for 3.73:  
1H NMR:	(600 MHz, Chloroform-d) δ 7.50 (d, J = 8.7 Hz, 2H), 7.41 (d, J = 8.7 Hz, 2H), 4.65 
(dd, J = 12.4, 2.4 Hz, 1H), 4.60 (d, J = 12.3 Hz, 1H), 3.01 (ddd, J = 19.6, 9.5, 7.3 Hz, 1H), 2.72 – 
2.64 (m, 2H), 2.61 (dtt, J = 13.8, 7.0, 3.4 Hz, 1H). 
13C NMR: (151 MHz, CDCl3) δ 167.92, 137.75, 135.28, 129.21, 127.32, 76.63, 65.40, 34.27, 
27.53. 
IR (thin film cm-1): 1745, 1495, 1401, 1186, 1086, 1013, 811, 578 
HRMS m/z calculated for C11H10Cl2O2 [H]+:245.0131 and 247.0101; found: 245.0131 and 
247.0101 
 
 
 
5-(Chloro(4-chlorophenyl)methyl)dihydrofuran-2(3H)-one (3.75): 
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The average yield for the title compound was 72% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 102 mg of the starting carboxylic 
acid (0.1M in DCE), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. The average regioisomeric ratio was 19:1. The products were 
isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc/hexanes) as a white solid.  
 
Analytical data for 3.75:  
1H NMR Major/minor regioisomers:(600 MHz, Chloroform-d) δ 7.73 – 7.49 (m, 4H-2 major, 2 
minor), 7.49 – 7.35 (m, 6H-3 major, 3 minor), 5.24 (d, J = 12.5 Hz, 1H-major), 4.70 (d, J = 12.4 
Hz, 1H-major), 4.10 (d, J = 12.4 Hz, 1H-minor), 3.97 (d, J = 12.4 Hz, 1H-minor), 3.01 (d, 1H-
minor), 2.83 (d, J = 18.0 Hz, 1H-major), 2.38 (d, J = 18.1 Hz, 2H-1 major, 1 minor), 1.46 (s, 3H-
minor), 1.19 (s, 3H-major), 1.06 (s, 3H-major), 0.70 (s, 3H-minor). 
13C NMR Major/minor regioisomers: (151 MHz, CDCl3) δ 174.69 (minor), 169.08 (major), 
137.66 (minor), 137.21 (major), 128.67 (major), 128.58 (minor), 128.41 (minor), 128.26 (minor), 
128.05 (major), 127.96 (major), 124.49 (minor), 90.92 (minor), 75.46 (major), 74.48 (major), 
49.26 (minor), 44.87 (minor), 42.57 (major), 39.40 (major), 28.11 (minor), 25.11 (major), 24.85 
(major), 22.20 (minor). 
IR (thin film cm-1): 2977, 1744, 1445, 1251, 1213, 1068, 701, 641 
HRMS m/z calculated for C13H15ClO2 [H]+:239.0833 and 241.0804; found: 239.0832 and 
241.0803
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5-Bromo-4,4-dimethyl-5-phenyltetrahydro-2H-pyran-2-one (3.76) 
 
The average yield for the title compound was 84% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 102 mg of the starting carboxylic acid 
(0.1M in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-
bipyridine, 6 μL 2,6-lutidine, and an irradiation time of 16 hours. The products were isolated by 
silica gel (40 mL dry silica, 2.5 cm column, 10% EtOAc/hexanes) as an off-white solid.  
 
Analytical data for 3.76:  
1H NMR : (600 MHz, Chloroform-d) δ 7.59 (dd, J = 8.0, 1.7 Hz, 2H), 7.40 – 7.31 (m, 3H), 5.23 
(d, J = 12.5 Hz, 1H), 4.92 (d, J = 12.5 Hz, 1H), 2.73 (d, J = 18.0 Hz, 1H), 2.35 (d, J = 18.0 Hz, 
1H), 1.34 (s, 3H), 1.09 (s, 3H). 
13C NMR: (151 MHz, Chloroform-d) δ 168.98, 138.41, 128.97, 128.72, 127.93, 75.08, 73.01, 
42.98 , 39.78, 27.04, 24.63. 
IR (thin film cm-1): 2972, 1744, 1444, 1250, 1067, 701 
HRMS m/z calculated for C13H15BrO2 [H]+:283.0328 and 285.0308; found: 283.0324 and 
285.0307 
 
5-Chloro-3,3-dimethyl-5-phenyltetrahydro-2H-pyran-2-one (3.78): 
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The average yield for the both regioisomers was 66% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 102 mg of the starting carboxylic 
acid (0.1M in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
an irradiation time of 2 hours. After the reaction, the contents were transferred to a separatory 
funnel and diluted with DCM. The organic layer was washed with H2O to remove succinimide. 
The aqueous layer was extracted twice more with DCM. All organics were combined and dried 
over Na2SO4. The organics were passed through a small plug of silica to remove any remaining 
Cu or acridinium impurities. After removing the solvent in vacuo the title compounds were 
isolated as a mixture of regioisomers (4.4:1). The major regioisomer could be isolated by column 
chromatography on silica gel (15 mL dry silica, 2 cm column, 5% EtOAc/hexanes) as a white 
solid. 
 
Analytical data for 3.78:  
1H NMR Major regioisomer:(600 MHz, Chloroform-d) δ 7.59 – 7.50 (m, 2H), 7.42 (td, J = 7.3, 
6.3, 1.4 Hz, 2H), 7.39 – 7.35 (m, 1H), 4.77 (d, J = 11.8 Hz, 1H), 4.69 (dd, J = 11.9, 1.9 Hz, 1H), 
2.67 – 2.60 (m, 2H), 1.50 (s, 3H), 1.19 (s, 3H). 
13C NMR Major regioisomers:	13C NMR (151 MHz, CDCl3) δ 175.61, 139.57, 129.05, 128.93, 
125.87, 75.05, 66.57, 50.43, 37.98, 30.16, 30.05. 
IR (thin film cm-1): 2977, 2359, 1739, 1447, 1389, 1134, 1064, 762, 697 
HRMS  m/z calculated for C13H15ClO2 [H]+:239.0833 and 241.0804; found: 239.0832 and 
241.0803 
	 192 
5-Chloro-3,3-dimethyl-5-phenyltetrahydro-2H-pyran-2-one (3.80): 
 
 
 
The average yield for the both regioisomers was 64% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 81.1 mg of the starting carboxylic 
acid (0.1M in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and 
150µL of 95:5 Acetic acid:Acetic anhydride an irradiation time of 2 hours. After the reaction, the 
contents were transferred to a separatory funnel and diluted with DCM. The organic layer was 
washed with H2O to remove succinimide. The aqueous layer was extracted twice more with 
DCM. All organics were combined and dried over Na2SO4. The average regioisomeric ratio was 
2.5:1. Purified on column chromatography on silica gel (25 mL dry silica, 2 cm column, 10% 
EtOAc:Hexanes).  
 
 
Analytical data for 3.80:  
1H NMR Major/minor regioisomers (600 MHz, Chloroform-d) δ 8.13 (dd, J = 7.8, 1.4 Hz, 1H-
major), 7.91 (dt, J = 7.7, 1.0 Hz, 1H-minor), 7.72 – 7.64 (m, 4H-2 major, 2 minor), 7.58 (td, J = 
7.5, 1.0 Hz, 1H-minor), 7.51 (td, J = 7.5, 1.5 Hz, 1H-major), 4.62 (d, J = 11.7 Hz, 1H-major), 
4.49 (d, J = 11.6 Hz, 1H-major), 3.91 – 3.75 (m, 2H-minor), 1.99 (s, 3H-major), 1.78 (s, 3H-
minor). 
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13C NMR Major/minor regioisomers (151 MHz, CDCl3) δ 163.54 (major), 150.76 (minor), 
143.22 (major/minor), 134.57 (major), 134.28 (minor), 130.78 (major), 129.80 (minor), 129.38 
(major), 126.25 (minor), 125.93 (minor), 124.48 (major), 122.91 (major), 121.59 (minor), 85.16 
(minor), 75.83 (major), 61.54 (major), 49.51 (minor), 27.64 (major), 23.51 (minor). 
IR (thin film cm-1):2926, 1768, 1735, 1604, 1464, 1281, 1247, 1102, 765 
HRMS m/z calculated for C10H9ClO2 [H]+:197.0364 and 199.0334; found: 197.0363 and 
199.0334 
 
2-Chloro(phenyl)methyl)-4,4-dimethyltetrahydrofuran (3.84): 
 
 
 
The average yield for the title compound was 61% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 95.1 mg of the starting alcohol 
(0.1M in MeCN), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and an 
irradiation time of 2 hours. The average diastereomeric ratio was 1.9:1. The products were 
isolated by column chromatography on silica gel (25 mL dry silica, 2 cm column, 5% 
EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.84:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.45 – 7.39 (m, 4H-2 major, 2 
minor), 7.38 – 7.34 (m, 4H-2 major, 2 minor), 7.34 – 7.29 (m, 2H-1 major, 1 minor), 4.86 (d, J = 
O
Cl
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7.0 Hz, 1H-major), 4.78 (d, J = 7.5 Hz-1H, minor), 4.55 – 4.40 (m, 2H-1 major, 1 minor), 3.60 – 
3.54 (m, 3H-1 major, 2 minor), 3.51 (d, 1H, J = 8.3 Hz-major), 1.92 (dd, J = 12.6, 6.8 Hz, 1H-
major), 1.83 (dd, J = 12.6, 9.0 Hz, 1H-major), 1.51 (dd, J = 12.6, 6.7 Hz, 1H-minor), 1.42 (dd, 
12.6, 9.4 Hz, 1H-minor), 1.11 (s, 3H-major), 1.09 (s, 3H-major), 1.06 (s, 3H-minor), 1.04 (s, 3H-
minor). 
13C NMR Major/minor diastereomers:	 (151 MHz, CDCl3) δ 138.94 (major), 138.74 (minor), 
128.57 (major), 128.53 (minor), 128.49 (major), 128.42 (minor), 127.80 (minor), 127.72 (major), 
82.86 (minor), 82.46 (major), 80.79 (major), 80.54 (minor), 66.43 (minor), 65.88 (major), 44.50 
(minor), 44.16 (major), 40.03 (minor), 39.81 (major), 26.30 (major), 26.23 (minor), 25.79 
(minor), 25.55 (major). 
IR (thin film cm-1): 2959, 2869, 1726, 1496, 1453, 1368, 1062, 698 
HRMS m/z calculated for C13H17ClO [H]+:225.1041, and 227.1011; found: 225.1040, and 
227.1014 
 
2-Bromo(phenyl)methyl)-4,4-dimethyltetrahydrofuran (3.85): 
 
 
 
The average yield for the title compound was 71% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Bromofunctionalization using 95.1 mg of the starting alcohol (0.1M 
in MeCN), 85 μL diethyl bromomalonate, 10 mg NMA, 11.2 mg CuBr2, 7.8 mg 2,2’-bipyridine, 
and an irradiation time of 16 hours. The average diasteromeric ratio was 1.9:1. The products 
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were isolated by silica gel (40 mL dry silica, 2.5 cm column, 10% EtOAc/hexanes, 20% 
EtOAc/hexanes, then 30% EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.85:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.43 (dd, J = 11.3, 7.5 Hz, 
4H-2 major, 2 minor), 7.39 – 7.32 (m, 4H-2 major, 2 minor), 7.29 (q, J = 7.0, 6.1 Hz, 2H-1 
major, 1 minor), 4.90 (d, J = 7.9 Hz, 1H-major), 4.87 (d, J = 7.8 Hz, 1H-minor), 4.59 (qd, J = 
9.0, 6.8 Hz, 2H-1 major, 1 minor), 3.61 (d, J = 2.4 Hz, 2H-minor), 3.59 – 3.51 (m, 2H-major), 
2.07 (dd, J = 12.6, 6.4 Hz, 1H-major), 1.79 (dd, J = 12.6, 8.9 Hz, 1H-major), 1.59 – 1.55 (m, 1H-
minor), 1.39 (dd, J = 12.6, 9.2 Hz, 1H-minor), 1.11 (s, 6H-major), 1.08 (s, 3H-minor), 1.06 (s, 
3H-minor). 
13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 139.50 (major), 139.37 
(minor), 128.66 (minor), 128.58 (major), 128.52 (minor), 128.45 (major), 128.16 (major), 128.08 
(minor), 82.71 (minor), 82.01 (major), 80.87 (major), 80.47 (minor), 58.47 (minor), 58.06 
(major), 46.08 (major), 45.30 (minor), 40.27 (minor), 39.95 (major), 26.32 (minor/major), 25.95 
(minor), 25.59 (major). 
IR (thin film cm-1): 3031, 2959, 2868, 1496, 1454, 1368, 1059, 697, 664 
HRMS m/z calculated for C13H17BrO [H]+:269.0536, and 271.0515; found:269.0535, and 
271.0514 
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3-Chloro-3-phenyltetrahydro-2H-pyran (3.87): 
 
 
 
The average yield for the title compound was 57% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 81 mg of the starting alcohol (0.1M 
in DCE), 67 mg NCS, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and an 
irradiation time of 2 hours. After the reaction, the contents were transferred to a separatory 
funnel and diluted with DCM. The organic layer was washed with H2O to remove succinimide. 
The aqueous layer was extracted twice more with DCM. All organics were combined and dried 
over Na2SO4. The organics were passed through a small plug of silica to remove any remaining 
Cu or acridinium impurities. After removing the solvent in vacuo the title compound was 
obtained as a single regioisomer. The product was found to be volatile, therefore the use of high 
vacuum was avoided. 
 
Analytical data for 3.87:  
1H NMR (600 MHz, Chloroform-d) δ 7.61 – 7.56 (m, 2H), 7.39 (dd, J = 8.4, 6.9 Hz, 2H), 7.35 – 
7.29 (m, 1H), 4.06 (dd, J = 12.2, 1.6 Hz, 1H), 3.99 (d, J = 12.3 Hz, 1H), 3.91 (dt, J = 11.5, 4.7 
Hz, 1H), 3.62 (ddd, J = 11.7, 8.6, 3.3 Hz, 1H), 2.45 (dd, J = 9.2, 4.2 Hz, 1H), 2.41 (dddd, J = 
13.8, 6.8, 3.0, 2.0 Hz, 1H), 2.09 (tq, J = 8.9, 4.4 Hz, 1H), 1.64 – 1.58 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 142.02, 128.47, 128.16, 126.31, 76.16, 69.25, 67.99, 37.94, 
23.20. 
OCl
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IR (thin film cm-1): 2958, 2852, 1723, 1685, 1493, 1447, 1099, 1030, 755, 698, 587 
LRMS m/z calculated for C11H13ClO+: 196.06 and 198.06, found: 196.10 and 198.05 
 
 
tert-Butyl 2-(chloro(phenyl)methyl)-4,4-dimethylpyrrolidine-1-carboxylate (3.89) 
 
The average yield for the title compound was 59% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure for Chlorofunctionalizations using 144.7 mg of the starting amine 
(0.1M in DCE), 90.8 mg NCP, 10 mg NMA, 6.7mg CuCl2, 9mg of 1,10-phenanthroline, and an 
irradiation time of 3 hours. The average diastereomeric ratio was 1.2:1. The products were 
isolated by column chromatography on silica gel (40 mL dry silica, 2.5 cm column, 10% 
EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.89:  
1H NMR Major/minor diastereomers: (600 MHz, Chloroform-d) δ 7.44 (d, J = 7.3 Hz, 2H-1 
major, 1 minor), 7.36 – 7.26 (m, 8H-4 major, 4 minor), 6.04 (d, J = 3.0 Hz, 1H-major), 5.75 (d, J 
= 3.1 Hz, 1H-minor), 4.21 (ddd, J = 9.9, 7.3, 3.0 Hz, 1H-major), 4.17 – 4.08 (m, 1H-minor), 3.52 
(dd, J = 10.5, 1.9 Hz, 1H-minor), 3.35 (dd, J = 10.5, 1.8 Hz, 1H-major), 3.08 (dd, J = 12.7, 10.5 
Hz, 2H- 1 major, 1 minor), 2.03 (ddd, J = 22.0, 12.6, 9.3 Hz, 2H-1 major, 1 minor), 1.56 (s, 9H-
minor), 1.50 (s, 9H-major), 1.36 – 1.29 (m, 2H-1 major, 1 minor), 1.10 (d, J = 8.3 Hz, 6H-
minor), 0.90 (s, 6H-major). 
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13C NMR Major/minor diastereomers: (151 MHz, Chloroform-d) δ 155.09 (major), 154.42 
(minor), 138.59 (major), 138.53 (minor), 128.43 (minor), 128.27 (major), 128.03 (minor), 127.85 
(major), 127.24 (major), 127.01 (minor), 80.00 (minor), 79.63 (major), 65.63 (minor), 64.57 
(major), 63.01 (minor), 62.94 (major), 60.45 (major), 59.52 (minor), 39.61 (minor), 38.72 
(major), 36.91 (major), 36.68 (minor), 28.62 (minor), 28.56 (major), 26.50 (major), 26.48 
(minor), 25.48 (major), 25.43 (minor). 
IR (thin film cm-1): 2960, 2871, 1690, 1452, 1401, 1366, 1253, 1164, 1104, 950, 699 
HRMS m/z calculated for C18H26ClNO2 [H]+:324.1725, and 326.1695; found: 324.1724 and 
326.1694 
 
Procedure for photoredox/copper mediated intermolecular chloroacetoxylation 
 
91 mg of N-chlorophthalimide (NCP, 1.0 equiv), 7 mg CuCl2 (0.1 equiv), 9 mg 1,10-
phenanthroline (0.1 equiv), 10 mg NMA (0.05 equiv), were weighed and dispensed into a flame-
dried vial (1-dram) equipped with a stir bar and Teflon-coated septum cap. The vial was moved 
to a nitrogen filled glovebox where 65 μL β-methylstyrene, 429 μL glacial acetic acid (AcOH, 
15.0 equiv) with 5% v/v acetic anhydride, and solvent (MeCN 0.5 M) were dispensed by syringe. 
The vial was then sealed and removed from the glovebox and the reaction vial was sealed with 
electrical tape. The reactions were irradiated (2x455 nm blue LED lamps) and stirred for 2 hours. 
Upon completion, the crude reactions were passed through a silica plug to remove CuCl2 before 
NMR analysis.  
OAc
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10 mol% CuCl2
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1eq N-Chlorophalimide
0.5M MeCN
450 nm LEDs
	 199 
1-Chloro-1-phenylpropan-2-yl acetate (3.91) 
 
 
The average yield for the title compound was 51% (2 trials) at the 0.5 mmol scale. The average 
diastereomeric ratio was 1.4:1. The products were isolated by column chromatography on silica 
gel (10 mL dry silica, 1.0 cm column, 5% EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.91:  
1H NMR (400 MHz, Chloroform-d) δ 7.44 – 7.29 (m, 10H- 5 major, 5 minor), 5.38 – 5.24 (m, 
2H-1 major, 1 minor), 4.98 (d, J = 5.7 Hz, 1H-major), 4.84 (d, J = 7.5 Hz, 1H-minor), 2.10 (s, 
2H-minor), 1.97 (s, 3H-major), 1.32 (d, J = 6.3 Hz, 3H-major), 1.14 (d, J = 6.4 Hz, 3H-minor). 
13C NMR (151 MHz, Chloroform-d) δ 170.19 (minor), 170.02 (major), 137.87 (minor), 137.61 
(major), 128.79 (minor), 128.65 (major), 128.47 (minor), 128.38 (major), 127.82 (major/minor), 
73.19 (minor), 73.05 (major), 65.25 (minor), 64.89 (major), 21.09 (minor), 20.97 (major), 17.55 
(minor), 16.01 (major) 
IR (thin film cm-1): 3033, 2989, 2938, 1742, 1495, 1454, 1372, 1238, 1059, 959, 699, 603 
HRMS m/z calculated for C11H13ClO2 [H]+:213.0677, and 215.0647; found: 213.0679 and 
215.0649 
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Procedure for photoredox/copper mediated intermolecular bromoamination 
 
 
48 mg methanesulfonamide, 113 mg N-bromophthalimide (NBP, 1.0 equiv), 11 mg CuBr2 (0.1 
equiv), 9. mg 1,10-phenanthroline (0.1 equiv),  10 mg NMA (0.05 equiv), were weighed and 
dispensed into a flame-dried vial (2-dram) equipped with a stir bar and Teflon-coated septum 
cap. The vial was moved to a nitrogen filled glovebox where 65 µL β-methylstyrene and solvent 
(DCE 0.1 M) were dispensed by syringe. The vial was then sealed and removed from the 
glovebox and the reaction vial was sealed with electrical tape. The reactions were irradiated 
(2x455 nm blue LED lamps) and stirred for 3 hours. Upon completion, the crude reactions were 
passed through a silica plug to remove CuBr2 before NMR analysis.  
 
 
N-(1-Bromo-1-phenylpropan-2-yl)methanesulfonamide (3.92) 
 
 
The average yield for the title compound was 27% (2 trials) at the 0.5 mmol scale. The average 
diastereomeric ratio was 1.8:1. The average regioisomeric ratio was 11.7:1. The products were 
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isolated by column chromatography on silica gel (60 mL dry silica, 2.5 cm column, 10% 
EtOAc/hexanes then 30% EtOAc/hexanes) as a colorless oil.  
 
Analytical data for 3.92:  
1H NMR Major/minor diastereomers (minor regioisomer noted for observable peaks): (600 
MHz, Chloroform-d) δ 7.44 (ddd, J = 7.6, 3.2, 1.9 Hz, 4H- 2 major, 2 minor), 7.39 – 7.34 (m, 
4H- 2 major, 2 minor), 7.34 – 7.28 (m, 2H- 1 major, 1 minor), 5.39 (d, J = 8.8 Hz, 1H-minor 
regioisomer), 5.13 (d, J = 5.0 Hz, 1H-major), 4.99 (d, J = 5.5 Hz, 1H-minor), 4.65 (dd, J = 8.8, 
4.4 Hz, 1H-minor regioisomer), 4.60 (d, J = 9.0 Hz, 1H-minor), 4.56 (d, J = 9.2 Hz, 1H-major), 
3.94 – 3.83 (m, 2H- 1 mjor, 1 minor), 2.82 (s, 3H-major), 2.71 (s, 3H-minor ), 2.67 (s, 3H- minor 
regioisomer), 1.58 (d, J = 6.9 Hz, 3H- minor regioisomer), 1.35 (dd, J = 8.7, 6.6 Hz, 6H-3 major, 
3 minor). 
13C NMR Major/minor diastereomers:(151 MHz, Chloroform-d) δ  138.07 (minor), 137.90 
(major), 128.84 (minor), 128.69 (major), 128.66 (minor), 128.64 (major), 128.49 (major), 128.39 
(minor), 60.64 (major), 59.59 (minor), 56.27 (minor), 55.86 (major), 42.08 (major), 41.49 
(minor), 21.48 (minor), 19.06 (major). 
IR (thin film cm-1): 3281, 2927, 1452, 1319, 1149, 993, 755, 700 
HRMS m/z calculated for C10H14BrNO2S [K+]: 329.9560 and 331.9540; found: 329.9560 and 
331.9540 
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General Procedure for Polar Chlorofunctionalization: 
 
 
 
The carboxylic acid substrate (1.0 equiv, 102 mg) and Dichlorodimethyl hydantoin (DCDMH, 
1.1 equiv, 108 mg) were weighed and dispensed into a flame-dried vial (2-dram) equipped with a 
stir bar and Teflon-coated septum cap.  The vial was moved to a nitrogen filled glovebox where 
solvent was dispensed by syringe (CHCl3 to 0.1 M), and 6 µL of 2,6-Lutidine was added via 
syringe. The vial was then sealed and removed from the glovebox and the reaction vial was 
sealed with electrical tape. The reaction was then heated at 40˚C with a heating block for 24 hrs. 
CHCl3 was then removed in vacuo and NMR analysis revealed the reaction had reached full 
conversion. The compound could be partially purified on column chromatography (10% 
EtOAc:Hex) however the product coeluted with monochlorodimethyl hydantoin. This impurity 
could be removed by bringing the sample up in DCM and washing with 10% sodium hydroxide 
solution. The isolated yield for the sole trial was 58%, however the purification was not 
optimized.  
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5-Chloro-3,3-dimethyl-6-phenyltetrahydro-2H-pyran-2-one : 
 
 
Analytical data for 5-chloro-3,3-dimethyl-6-phenyltetrahydro-2H-pyran-2-one:  
1H NMR (400 MHz, Chloroform-d) 1H NMR 7.64 – 7.33 (m, 5H), 5.19 (d, J = 9.8 Hz, 1H), 4.28 
(ddd, J = 11.1, 9.8, 4.8 Hz, 1H), 2.49 – 2.21 (m, 2H), 1.46 (s, 3H), 1.43 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 175.10, 136.45, 129.27, 128.52, 127.19, 86.41, 54.34, 44.76, 
39.70, 28.19, 27.70. 
IR (thin film cm-1):3035, 2982, 2931, 2872, 1731, 1459, 1388, 1236, 1129, 1000, 842, 716, 642 
HRMS m/z calculated for C13H15ClO2 [H]+: 239.0833 and 241.0804; found: 239.0832 and 
241.0803 
 
 
General Procedure for Polar Bromofunctionalization: 
	
The carboxylic acid substrate (1.0 equiv, 102 mg) and N-bromosuccinimide (1.0 equiv, 89 mg) 
were weighed and dispensed into a flame-dried vial (2-dram) equipped with a stir bar and 
Teflon-coated septum cap. The vial was moved to a nitrogen filled glovebox where solvent was 
dispensed by syringe (MeCN to 0.1 M). The vial was then sealed and removed from the 
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glovebox and the reaction vial was sealed with electrical tape. The reaction was stirred in the 
dark overnight. The product was isolated via column chromatography (40 mL dry silica, 2.5 cm 
column, 10% EtOAc/hexanes) as white solid. The regioisomers were inseparable and resulted in 
a single isolated yield of 83% 10:1 rr 
 
5-Bromo-3,3-dimethyl-6-phenyltetrahydro-2H-pyran-2-one  
 
Analytical data for 5-bromo-3,3-dimethyl-6-phenyltetrahydro-2H-pyran-2-:  
1H NMR Major/minor regioisomers:  (600 MHz, Chloroform-d) δ 7.44 – 7.36 (m, 10H-5 major, 
5 minor), 5.30 (d, J = 10.4 Hz, 1H-major), 4.94 (d, J = 7.7 Hz, 1H-minor), 4.87 – 4.77 (m, 1H-
minor), 4.37 (td, J = 10.2, 6.3 Hz, 1H-major), 2.45 – 2.38 (m, 3H-2 major, 1 minor), 2.09 (dd, J 
= 13.0, 9.7 Hz, 1H-minor), 1.47 (s, 3H-major), 1.42 (s, 3H-major), 1.29 (d, J = 5.1 Hz, 6H-
minor). 
13C NMR Major/minor regioisomers: (151 MHz, Chloroform-d) δ 180.83 (minor), 175.11 
(major), 137.42 (minor), 136.75 (major), 129.35 (major), 129.05 (minor) 128.80 (minor), 128.51 
(major), 128.20 (minor), 127.34 (major), 86.83 (major), 78.17 (minor), 55.53 (minor), 45.83 
(major), 45.18 (major), 42.30 (minor) 40.71 (major), 40.66 (minor), 27.99 (major), 27.50 
(major), 24.81(minor), 24.70 (minor). 
IR (thin film cm-1): 1725, 1459, 1387, 1210, 1130, 984, 706 
HRMS m/z calculated for C13H15BrO2 [H]+: 283.0328 and 285.0308; found: 283.0327 and 
285.0306  
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General Procedure for Polar Bromoetherification: 
 
 
 
The alcohol substrate (1.0 eqiv, 95 mg) and N-bromosuccinimide (NBS, 1.0 eqiv, 89 mg) were 
weighed and dispensed into a flame-dried vial (2-dram) equipped with a stir bar and Teflon-
coated septum cap. The vial was moved to a nitrogen filled glovebox where solvent was 
dispensed by syringe (MeCN to 0.1 M). The vial was then sealed and removed from the 
glovebox and the reaction vial was sealed with electrical tape. The reaction was stirred in the 
dark overnight. The product was isolated via column chromatography (40 mL dry silica, 2.5 cm 
column, 10% EtOAc) colorless oil. The regioisomers were inseparable and resulted in a single 
isolated yield of 67% 8:1 rr 
 
3-Bromo-5,5-dimethyl-2-phenyltetrahydro-2H-pyran 
 
 
Analytical data for 3-bromo-5,5-dimethyl-2-phenyltetrahydro-2H-pyran:  
1H NMR Major/minor regioisomers: (600 MHz, Chloroform-d) 7.50 – 7.43 (m, 4H-2 major, 2 
minor), 7.43 – 7.34 (m, 6H-3 major, 3 minor), 4.94 (d, J = 7.9 Hz, 1H-minor), 4.64 (ddd, J = 8.9, 
7.9, 6.4 Hz, 1H-minor), 4.33 – 4.21 (m, 2H-major), 3.69 (dd, J = 11.3, 2.6 Hz, 1H-major), 3.62 – 
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3.56 (m, 2H-minor), 3.45 (d, J = 11.2 Hz, 1H-major), 2.40 – 2.28 (m, 1H-major), 2.10 (ddd, J = 
12.6, 6.4, 0.9 Hz, 1H-minor), 2.06 – 1.96 (m, 1H-major), 1.83 (dd, J = 12.6, 8.9 Hz, 1H-minor), 
1.26 (s, 3H-major), 1.15 (d, J = 1.9 Hz, 6H-minor), 0.97 (s, 3H-major). 
13C NMR Major/minor regioisomers:  (151 MHz, Chloroform-d) δ  139.32 (minor), 139.25 
(major), 128.48 (minor), 128.41 (major), 128.36 (minor), 128.14 (major), 128.10 (minor), 127.45 
(major), 85.47 (major), 81.93 (minor), 80.75 (minor), 78.26 (major), 58.00 (minor), 50.61 
(major), 49.08 (major), 45.99 (minor), 39.75 (minor), 34.99 (major), 26.43 (major), 26.26 
(minor), 25.52 (minor), 23.56 (major). 
IR (thin film cm-1): 2956, 2866, 1646, 1455, 1368, 1277, 1078, 791, 756, 698 
HRMS m/z calculated for C13H17BrO [H+]: 269.0536 and 271.0515; found 269.0536 and 
271.0515 
 
General Procedure for Polar Chloroacetoxylation: 
 
 
 
Dichlorodimethyl hydantoin (DCDMH, 1.1 equiv, 108 mg) was weighed and dispensed into a 
flame-dried vial (1-dram) equipped with a stir bar and Teflon-coated septum cap.  The vial was 
moved to a nitrogen filled glovebox where solvent was dispensed by syringe (CHCl3 to 0.5 M). 
This was followed by the addition of 430 µL (15 equiv) of acetic acid, and 6 µL of 2,6-lutidine 
(0.1 equiv). Finally, 65 µL of trans-betamethyl styrene was added (single alkene isomer). The 
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vial was then sealed and removed from the glovebox and the reaction vial was sealed with 
electrical tape. The reaction was then heated at 40˚C with a heating block for 24 hrs. CHCl3 and 
acetic acid were then removed in vacuo and NMR analysis revealed the reaction had reached full 
conversion. The product was isolated on silica gel (20 mL dry silica, 2cm column, 10% 
EtOAc:Hexanes) as a mixture of diastereomers (80% yield, 2:1 dr).  
 
2-Chloro-1-phenylpropyl acetate: 
 
 
Analytical data for 2-chloro-1-phenylpropyl acetate:  
1H NMR (600 MHz, Chloroform-d) δ 7.39 – 7.31 (m, 10H-5 major, 5 minor), 5.91 (d, J = 5.2 
Hz, 1H-major), 5.79 (d, J = 7.6 Hz, 1H-minor), 4.33 – 4.24 (m, 2H-1 major, 1 minor), 2.15 (s, 
3H-major), 2.13 (s, 3H-minor), 1.47 (d, J = 6.7 Hz, 3H-major), 1.35 (d, J = 6.7 Hz, 3H-minor). 
13C NMR (151 MHz, CDCl3) δ 169.76 (minor), 169.73 (major), 137.01 (minor), 136.71 (major), 
128.73 (minor), 128.55 (major), 128.48 (minor), 128.30 (major), 127.29 (minor), 127.19 (major), 
79.11 (minor), 78.12 (major), 58.87 (major), 58.53 (minor), 21.33 (minor), 20.99 (major/minor), 
19.99 (major). 
IR (thin film cm-1): 2983, 1746, 1454, 1372, 1228, 1029, 758, 703, 623 
HRMS m/z calculated for C11H13ClO2 [H]+: 213.0677 and 215.0647; found: 213.0677 
 
  
Me
OAc
Cl
Me
OAc
Cl+
Major Minor
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Product identification: distinguishing regio- and diasteroisomers 
 
Distinguishing Regioisomers: 
 
Regioisomers of chlorofunctionalization could generally be distinguished by analysis of the 1H 
NMR. The 6-endo product was generated via reaction of the corresponding alkene with 
dichlorodimethylhydantoin. Comparing the two regioisomers shows Ha in the 6-endo product is 
further downfield than Ha in the 5-exo product. Hb in the 6-endo product is further upfield than 
Hb in the 5-exo product. The shifts of both Ha and Hb in each product match with the expected 
relative shifts. 
 
 
 
 
  
 
 
 
 
 
HSQC data could be used as further evidence of the regioselectivity of the reaction. Via HSQC 
correlation Ca and Cb could be assigned for each product. As expected Ca is further downfield in 
the 6-endo product, while Cb is further upfield.  
 
 
 
 
 
 
 
 
 
These analyses could be extrapolated to products 3.49-3.63 and 3.91. Analysis of HSQC data 
alone was sufficient for determining the regioisomer for products 3.65, 3.67, 3.84, and 3.85 (the 
relevant carbon shifts were more consistent with being adjacent to oxygen rather than a halogen).  
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1H and 13C spectra of products 3.87,10 3.8018 and 3.877 were compared to reported literature 
values of the corresponding regioisomers. These shifts were inconsistent with the reported values 
herein. This analysis could be further extrapolated to products 3.71-3.78. 
 
UV/vis Spectroscopy: 
 
UV/vis spectra were taken on a Hewlett-Packard 8453 Chemstation absorption spectrometer. 
[CuCl/Phen]2: A solution of [CuCl/Phen]2 was prepared by weighing equimolar amounts of 
CuCl and 1,10-phenanthroline into a vial (0.05 mmol). In a glovebox, 10 mL MeCN (N2 
sparged) was added to give a 5 x 10-3 M solution of the complex. 350µL of this solution was 
transferred to a 2-dram vial and then diluted to 3.5 mL total volume, giving a 5 x 10-4 M solution 
of [CuCl/Phen]2. 3mL of this solution was transferred to a quartz cuvette and a UV/vis spectrum 
was obtained. 
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CuCl2/Phen: A saturated solution of CuCl2/Phen was prepared by weighing equimolar amounts 
of CuCl2 and 1,10-phenanthroline into a vial (0.05 mmol). In a glovebox 10 mL MeCN (N2 
sparged) was added to give a saturated solution of unknown concentration of CuCl2/Phen (due to 
the low solubility of CuCl2/Phen). 350µL of this solution was transferred to a 2-dram vial and 
then diluted to 3.5 mL total solution volume of CuCl2/Phen. 3mL of this solution was transferred 
to a quartz cuvette and a UV/Vis spectrum was obtained. 
 
 
 
[CuCl/Phen]2 + NCP: To the cuvette containing [CuCl/Phen]2 discussed above, was added 1 
mL of 7.5 x 10-3 M solution of NCP in MeCN (5 equiv relative to Cu+). The solution 
immediately lost its orange color and became a light blue solution. Adjusted concentrations of 
Cu+ and NCP were 3.75 x 10-4 M and 1.875 x 10-3 M respectively. A UV/vis spectrum was 
recorded immediately after mixing the solution. 
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Solutions of [CuBr/Bpy]2, CuBr2/Bpy, and DEBM were made analogously to their counterparts 
as described above.  
 
UV/vis spectra were taken on a Hewlett-Packard 8453 Chemstation absorption spectrometer. 
[CuBr/Bpy]2: A solution of [CuBr/Bpy]2 was prepared by weighing equimolar amounts of CuBr 
and 2,2′-bipyridine into a vial (0.05 mmol). In a glovebox, 10 mL MeCN (N2 sparged) was added 
to give a 5 x 10-3 M solution of the complex. 350µL of this solution was transferred to a 2-dram 
vial and then diluted to 3.5 mL total volume, giving a 5 x 10-4 M solution of [CuBr/Bpy]2. 3mL 
of this solution was transferred to a quartz cuvette and a UV/vis spectrum was obtained. 
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CuBr2/Bpy: A saturated solution of CuBr2/Bpy was prepared by weighing equimolar amounts of 
CuBr2 and 2,2′-bipyridine into a vial (0.05 mmol). In a glovebox 10 mL MeCN (N2 sparged) was 
added to give a saturated solution of unknown concentration of CuBr2/Bpy (due to the low 
solubility of CuBr2/Bpy). 350µL of this solution was transferred to a 2-dram vial and then diluted 
to 3.5 mL total solution volume of CuBr2/Bpy. 3mL of this solution was transferred to a quartz 
cuvette and a UV/vis spectrum was obtained. 
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[CuBr/Bpy]2 + DEBM: To the cuvette containing [CuBr/Bpy]2 discussed above, was added 1 
mL of 7.5 x 10-3 M solution of DEBM in MeCN (5 equiv relative to Cu+). The solution 
immediately lost its orange color and became a light blue solution. Adjusted concentrations of 
Cu+ and DEBM were 3.75 x 10-4 M and 1.875 x 10-3 M respectively. A UV/Vis spectrum was 
recorded immediately after mixing the solution. 
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Upon the addition of the respective halogenating reagents to each Cu+ complex, the characteristic 
absorbance (439 nm for [CuCl/Phen]2 and 424 nm for [CuBr/Bpy]2) immediately disappeared. In 
both cases new features were observed which closely correspond with those observed in the 
UV/vis spectrum of the independently synthesized Cu2+ complexes. This is sufficient evidence to 
support the oxidation of the Cu+ metal center. Unfortunately, due to the very low solubility of 
both Cu2+ complexes quantitative data could not be recorded and the present data cannot be used 
to determine whether CuCl2/Phen or CuBr2/Bpy are the sole products of the oxidation. While at 
least some amount of Cu2+ does seem to be forming, it is still feasible that a Cu(III) intermediate 
could be formed under these conditions as well.  
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